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Abstract 
Background: Unhealthy lifestyle behaviours such as physical inactivity are global risk factors 
for chronic disease. Despite this, a substantial proportion of the UK population fail to achieve 
the recommended levels of physical activity. This may partly be because the health messages 
presently disseminated are not sufficiently potent to evoke behaviour change. There has been 
an exponential growth in the availability of digital health technologies within the consumer 
marketplace. This influx of technology has allowed people to self-monitor a plethora of health 
indices, such as their physical activity, in real-time. However, changing movement behaviours 
is difficult and often predicated on the assumption that individuals are willing to change their 
lifestyles today to reduce the risk of developing disease years or even decades later. One 
approach that may help overcome this challenge is to present physiological feedback in parallel 
with physical activity feedback. In combination, this approach may help people to observe the 
acute health benefits of being more physically active and subsequently translate that insight 
into a more physically active lifestyle. 
Aims: Study One aimed to review existing studies employing fMRI to examine neurological 
responses to health messages pertaining to physical activity, sedentary behaviour, smoking, 
diet and alcohol consumption to assess the capacity for fMRI to assist in evaluating health 
behaviours. Study Two aimed to use fMRI to evaluate physical activity, sedentary behaviour 
and glucose feedback obtained through wearable digital health technologies and to explore 
associations between activated brain regions and subsequent changes in behaviour. Study 
Three aimed to explore engagement of people at risk of type 2 diabetes using digital health 
technologies to monitor physical activity and glucose levels. 
Methods: Study One was a systematic review of published studies investigating health 
messages relating to physical activity, sedentary behaviour, diet, smoking or alcohol 
consumption using fMRI. Study Two asked adults aged 30-60 years to undergo fMRI whilst 
presented personalised feedback on their physical activity, sedentary behaviour and glucose 
levels, following a 14-day wear protocol of an accelerometer, inclinometer and flash glucose 
monitor. Study Three was a six-week, three-armed randomised feasibility trial for individuals 
at moderate-to-high risk of developing type 2 diabetes. The study used commercially available 
wearable physical activity (Fitbit Charge 2) and flash glucose (Freestyle Libre) technologies. 
Group 1 were offered glucose feedback for 4 weeks followed by glucose plus physical activity 
feedback for 2 weeks (G4GPA2). Group 2 were offered physical activity feedback for 4 weeks 
 ii 
 
followed by glucose plus physical activity feedback for 2 weeks (PA4GPA2). Group 3 were 
offered glucose plus physical activity feedback for six weeks (GPA6). The primary outcome 
for the study was engagement, measured objectively by time spent on the Fitbit app, LibreLink 
app (companion app for the Freestyle Libre) as well as the frequency of scanning the Freestyle 
Libre and syncing the Fitbit. 
Results: For Study One, 18 studies were included in the systematic review and of those, 15 
examined neurological responses to smoking related health messages. The remaining three 
studies examined health messages about diet (k=2) and physical activity (k=1). Areas of the 
prefrontal cortex and amygdala were most commonly activated with increased activation of the 
ventromedial prefrontal cortex predicting subsequent behaviour (e.g. smoking cessation). 
Study Two identified that presenting people with personalised feedback relating to interstitial 
glucose levels resulted in significantly more brain activation when compared with feedback on 
personalised movement behaviours (P<.001). Activations within regions of the prefrontal 
cortex were significantly greater for glucose feedback compared with feedback on personalised 
movement behaviours. Activation in the subgyral area was correlated with moderate-to-
vigorous physical activity at follow-up (r=.392, P=.043). In Study Three, time spent on the 
LibreLink app significantly reduced for G4GPA2 and GPA6 (week 1: 20.2±20 versus week 6: 
9.4±14.6min/day, p=.007) and significantly fewer glucose scans were recorded (week 1: 
9.2±5.1 versus week 6: 5.9±3.4 scans/day, p=.016). Similarly, Fitbit app usage significantly 
reduced (week 1: 7.1±3.8 versus week 6: 3.8±2.9min/day p=.003). The number of Fitbit syncs 
did not change significantly (week 1: 6.9±7.8 versus week 6: 6.5±10.2 syncs/day, p=.752). 
Conclusions:  
Study One highlighted the fact that thus far the field has focused on examining neurological 
responses to health messages using fMRI for smoking with important knowledge gaps in the 
neurological evaluation of health messages for other lifestyle behaviours. The prefrontal cortex 
and amygdala were most commonly activated in response to health messages. Using fMRI, 
Study Two was able to contribute to the knowledge gaps identified in Study One, with 
personalised glucose feedback resulting in a greater neurological response than personalised 
feedback on physical activity and sedentary behaviour. From this, Study Three found that 
individuals at risk of developing type 2 diabetes were able to engage with digital health 
technologies offering real-time feedback on behaviour and physiology, with engagement 
diminishing over time. Overall, this thesis demonstrates the potential for digital health 
technologies to play a key role in feedback paradigms relating to chronic disease prevention. 
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1.1. Introduction 
There is a global prevalence of physical inactivity and sedentary behaviour (Kohl et al., 2012; 
Lee et al., 2012). Daily exposure to hypokinetic and obesogenic environments are in part 
contributing to their prevalence and resultantly are putting the UK (and global) population at 
risk of developing chronic diseases such as type 2 diabetes, hypertension and cardiovascular 
disease (Cardinal, 2016; Hamilton et al., 2008; Perrin et al., 2016). So much so, physical 
inactivity has been labelled the biggest public health concern of the 21st century and has been 
incorporated into the World Health Organisation targets for 2020 (Blair, 2009; World Health 
Organization, 2013b). In addition, physical inactivity causes substantial economic burden 
globally (Ding et al., 2016) with an estimated cost of $53.8 billion imposed on healthcare 
systems (Ding et al., 2016) and burdening the UK £1 billion annually (Allender et al., 2007). 
Adults spend an estimated 55% of the waking day sedentary (Matthews et al., 2008) or, put 
another way, adults spend 78 days each year sitting (British Heart Foundation, 2017); in part 
attributable to the number of potential chair opportunities met within 24 hours (Hamilton et al., 
2008). In parallel, only 5% (Chaudhury & Esliger, 2008) or 13.5% of UK adults (Sport 
England, 2017) achieve the recommended physical activity guidelines. Therefore, more needs 
to be done to combat the prevalence of physical inactivity and sedentary behaviour (movement 
behaviours). A 2012 Lancet paper (Lee et al., 2012) acknowledged that adjusting population 
level rates of physical inactivity can deliver comparable global life expectancy benefits as to 
obesity (Olshansky et al., 2005) and smoking (National Research Council Committee on 
Population, 2011). This finding has added additional support (and urgency) to change 
movement behavioural patterns. Therefore, efforts to increase physical activity and minimise 
sedentary time to help counteract the continuing incidence of disease incidence are crucial 
moving forward.  
Physical inactivity and sedentary behaviour are independent movement behaviours, yet they 
can (and often do) co-exist within each 24-hour period. This means that individuals can be 
highly sedentary, for instance by having an office-based job, yet be physically active, by 
achieving the weekly physical activity recommendations. Studies to date have investigated the 
health benefits of interrupting prolonged sedentary time with brief bouts of physical activity 
and observed promising results (e.g. Buman et al., 2014; Healy et al., 2015). However, the ill-
effects of negative lifestyle behaviours (such as physical inactivity or prolonged sitting) are 
only perceived to impact us decades down the line. Therefore, it is a substantial and often 
overwhelming challenge to encourage people to act today to prevent the onset of chronic 
Introduction 
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disease years or even decades later. One way that might overcome this aligns well with 
continuing advancements in technologies that deliver personalised feedback. Behavioural 
monitoring technologies often present step count, laps swam, distance ran and, more recently, 
sitting time whilst physiological monitoring technologies can deliver feedback relating to heart 
rate, blood pressure and glucose levels. Delivering physiological and behavioural feedback 
may be one approach to help guide individuals to observe the acute benefits of positive 
behavioural decisions. 
Efforts to date have included population-level and individual-level (personalised) health 
messages to inform and encourage individuals to be more physically active. Health messages 
are often targeted to specific audiences (Latimer et al., 2010); for instance, health messages can 
be positioned at specific locations to deliver point-of-decision prompts to help nudge 
individuals toward making positive choices. This could involve positioning health messages to 
encourage individuals to use the stairs rather than the escalator and have demonstrated short-
term promise (Webb & Eves, 2005). The method of dissemination or communication is crucial 
to determine the level of effectiveness and this can be done using subjective and objective tools 
to observe impact on behaviour change. Additional efforts to explore the delivery of individual-
level health messages via personalised feedback are also warranted. 
A growing marketplace is for digital health technologies which has seen an influx of consumer 
interest. These technologies aim to provide personalised, real-time feedback via wearable 
devices worn at variable body positions and/or smartphone apps. With technological 
advancements increasing capability to more accurately detect movement (and physiology) and 
immediate data presentation, it is becoming more feasible to reveal feedback ‘at-a-glance’. One 
example would be within diabetes management, whereby individuals can receive real-time 
insight into their glucose levels via a continuous glucose monitor (Wagner et al., 2012). This 
technology hopes to minimise the occurrence of hypo- and hyper-glycaemic events and so 
improve individual adherence to maintaining good glucose regulation. To date, available 
technologies deliver step count, distance travelled, floors climbed, laps swam, estimated caloric 
expenditure and heart rate (Sanders et al., 2016). In combination with other physiological 
technologies, such as continuous glucose monitors, the prospect of delivering behavioural and 
physiological feedback in parallel is emerging. With individuals able to access feedback about 
their behaviour and health at their fingertips, the opportunity to observe this relationship in 
action may help guide individuals to make better immediate decisions. This would be on the 
basis that individuals are able to view the acute physiological benefit of a positive behavioural 
Introduction 
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decision using the personalised feedback displayed. However, it will be crucial to recognise 
how individuals receive (or absorb) the data and observe what challenges may be faced during 
use. 
There are many challenges to delivering optimal feedback to individuals. Referring back to 
diabetes management, it is well acknowledged that the value assigned to a technology is highly 
dependent on the user having sufficient levels of literacy, education and motivation 
(International Diabetes Federation, 2009). For instance, individuals living with diabetes may 
be provided with a continuous glucose monitor but if they do not have sufficient levels of 
education to understand what the information means, they are very unlikely to benefit from 
accessing the information it provides. This aligns well with the need to graphically display 
information in a way that is informative and motivational to the user (Western et al., 2015). 
When exactly feedback should be delivered is another challenge given that it is not always 
appropriate for behaviour change. Sending insightful feedback at times when positive 
behaviours can occur would be ideal (and is increasingly available given advances in context-
based technologies i.e. Loveday et al., 2016). Digital technologies can help disrupt undesirable 
habits (Hermsen et al., 2016) but current evidence remains inconclusive as to whether these 
habitual changes are sustained. Maintaining use beyond the honeymoon period, which is 
generally within six months for the majority of users (Ledger et al., 2014), is crucial to prevent 
devices from being placed in the sock drawer, never to be worn again. With a view to sustain 
technology use, efforts to revamp or identify how users engage (or interact) with these 
technologies may help sustain use. Approaches to deliver more persuasive (or potent) feedback 
are needed and it may be sensical to increase feedback resonance by making the behavioural 
feedback tie into its physiological consequence.  
The aim of this thesis was to assess how people responded to information presented via digital 
health technologies and to observe whether people would change movement behaviours 
(physical activity) when presented behavioural and physiological feedback in parallel. More 
specifically, Study One provides a review of published research using functional magnetic 
resonance imaging (fMRI) to assess how people’s brains respond to health messages about key 
lifestyle behaviours. Study Two targeted a research gap within fMRI to assess people’s neural 
responses to personalised health messages relating to physical activity, sedentary behaviour 
and glucose levels. Study Three intervened on individuals identified at risk of developing type 
2 diabetes. The six-week intervention involved two novel digital health technologies that 
presented real-time physiological and behavioural feedback.
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1.2. Literature Review 
1.2.1. Communicable and non-communicable diseases 
Transition from communicable disease to non-communicable diseases 
In the past century, the major cause of mortality has shifted from communicable diseases 
toward non-communicable diseases (NCDs). The term NCDs has been used since the first 
Global Burden of Disease study in 1990, alongside infectious (communicable) diseases and 
injuries (Murray et al., 1994). However, recommendations confirm the need to reframe NCDs 
to void the inclusion of “non” (which can promote confusion) and promote a sense of urgency 
(Allen & Feigl, 2017). Therefore, NCDs will hereon be referred to as chronic diseases. Chronic 
diseases or long-term diseases are a leading cause of adult mortality worldwide (World Health 
Organization, 2002), with 68% of 56 million cases accounted for by chronic diseases (World 
Health Organization, 2014). Many of these deaths, increasing by 14.1% from 2005 to 2015, 
are attributed to cardiovascular disease (in particular coronary heart disease and stroke), cancer, 
respiratory disease and diabetes (Global Burden of Disease, 2016) (Figure 1.1). The total 
number of mortality cases exceeds the number of deaths (14.4 million) attributed to infectious 
disease recorded in 1990 (Murray & Lopez, 1997b). Communicable diseases (such as cholera 
and chickenpox) were transmitted from one individual to another via bodily fluids, direct 
physical contact or were airborne; affecting many individuals. Similarly, chronic diseases 
affect people across all income groups and put men, women and children at risk in developed 
and developing countries (World Health Organization, 2005). The Chief Knowledge Officer to 
the National Health Service (NHS), Sir Muir Gray, outlined that chronic diseases occur because 
of unhealthy environments or unhealthy lifestyles with extended exposure likely resulting in 
disease later in life (Gray, 2015). With the rapid pace of globalisation (Beaglehole & Yach, 
2003; Reubi, 2016), it is increasingly important to consider the widespread presence of chronic 
diseases. Projections estimate that mortality attributable to chronic disease will increase to 49.7 
million cases in 2020 from 28.1 million in 1990 (Murray & Lopez, 1997a) or from 59% in 
2002 to 69% in 2030 (Mathers & Loncar, 2006). Consequently, it is important to consider how 
targeted efforts can be made to challenge the increasing prevalence of chronic disease and, in 
the process, contribute to improvements in life expectancy and quality of life. 
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Figure 1.1. Proportion of deaths attributable to chronic diseases adapted from World Health 
Organization, 2014 
Clinical forms of chronic disease 
Cardiovascular diseases are ranked as the leading cause of mortality globally (Bauer et al., 
2014) with approximately 17 million deaths recorded annually (World Health Organization, 
2011a). Of these mortality cases, 42% were attributed to coronary heart disease. Coronary heart 
disease, resulting in a blockage to the heart’s blood supply or an excessive accumulation of 
plaque, is a leading UK public health concern that costs the NHS £1.73 billion annually (Liu 
et al., 2002). The chronic condition generally affects men more frequently than women (11% 
versus 25%) as men demonstrate fewer favourable behaviours (e.g. energy intake, physical 
activity and non-smoking) and health factors (e.g. optimal blood lipids, blood pressure and 
glucose levels) (Mozaffarian et al., 2015). Given similarities between the UK and America, the 
prevalence of coronary heart disease will likely be comparable. Annually, more than 600,000 
Americans experience a new coronary attack and more than 300,000 people experience a 
recurrent attack; demonstrating the importance of reducing its prevalence. With only 18% of 
Americans presenting at least five favourable cardiovascular health factors and benefits, it may 
come as no surprise that one in seven deaths were attributed to coronary heart disease in 2011 
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(Mozaffarian et al., 2015). Hypertension, or elevated blood pressure, has been attributed to 
45% of coronary heart disease mortality cases. From 1990 to 2015, rates of elevated systolic 
blood pressure (and their estimated associated deaths) have substantially increased based on 
844 studies across 154 countries (Forouzanfar et al., 2017). Hypertension is considered one of 
the most commonly treated conditions in the UK; affecting 26% and 31% of women and men, 
respectively (Health Survey for England, 2016). Hypertension has been identified as a leading 
risk factor that is attributable to 7% (6.2-7.7%) of global disease burden (Lim et al., 2013). 
Diabetes (or diabetes mellitus) is one of four priority chronic diseases targeted for action 
(World Health Organisation, 2016). People living with diabetes are generally unable to 
adequately absorb glucose. This physiological restriction prevents circulating levels of glucose 
from freely entering appropriate sites (e.g. muscle tissue). Despite attributed to fewer deaths 
(i.e. 8.4% of all deaths for adults aged 20-79 years [International Diabetes Federation, 2013]), 
diabetes is one of the most prevalent chronic diseases. The global prevalence of diabetes has 
quadrupled between 1980 and 2014 with 382 million (8.3% of the world’s population) 
diagnosed (International Diabetes Federation, 2013). Moreover, this number is expected to rise 
further to 592 million by 2035 (Guariguata et al., 2014). In the UK, there are approximately 
3.2 million people living with diabetes (Health and Social Care Information Centre, 2013) at 
an estimated cost of £9.8 billion annually (Hex et al., 2012). There is also a large proportion of 
individuals (projected to be 174.8 million) who are living with undiagnosed diabetes (Beagley 
et al., 2014) who collectively account for 46% of current prevalence statistics (International 
Diabetes Federation, 2013). Approximately one quarter of American adults are living with 
undiagnosed diabetes (Menke et al., 2015). Type 2 diabetes frequently goes undiagnosed 
because of its gradual development and often the lack of immediate symptom manifestation, 
which leaves individuals unaware until classic symptoms present. The number of expected 
deaths aligned to the complications of diabetes is expected to double from 2005 to 2030 and 
an increased presence of diabetes complications occurring in adults aged 45-64 years (Gregg 
et al., 2016); requiring effective global action to halt the rise in diabetes prevalence (World 
Health Organisation, 2013). As a result, it is highly important to target efforts toward the 
prevention of diabetes.  
Diabetes presents in one of three forms: type 1, type 2 or gestational with each presenting their 
own complications and negative health outcomes. However, due to sophisticated laboratory 
testing equipment, separate global prevalence statistics are unavailable (World Health 
Organisation, 2016). Briefly, type 1 diabetes has an unknown exact cause but is characterised 
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by insufficient insulin production and occurs most often in children and adolescents. Type 2 
diabetes is often attributed to an interplay between metabolic and genetic factors and is 
characterised by inefficient use of insulin produced by the body. In comparison, gestational 
diabetes is temporary (occurs during pregnancy) and is associated with several factors, 
including but not limited to age, weight status and family history (World Health Organisation, 
2016). Type 2 diabetes is most common accounting for approximately 90-95% of all diabetes 
cases (International Diabetes Federation, 2013). Consequently, as alluded to by Barry and 
colleagues (Barry et al., 2017), the management and prevention of type 2 diabetes has 
international priority moving forward. 
Preclinical forms of chronic disease 
Preventing the onset of chronic diseases is crucial and may in part be supported by recognising 
how lifestyle behaviours contribute. With projections estimating an increasing prevalence of 
chronic disease, efforts to identify individuals at risk of chronic disease is paramount. 
Individuals at high risk of developing diabetes (i.e. presenting the early stages of impaired 
insulin sensitivity and insulin resistance) represent an important target cohort for disease 
prevention (Soliman et al., 2014). Impaired glucose tolerance and impaired fasting glucose are 
the two forms of prediabetes with individuals exhibiting impaired glucose tolerance more likely 
to develop diabetes earlier compared with those living with impaired fasting glucose. From 
2003 to 2011, prevalence of prediabetes increased from 11.6% to 35.3% in UK adults aged ≥16 
years old (Mainous et al., 2014) and thus there is an impending influx who are likely to develop 
type 2 diabetes in the coming years unless early efforts to intervene are employed. Left 
undetected, an estimated 5-10% of people living with undiagnosed pre-diabetes progress 
annually onto type 2 diabetes (Bansal, 2015). Therefore, early detection of levels indicative of 
prediabetes is pivotal as it poses a negating effect on several human, social, medical and 
economical factors (Soliman et al., 2014). Prevention of chronic disease is also crucial in 
individuals living with multiple chronic diseases (i.e. comorbidities) with hypertension and 
diabetes in combination resulting in a magnitude of negative health issues. More specifically, 
having hypertension, a high body mass index, high glucose levels and/or high cholesterol 
resulted in 10.8 million deaths in a single year (Danaei et al., 2014). Clustering of risk factors 
can result in a diagnosis of metabolic syndrome. Metabolic syndrome is an important cluster 
of heart disease risk factors and has a 33% prevalence in US adults (Aguilar et al., 2015).  
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Screening and treatment for type 2 diabetes prevention 
Barry and colleagues outlined two strategies to help identify people living with prediabetes; 
namely, screen and treat and population-wide approaches (Barry et al., 2017). Population-wide 
approaches involve the wide dissemination of materials to inform individuals about public 
health opportunities to positively change behaviour, by encouraging access to green spaces 
(e.g. walking at the local park) and transport (e.g. active commute). This far-reaching approach 
contrasts with screen and treat. Screen and treat initiatives generally assess fasting plasma 
glucose, glycated haemoglobin (HbA1c) or involve an oral glucose tolerance test. Each test is 
conducted by a healthcare professional with results compared to a threshold. For instance, 
prediabetes using HbA1c as the blood marker is classified as 5.7-6.4% by the American 
Diabetes Association (American Diabetes Association, 2015) or as 6-6.4% by the National 
Institute for Health and Clinical Excellence (National Institute for Health and Clinical 
Excellence, 2012). Accurately identifying individuals living with prediabetes is an imperative 
step for the identification of who best to intervene on. Alternative approaches can incorporate 
risk assessment surveys to capture a predicted level of risk. For instance, Gray and colleagues 
produced a Leicester Risk Assessment tool to identify those at high risk of impaired glucose 
regulation and type 2 diabetes (Gray et al., 2010). It involves individuals responding to 
questions about their age, ethnicity, gender, family history of diabetes, diagnosis of 
hypertension, waist circumference and body mass index. Asking individuals to accurately 
reveal their current waist circumference and/or body mass index may be unrealistic. However, 
these tools are enticing to use given their minimal cost (and burden) and they can help support 
the early detection of cases before complications arise (Harris et al., 2003). Therefore, these 
tools are more practical for population level screening efforts (Gray et al., 2010). In light of 
evidence relating to pre-diabetes, the four major risk factors identified for the development of 
chronic disease are tobacco use, alcohol consumption, poor dietary intake and physical 
inactivity (World Health Organization, 2015). An additional, emerging risk factor is the 
prevalence of time spent sedentary (Hamilton et al., 2016). 
1.2.2. Lifestyle Risk Factors for Chronic Diseases 
Physical Inactivity 
Physical activity is a complex, multi-dimensional behaviour that varies according to the 
duration, regularity and intensity (i.e. light, moderate, vigorous, or a combination thereof) 
(Marschollek, 2013). Caspersen and colleagues defined activity as ‘any bodily movement 
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produced by skeletal muscle that results in energy expenditure’ (Caspersen et al., 1985). A 
consensus was published in 2017 to help clarify differences (and encourage consistent 
terminology) between the various movement behaviours (Tremblay et al., 2017). Physical 
activity varies by intensity with vigorous intensity physical activity positioned at the higher 
end of energy expenditure in the movement continuum (Tremblay et al., 2010). Energy 
expenditure can be quantified by using metabolic equivalents of task (METS) and this indicator 
of intensity has been used to classify METS values to activities of daily living for adults aged 
18-65 years (Ainsworth et al., 2011). This compendium was produced to help increase 
transparency and comparability of physical activities completed across studies using self-report 
methods.  
Physical inactivity, in comparison, denotes individuals who do not achieve the recommended 
levels of physical activity. Current UK guidelines endorsed by the Chief Medical Officer were 
published in 2011 and segmented according to age; releasing guidance for early years (<5 
years), children and young people (5-18 years old), adults (19-64 years old) and older adults 
(≥65 year olds) (UK Department of Health, 2011). These age-specific guidelines recommend 
that adults aged 19-64 years accumulate ≥150 minutes of moderate-to-vigorous intensity 
physical activity in continuous bouts of ≥10 minutes (or 75 minutes of vigorous physical 
activity weekly, or a combination thereof) per week (UK Department of Health, 2011). A 
national survey conducted in England demonstrated that only 6% and 4% of UK men and 
women (Chaudhury et al., 2008) or 13.5% of UK adults (Sport England, 2017) achieved the 
recommended levels of physical activity using objective tools. Similarly, Troiano and 
colleagues outlined that fewer than 5% of US adults obtain sufficient levels of physical activity 
using data from the 2003-2004 National Health and Nutritional Examination Survey 
(NHANES) (Troiano et al., 2008). These objectively measured cohort findings differ largely 
to physical activity levels quantified via questionnaires. For instance, the Health Survey for 
England (HSE) survey also captured self-reported levels of physical activity and observed that 
39% and 29% of men and women, respectively, achieved the recommendations (Chaudhury et 
al., 2008). This discrepancy is likely attributable to the limitations related to self-reported 
approaches of data collection (e.g. social desirability bias) (Sallis & Saelens, 2000). In parallel 
with high levels of inactivity across the adult population, demographic variations are also 
observed with females and older people achieving greater levels of physical inactivity (Hallal 
et al., 2012). Findings from the UK Biobank study in over 100,000 participants support this by 
outlining an age-related decline of around 7.5% per decade in physical activity from those aged 
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45-54 to 75-79 years (Doherty et al., 2017). In addition, seminal research conducted in the 
1950’s (Morris et al., 1953) and the 1970’s (Paffenbarger et al., 1970) highlighted significant 
occupational differences in physical activity levels and associated ill-effects on health 
outcomes. The authors identified that individuals who were least active during working hours 
exhibited an elevated risk for myocardial infarction and the development of atherosclerosis 
(Paffenbarger et al., 1970). Given its position as the fourth leading cause of death worldwide 
(Kohl et al., 2012) and being attributed to 9% of premature mortality cases worldwide (Lee et 
al., 2012). Overall, efforts to eliminate the prevalence of physical inactivity would have a 
significant impact by helping increase the world population’s life expectancy by 0.68 years 
(Lee et al., 2012). 
Estimating levels of physical activity using self-report methods is frequently employed with 
the distribution of questionnaires common. Self-report tools can provide valuable information 
pertaining to the context of activity completed. For instance, questionnaires can identify the 
type of activity carried out (e.g. cycling, swimming or walking). In addition, they are also able 
to collect environmental and psychosocial information, perceived time and intensity as well as 
the purpose of the activity completed (Troiano et al., 2014). However, as previously outlined, 
these methods can often reveal inaccurate data at an individual level (e.g. Chaudhury & Esliger, 
2008). Within the HSE data, it must be acknowledged that the self-reported and objective data 
were not collected at an identical timepoint; however, the results are unlikely to be too 
dissimilar from usual behaviour and thus highlights a clear discrepancy between the two data 
sources. These differences may in part be attributed to participants offering socially-desirable 
responses (Sallis et al., 2000) by feeling inclined to overestimate time spent doing physical 
activity (Klesges et al., 1990). These inaccuracies may be minimised by shortening the recall 
period. For instance, having shortened the recall period to 24 hours, responses were within 3-
10% of the doubly labelled water measures and within 1-3% of objectively measured activity 
and sedentary time (Matthews et al., 2017). Another limitation to self-reported tools eludes to 
participant capability to stating their accumulation of activity in bouts of ≥10 minutes, which 
can be difficult to recall. Despite these limitations, many large epidemiological studies employ 
a combination of self-reported tools and accelerometers (such as Doherty et al., 2017) to 
capture a comprehensive overview of participants’ physical activity levels. 
Using objective measurement tools to capture a more accurate assessment of physical activity 
are evermore important for population level physical activity surveillance programmes 
(Bauman et al., 2016). Objective tools are largely small, non-invasive and minimally intrusive 
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and worn during free-living settings (Chen & Bassett, 2005). With advancing sophistication of 
technology, objective tools (such as accelerometers) are becoming increasingly deployed in 
large physical activity epidemiological studies such as UK Biobank (Doherty et al., 2017). To 
date, these devices have been commonly used to monitor and quantify behaviour patterns (Allet 
et al., 2010) having been deployed to the waist and interpreted using cut-points (thresholds) to 
interpret movement intensity (e.g. Freedson et al., 1998). Accelerometers are now widely used 
to characterise physical activity (e.g. Troiano et al., 2014) and, when compared with self-report 
tools, accelerometers provide a direct assessment of physical activity (Prince et al., 2008). They 
provide a more comprehensive profile of physical activity, beyond the traditional step count 
delivered by pedometers (Bauman et al., 2016). However, accelerometers do have their 
limitations. 
For instance, there is often a lack in consistency when reporting accelerometer data; in 
particular the methods used to clean and process data which limits transparency between 
studies (Esliger et al., 2005). In addition, differing device models and cut points limits the 
opportunity to compare estimates of national levels of physical activity over time (Bauman et 
al., 2016). Another limitation relates to device wear or compliance. Data from 2003-2004 
NHANES, recorded that 60-86% of adults aged ≥20 years provided ≥4 valid days of 
accelerometer wear (Troiano et al., 2008). In an effort to improve compliance to device wear, 
and capture the full 24-hour period, many large epidemiological studies have started to deploy 
accelerometers at the wrist. For instance, UK Biobank demonstrated that 81% of participants 
wore the device for ≥150 hours of a possible 168 hours (and observed minimal differences 
between males and females (Doherty et al., 2017). Consequently, wrist-worn deployment may 
become the favoured approach with ongoing development and support for established 
thresholds. Emerging analytical techniques are beginning to provide more sensitive 
information about physical activity (Clark et al., 2017). Efforts to improve the quantification 
and characterisation of movement behaviours is crucial given that behaviours such as physical 
activity are multi-faceted. 
Sedentary Behaviour 
Sedentary behaviour is an independent construct to physical inactivity and has been gaining 
increasing recognition given its ubiquitous nature in modern society. Individuals can be both 
highly sedentary and physically active and these individuals have been called ‘active coach 
potatoes’ (Healy et al., 2008). Therefore, emphasising the difference between these two 
movement behaviours is crucial moving forward. Sedentary behaviour has been defined as ‘any 
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waking behaviour done while lying, reclining, sitting, or standing, with no ambulation, 
irrespective of energy expenditure’ (Tremblay et al., 2017) and is positioned toward the lower 
end of energy expenditure (Tremblay et al., 2010). Common sedentary postures include sitting, 
lying and reclining (aligning with its translation; ‘sedere’ meaning to sit) (see Figure 1.2). 
Similarly to physical activity, UK guidelines have been produced for sedentary behaviour, 
which recommend adults to minimise time spent sedentary (Department of Health, 2011). 
Despite the fundamental role of human evolution and the need to move, data from the 2003-
2004 NHANES survey identified that adults alarmingly spend 55% of their waking day 
sedentary (Matthews et al., 2008). Spending as much time as a whole working day seated offers 
deleterious effects at a population level and also compromises metabolic health (Healy et al., 
2008). Knowing how a person accumulates sedentary behaviour and their physical activity 
status is important for their interaction with all-cause mortality. 
An important question is whether sedentary behaviour has an association with health, 
independent of physical activity. Ekelund and colleagues published a harmonised meta-
analysis of 16 studies observing associations between all-cause mortality and sitting time 
(Ekelund et al., 2016). In total, participants were followed up at 2-18.1 years and over 84,000 
deaths were noted. Findings demonstrated that daily sitting was not associated with all-cause 
mortality in individuals identified as being in the most active physical activity quartile. 
Furthermore, individuals in the two lowest physical activity quartiles observed greater 
mortality rates (12-59%) than those who accumulated <4 hours/day and >35.5 MET-hr/week. 
However, when physical activity was at its highest (>35.5 MET-hr/week), individuals sitting 
<4 hour/day and >8 hour/day observed no increased risk of mortality (HR=1.04, CI95% 0.99-
1.10) during follow up. This suggests that having a physically active lifestyle overrides the 
potential ill-health effects of being sedentary daily. This meta-analysis concludes that moderate 
intensity activities eliminate the risk of death but only attenuates risk of death for high levels 
of time spent watching television. In contrast, Katzmarzyk and colleagues demonstrated a dose-
response association between siting time and all-cause and cardiovascular disease mortality, 
independent of leisure time physical activity (Katzmarzyk et al., 2009). This study requested 
participants to evaluate daily sitting time as ‘almost none of the time’ extending to ‘almost 
most of the time’, which limited their ability to offer a magnitude of time spent sedentary, but 
they concluded the need to minimise sedentary time. Overall, the notions of ‘even a little is 
good, more is better’ or ‘something is better than nothing’ could be applied to physical activity 
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guidance and ‘sit less, move more’ applies to sedentary behaviour (Blair et al., 1992; Lee, 
2007). 
Self-reported tools are also frequently used in sedentary behaviour research. In consideration 
of the hypokinetic society that we live in, and with a continual presence of labour-saving 
technology, sedentary pursuits such as television viewing, computer use and car-based 
commuting are increasingly familiar (Owen et al., 2010). Time spent watching the television 
has been widely used as an indicator of time spent sedentary during leisure time given that 
people are most often seated whilst watching a programme and it is a hugely popular sedentary 
pursuit (Dunstan et al., 2007; Hu et al., 2003). However, with an ever-increasing prevalence of 
emerging technologies at home, in the workplace and within the community, television viewing 
is no longer a good proxy of sedentary behaviour. As a result, it is crucial to begin designing 
questionnaires that can distinguish between different sedentary pursuits. For instance, screen 
versus non-screen sedentary time is one approach (Tremblay et al., 2017) and this could be 
further divided into time whilst using different screen-based devices such as tablets, laptops 
and smartphones (Stamatakis et al., 2013). A review conducted in 2017 identified interventions 
using digital tools to reduce sedentary time and observed that computer based mobile and 
wearable technologies appear promising (Stephenson et al., 2017). This emphasises the need 
to accurately capture sedentary time whilst using these technologies. Difficulties with this 
approach relate to the potential for over-reported time spent sedentary given that these 
sedentary pursuits can co-exist simultaneously (e.g. watching television whilst using a 
smartphone). Therefore, efforts are needed to help minimise this outcome. Identifying the 
specific domain of sedentary behaviour may help by requesting time within specific domains 
such as at work, during leisure time and whilst travelling (Marshall et al., 2010). However, 
similarly to physical activity measurement, it may be worthwhile investigating what objective 
tools are available. 
Objective measurement tools to quantify sedentary behaviour vary given that posture rather 
than intensity is the primary component. Comparable to accelerometers, inclinometers are often 
small and lightweight in design. To date, many studies have used accelerometers to measure 
sedentary behaviour but they have been unable to distinguish between postures such as standing 
and sitting (Atkin et al., 2012). The consensus now confirms that sedentary behaviour measured 
using accelerometry should refer to stationary time given these devices are unable to determine 
posture, only intensity of movement (Tremblay et al., 2017). Inclinometers distinguish between 
different postures because of placement and tilt which helps identify interruptions or breaks in 
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time spent sedentary (Tremblay et al., 2017). In an effort to better quantify sedentary behaviour, 
inclinometers are becoming more abundant (e.g. ActivPAL) with acceleration and the angle of 
the thigh measured (Bassett et al., 2014). Similarly to accelerometers, recommendations 
suggest the deployment of inclinometers for ≥7 days and elude to 24-hour wear (Edwardson et 
al., 2016). Fewer models of inclinometer-based devices were available compared with 
accelerometers which has limited the quantity of free-living validation papers (Atkin et al., 
2012). However, inclinometers and accelerometers are now being incorporated into single 
devices to help quantify both movement behaviours. These advancements in objective 
measurement tools highlight that they are increasingly able to accurately quantify movement 
behaviours (see Figure 1.2) in parallel to supplementary information gleaned from self-report 
tools. 
 
Figure 1.2. A framework of movement behaviours, adapted from Tremblay et al., 2017 
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Behavioural associations with chronic diseases 
Physical activity associations with chronic disease 
Strong evidence published in the 1990’s suggested that physical activity was a significant factor 
in health promotion and disease prevention (Bouchard et al., 1993). This paper was further 
supported when physical activity was demonstrated to offer protection against incidents of 
coronary heart disease, hypertension, type 2 diabetes and result in improvements to insulin 
sensitivity (Shephard 1995). Physical activity toward the higher intensity end of the movement 
continuum has been shown to reduce resting blood pressure in normotensives, borderline 
hypertensives and hypertensives (Fagard & Tipton, 1994). Research conducted more recently 
continues to offer support that people achieving the minimum levels of physical activity are 
protected against hypertension (White et al., 2015), type 2 diabetes, cancer and cardiovascular 
disease (Warburton et al., 2006). The 2005-2006 NHANES data observed that physical activity 
was negatively associated with the metabolic syndrome and the major risk factors for chronic 
disease (Camhi et al., 2010). More specifically, with each additional 30 minutes of daily 
activity completed, 15% reductions to risk of developing metabolic syndrome were recorded 
(Camhi et al., 2010). The most compelling series of papers highlighting the associations of 
physical activity and chronic disease has to be the Lancet series published in 2012. Forming 
part of this collection of papers, Lee and colleagues revealed that physical inactivity was 
attributed to 6-10% of major chronic diseases including colon and breast cancer, coronary heart 
disease and type 2 diabetes worldwide (Lee et al., 2012). The paper also confirms that physical 
inactivity elucidates a similar effect to the ill-effects of tobacco consumption (National 
Research Council, 2011) and obesity (Olshansky et al., 2005). These findings were compelling 
and has provided momentum by increasing recognition toward physical inactivity as a major 
risk factor. Efforts must be made to better understand the reasons why physical activity can 
protect against the development of several chronic diseases. 
Sedentary behaviour associations with chronic disease 
An increasing body of epidemiological evidence suggests that sedentary behaviour is strongly 
associated with a number of adverse health outcomes (Katzmarzyk, 2010; Owen et al., 2010). 
To date, sedentary behaviour has been associated with metabolic syndrome (Healy et al., 2008), 
obesity (Jakes et al., 2003; Salmon et al., 2000), cardiovascular risk factors (Jakes et al., 2003; 
Thorp et al., 2010) and cardiovascular disease (Dunstan et al., 2010; Owen et al., 2010). 
Wijndaele and colleagues illustrated similar findings, having associated television viewing 
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with cardiovascular mortality with a hazard ratio of 1.08 over nine years (Wijndaele et al., 
2011). The Nurse’s Health Study identified that the relative risk for obesity and type 2 diabetes 
were 1.94 and 1.70, respectively, in those watching ≤40 hours/week compared with those only 
watching ≤1 hour/week of television (Hu et al., 2003). In contrast, findings from the Whitehall 
II cohort study described limited evidence linking incident diabetes with sitting time over 13 
years (Stamatakis et al., 2017). These studies are in part limited by their employment of self-
report tools to report sitting time. As previously outlined, using television as a proxy indicator 
for sedentary behaviour has been frequently used. Some literature, on the other hand, have 
focused on other domain-specific tools. When investigating time spent driving and during 
computer use, those in the upper quartile of time spent sedentary having a relative risk of 1.48 
for developing incident hypertension (Beunza et al., 2007). Furthermore, as part of the Canada 
Fitness Survey consisting of 17,000 men and women, a clear dose-response relationship 
between sitting time and cardiovascular disease mortality was recorded, even after accounting 
for activity status and gender (Katzmarzyk et al., 2009). Despite offering context of movement 
behaviour, objective tools also reveal similar outcomes by associations with cardiovascular risk 
factors (Katzmarzyk, 2010) and cluster scores for metabolic risk factors (Healy et al., 2008) 
observed. An increasing number of smaller, empirical studies have been published that reveal 
the ill-effects of accumulating more sedentary time, with increases in cardiometabolic risk 
observed. However, no evidence supported mediation by change in waist circumference or 
BMI whereas larger reductions in waist circumference were associated with moderate-to-
vigorous physical activity (Wijndaele et al., 2014). Therefore, to optimise prevention of chronic 
disease at a population level, it would be beneficial to target both the attainment of sufficient 
levels of physical activity and minimisation of prolonged sedentary behaviour in parallel. 
Changing physical activity and sedentary behaviour to benefit health 
Aforementioned evidence confirms that having greater levels of physical activity and reducing 
time spent sedentary (whether objectively or subjectively measured) can positively influence 
physiological markers. Given that lower activity levels have been associated with more 
abnormal blood glucose levels (Mainous et al., 2017), emphasising how people can achieve 
physiological benefits may be crucial. A Danish study observed that when healthy, active men 
reduced their ambulatory daily step count from 10,501 to 1,344 over a period of two weeks, 
impairments in metabolic markers (such as peripheral insulin sensitivity) were revealed 
(Krogh-Madsen et al., 2010). Similarly, asking participants to reduce their levels of physical 
activity to <5,000 steps over three days revealed reductions in cardiometabolic fitness (Mikus 
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et al., 2012). Another, albeit older, study demonstrated that differences between endurance 
runners and sedentary individuals for insulin sensitivity can be eliminated following 38-48 
hours of exercise cessation (Burstein et al., 1985). In combination, these findings highlight that 
acute behavioural changes (over the course of several days) can have a marked effect on 
physiological mechanisms. 
Similarly, marked effects on physiological outcomes have been observed when sedentary time 
has been investigated. Most often conducted in laboratory settings, empirical studies have 
deployed continuous glucose monitors (outlined in the next section) (DiPietro et al., 2013; 
Harris, 2001) and conducted frequent venous blood sampling (Dunstan et al., 2012; Peddie et 
al., 2013). Interestingly, these studies investigated the metabolic consequence of sitting (such 
as postprandial glucose and/or insulin) and imparted several conditions on participants. For 
instance, Dunstan and colleagues asked participants to undergo: (i) uninterrupted sitting, (ii) 
sitting with light-intensity walking and (iii) sitting with moderate-intensity (Dunstan et al., 
2012). As outlined in Figure 1.3, the interrupted conditions had participants doing two minute 
bouts of continuous walking at 20-minute intervals over the course of the observation period. 
Their findings revealed lowered postprandial glucose and insulin levels within the interrupted 
sitting conditions. Other studies have found similar findings with regular, brief activity breaks 
reducing postprandial levels in normal weight (Peddie et al., 2013) as well as overweight and 
obese adults (Dunstan et al., 2012). However, there is a need to extend the exposure time 
beyond distinct days in a laboratory. Other studies have deployed monitoring devices over 
periods extending up to 48 hours (DiPietro et al., 2013; Harris, 2001). Another implication to 
this can be that individuals compensate their behaviours such that regularly interrupting 
sedentary behaviour during the working day may result in reductions to activity and/or 
increases in sitting time after work (Mansoubi et al., 2016). On the other hand, one hour of 
physical activity does not overcome the negative effect of physical inactivity if the rest of the 
day is spent sedentary (Duvivier et al., 2013). Given that prolonged sedentary time can offer 
different physiological consequences to those implicated with physical inactivity (Tremblay et 
al., 2010), it is clear that messages as to the importance of achieving both physical activity and 
sedentary behaviour recommendations are crucial to obtain health benefits. 
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Figure 1.3. An example protocol to assess uninterrupted sitting with activity breaks, adapted 
from Dunstan et al., 2012 
1.2.3. Commercial grade, wearable technologies 
There are a multitude of health markers that can be monitored using commercially available 
technologies and given technological advancements, the volume and their capability will 
continue to expand. These devices are increasing able to quantify movement behaviours 
(physical activity and sedentary behaviour) and physiological markers. Devices aiming to 
quantify physical activity and/or sedentary behaviour have flooded the marketplace in recent 
years (Evenson et al., 2015; Sanders et al., 2016). Given the current ranking of chronic diseases 
and the need to prevent their onset, it is logical to first consider monitoring ambulatory blood 
pressure, given hypertension ranked as the most prevalent. However, wearable systems 
currently available are not yet optimal given the difficulty aligned with obtaining accurate 
readings (without being too cumbersome as a device to continually wear). In comparison, 
diabetes, which is ranked as the second most prevalent chronic disease, has an abundance of 
technologies available to quantify glucose levels which are continuing to advance. The three 
main technologies available to monitor glucose levels are: self-monitoring glucose, continuous 
glucose monitoring and flash glucose monitoring. 
Monitoring physical activity and sedentary behaviour  
The emerging market of commercial wearable technologies for quantifying human movement 
behaviours has been recognised as a leading trend (Ferguson et al., 2015) and have 
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subsequently encouraged their incorporation within research studies. The unflustered release 
of new devices, and the relatively slower rate of publication, can often restrict literature from 
maintaining pace with the marketplace. As a result, despite having the capacity to reach 
millions of people, their use within population level surveillance studies is restricted (Bauman 
et al., 2016). Consumer grade physical activity monitors, such as Fitbit and Garmin, appear 
increasingly capable of monitoring activities such as swimming (e.g. number of laps), cycling 
(e.g. distance covered) and resistance training (e.g. number of repetitions completed) which are 
often unclassified or misclassified by devices worn close to centre of mass. From a review 
conducted in 2016, a total of 146 technologies were identified as capable of monitoring 
sedentary time and/or physical activity (Sanders et al., 2016). Primarily marketed as tools to 
log or monitor movement behaviours and performance, these devices are engineered to be 
wearable to minimise device removal. Given their global position, these devices encourage 
real-world research by offering scalable prices and access ‘off-the-shelf’. However, efforts 
must focus on testing health applications because the sheer volume suggests they are not 
reviewed prior to release (Powell et al., 2014). In addition, ensuring affordable technologies 
are used and comparable over time will be essential to capture national physical activity levels 
(Bauman et al., 2016). 
The validity of these technologies have largely been assessed within laboratory settings; 
demonstrating a high correlation for indirect calorimetry with the Fitbit and Jawbone 
(independently, r≥0.80) for step count but over- and under-estimations were observed at slower 
and faster speeds, respectively (Evenson et al., 2016). Overall, high validity was observed for 
steps but low validity for quantifying sleep and energy expenditure (Evenson et al., 2016). 
Since this publication, however, the Jawbone has been retracted from the market which 
confirms that the industry is evolving rapidly and devices are often superseded with newer 
models (Bauman et al., 2016). Seven studies within the review reported on inter-device 
reliability and concluded a high inter-device reliability for steps, distance and energy 
expenditure (Evenson et al., 2016). Intra-device reliability, assessed by Dontje and colleagues, 
demonstrated good levels of agreement (at the minute, hour and day level) between ten 
identical Fitbit Ultra devices worn by one individual over eight consecutive days (Dontje et al., 
2015). When compared with research grade devices (e.g. ActiGraph GT3X worn on the waist), 
the Fitbit Flex (wrist) tended to underestimate proportion of time spent sedentary and light 
intensity by 20% and 34%, respectively (Dominick et al., 2016). Observed variations between 
models and within models emphasises the importance of selecting an appropriate device. 
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Digital health technologies are also increasing likely to incorporate photoplethysmography into 
devices. Photoplethysmography relies on optical-based sensing using a pulse oximeter to 
identify light absorption and so record heart rate. Commonly deployed at the wrist, tightly 
linked to increasing wear-ability, these devices offer information pertaining to heart rate and 
movement behaviours to offer a more comprehensive profile. As with accelerometers and 
inclinometers, digital health technologies obtain a wealth of data which can result in differing 
analysis methods (Thompson & Batterham, 2013). Regardless of the objective measurement 
tool utilised, an understanding of self-report and objective measurement and respective positive 
and negative aspects should be considered (Allet et al., 2010). 
Wearable devices provide convenient data collection, analysis and storage over extended 
periods of wear and, with increasing sophistication, reveal immediate feedback to the user 
(Mercer et al., 2016). They have been noted as appropriate tools to stimulate physical activity 
in people living with chronic disease in primary care (van der Weegen et al., 2013) and for 
public health and rehabilitation settings (Lyons et al., 2014). A review conducted by Conroy 
and colleagues identified that over 80% of the identified apps involved physical activity 
(Conroy et al., 2014). Another review demonstrated that interventions targeting overall daily 
reductions in sedentary time have largely used emails, websites and text messages (Stephenson 
et al., 2017); highlighting that more interventions using wearable technologies are warranted. 
Changing movement behaviours could be facilitated by wearable devices (Patel et al., 2015) 
with increases in physical activity observed when provided with devices that encouraged goal-
setting (French et al., 2014) and self-regulation (Floegel et al., 2015). Given only a quarter of 
studies to date have incorporated these behaviour change techniques (Conroy et al., 2014), 
many wearable technologies (and their respective applications) need to begin incorporating 
principles from theories of health behaviour. Health-related behaviours, encouraged by 
wearable technologies, can improve population health but only if positive behaviours are 
sustained. Studies to date have largely varied in intervention duration, ranging from 5 days to 
24 months (Stephenson et al., 2017). In another study, following three days of access to several 
commercial devices, participants (aged 52-84 years, living with ≥1 chronic disease) identified 
that these tools may be useful in promoting physical activity as a possible way to improve 
health (Mercer et al., 2016). However, future interventions targeting both physical activity and 
sedentary behaviour are warranted having recorded only 3 studies (Stephenson et al., 2017). 
Overall, wearable devices can help facilitate behaviour change but sustaining this is difficult 
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(Patel et al., 2015); therefore, it is intuitive that participant engagement with these technologies 
can help understand how people respond to the information presented. 
Monitoring glucose levels 
For people living with diabetes, it is crucial for these individuals to monitor changes in 
(blood/interstitial) glucose levels. There are three main tools used to capture this information 
and these include self-monitoring of blood glucose, continuous glucose monitoring and flash 
glucose monitoring (Figure 1.4). Self-monitoring of blood glucose has been a recognised and 
recommended, invasive technique to facilitate diabetes management  for many years 
(International Diabetes Federation, 2009). The approach involves participants pricking their 
finger and using a handheld reader to measure glucose in the blood sample. Continuous and 
flash glucose monitoring tools, on the other hand, use disposable, minimally-invasive sensors 
that have a needle penetrating the skin. Both of these monitoring technologies calculate glucose 
levels using the relative concentration of glucose in the interstitial fluid, rather than blood 
glucose levels within capillary circulation and provide greater resolution compared with self-
monitoring of blood glucose (Klonoff, 2005). Flash glucose monitors currently available are 
inserted into the left or right posterior brachium whilst the continuous monitors are often 
inserted into the abdomen. Continuous glucose monitors (e.g. Medtronic and iPro) have been 
suggested to help highlight pre-prandial, post-prandial and glucose levels during the night 
(Dungan, 2000) which still holds true nearly two decades later. Regardless of technological 
advancements and emerging techniques, all of these approaches can help, if used, to inform 
individuals of their fluctuating glucose levels which can, in turn, inform their treatment regime 
(e.g. when to take prescribed medication or how to manage dietary intake).  
       
Figure 1.4. Examples of self-monitoring blood glucose (left), continuous glucose monitoring 
(middle) and flash glucose monitoring (right) 
This provision of low, infrequent data can go some way in increasing user understanding and 
prompt the identification of patterns (e.g. magnitude of post-meal increases) (Inchiostro et al., 
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2013). However, it is acknowledged that more frequent measures offer greater insight into daily 
glucose fluctuations (American Diabetes Association, 1994) and this guidance has not changed 
since the 1990’s. However, even with multiple measures daily, self-monitoring blood glucose 
can only highlight the central tendency of glucose levels (Fonda et al., 2013) and subsequently 
fail to provide a complete glucose profile. As a result, many people living with diabetes raise 
concerns about how necessary these measures are given these limitations (Martin et al., 2006), 
and perceive these measures to not contribute to diabetes management (Polonsky et al., 2014) 
and so often fail to conduct enough measures to support them (Klonoff et al., 2008). With only 
39% of individuals using insulin and fewer than 6% of individuals conducted self-monitoring 
blood glucose at least once daily (Harris, 2001), it is important to help promote regular readings 
for self-management. 
In comparison, continuous and flash glucose monitoring technologies, given their similarities 
in information offered, may be perceived as less intrusive, with individuals able to limit their 
reliance on single, irregular measures (Pickup et al., 2015). With devices automatically 
recording regular readings daily (e.g. every 5-15 minutes), individuals are able to recognise 
patterns in glucose profiles and how movement and personal behaviours contribute (Bergenstal 
et al., 2013). However, there are limitations to consider when discussing these two 
technologies. Firstly, continuous glucose monitors have often required users to calibrate the 
reader which involves ≥1finger-prick sample each day (i.e. self-monitoring blood glucose) 
(Sacks et al., 2011). In an effort to overcome this, an expert panel of the US Food and Drug 
Administration have confirmed that the Dexcom G5, a CGM, can be sufficiently accurate and 
reliable for use without the need for calibrations (US Food and Drug Administration, 2016). In 
comparison, flash glucose monitoring devices are factory calibrated, meaning that they do not 
require people to conduct any finger-prick measures to function. Instead, the manufacturer 
advises users to finger-prick during times of rapidly changing glucose levels. Another 
limitation is that many individuals face psychological or financial barriers to using these forms 
of technology (Lodwig et al., 2014) and report sensor-related issues (e.g. 32% failed sensors) 
(Pickup et al., 2015). Due to the nature of monitoring interstitial glucose, results presented to 
the wear can often lag behind capillary blood glucose levels by 4.5±4.8mins (Bailey et al., 
2015); likely attributed to the time required for glucose to diffuse into the tissues from the 
capillaries (Cengiz & Tamborlane, 2009). Despite these limitations, these advancing 
technologies offer consistent results (88.4% at day 2 and 85.2% at day 14) across wear (Bailey 
et al., 2015; Hoss et al., 2013), regardless of body mass index, age, type of diabetes, clinical 
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site, HbA1c or insulin therapy regime (Bailey et al., 2015). Consequently, with appropriate 
guidance and education, these tools may be beneficial for users to engage further with their 
health. 
With greater exposure to information, individuals may feel more empowered (or competent) to 
make informed decisions for better self-regulation; aligning with the notion that individuals 
may feel better equipped to appreciate their current situation. Vigersky and colleagues 
demonstrated a significant 1% reduction in HbA1c% following three months in those 
individuals having access to continuous glucose monitors, compared with a 0.5% reduction in 
observed in the self-monitoring blood glucose group (Vigersky et al., 2012). This may be in 
part because individuals that engage more frequently with the feedback are better equipped to 
improve glucose control compared with people accessing the data less often (Fonda et al., 
2013). Furthermore, these differences may be achieved because of greater exposure to the 
dynamic and temporal characteristics of continuous glucose monitoring (Kovatchev et al., 
2015). Access to these technologies provides an opportunity for people to better manage 
glucose regulation by minimising levels of glucose variation (Rodbard, 2011). However, 
regardless of the frequency of accessing information, an adequate understanding is often a 
barrier in patients living with diabetes (Lodwig et al., 2014) and this still holds true today, 
especially with advancing sophistication of technologies. More specifically, the person wearing 
the device will be presented with information which may help them see the acute effects of 
behaviour on fluctuating glucose levels (Wagner et al., 2012). This process, termed temporal 
sequencing (Wagner et al., 2012), represents the identification and quantification of glucose 
levels in response to a given stimulus (e.g. consumption of food or bout of activity). Another 
approach prompted by Allen and colleagues highlighted that presenting individuals with 
another person’s data resulted in increases in physical activity, decreases in sedentary time and 
improved HbA1c (Allen et al., 2009). This contrasts with the more common notion of 
personalised data being most potent (or persuasive), but another person’s data is likely more 
potent than artificial data. 
Figure 1.5 illustrates how continuous/flash glucose monitors capture fluctuating glucose levels 
over the course of 12 hours (in this example). In comparison, self-monitoring of blood glucose 
only captures three distinct measures with each of these within the target range. Only having 
access to the three distinct measures would miss the two ‘high’ and three ‘low’ events. That 
said, it is important to acknowledge that target ranges vary by context (e.g. upon waking, pre-
meals and post-meals) as well as between people living with and without diabetes. It is 
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interesting to note that people living with diabetes aim to attain a flat line for their glucose 
whereas, in comparison, people living without diabetes observe largely fluctuating glucose 
levels across the 24-hour period. The target range is very important given its role in helping to 
identify high and low events. In Figure 1.5, the target range eludes to 2-hour postprandial 
glucose levels which may not be always relevant, so a dynamic target range may be more 
appropriate as technologies advance. As a result, it is advisable that these continuous glucose 
monitoring technologies become integrated tools to individuals living with diabetes (Fonda et 
al., 2013), which may help encourage routine behaviour with minimal (if any) restrictions 
imposed (Allet et al., 2010). Further investigation into how these technologies fare in samples 
of people at risk of (rather than diagnosed with) diabetes are warranted. 
 
Figure 1.5. An illustration of the information that self-monitoring blood glucose can provide in 
comparison with continuous and flash glucose monitoring 
1.2.4. Health Communication 
Population level versus personalised health messages 
Messaging is presenting information to large groups of people via media pathways such as 
television advertisements, print media, and the internet to a target audience (Latimer et al., 
2010). Wide-reaching campaigns aim to encourage positive (and avert negative) behaviours 
within populations for health (Wakefield et al., 2010). Technology has provided the field of 
health communication with a platform to access large audiences (Cascio et al., 2013). 
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Population level health messages 
The widely recognised public health campaign thus far for physical activity has been 
‘Change4Life’, an NHS supported campaign targeting families to move more, eat well and live 
longer (UK Department of Health, 2009). Improving awareness to achieve physical activity 
recommendations and minimising time spent sedentary remains a substantial challenge with 
82% of UK adults incorrectly recalling the national guidelines (Knox et al., 2013). 
Alternatively (or in addition) it may be attributable to individuals not receiving reasons why 
they should achieve these recommendations nor gain an understanding of how to achieve them 
(Latimer et al., 2010). This could be contributing to insufficient awareness about poor 
movement behavioural decisions and associated health implications. Others have highlighted 
that infographics, which attempt to draw a connection between healthcare professionals and 
the general public (Scott et al., 2016), may help display key information by largely using a 
visual format with key text included (Krum, 2013). Disseminating engaging messages is more 
likely when the behaviour targeted is episodic (or discrete) rather than habitual (Wakefield et 
al., 2010). As a result, encouraging people to change physical activity or time spent sedentary 
can be difficult. Another implication is whether messages should reveal the harms or the 
benefits (of physical activity and low time spent sedentary) is currently not fully decided (Wen 
& Wu, 2012). It has previously been suggested that loss-framed messages are best suited for 
screening whilst gain-framed messages for the prevention of behaviours (Rothman & Salovey, 
1997). Despite this, a mixture of loss- and gain-framed messages have been utilised across the 
key lifestyle behaviours; highlighting uncertainty about which method is best for the prevention 
of chronic disease. For example, given the ongoing century long war on tobacco addiction 
(Fiore & Baker, 2009), the UK government enforced legislation necessitating cigarette 
companies to display health warnings on packaging (e.g. images representing blackened lungs 
and yellow teeth); aligning with a loss-framed message framework. However, uncertainty 
remains about whether population level messages should deliver highly threatening messages 
(e.g. risk of chronic disease) to encourage positive behaviour change, with evidence that these 
types of messages can result in increases in physical activity (Cho & Salmon, 2006). To assess 
awareness achieved for a given message, it is pivotal to conduct an evaluation to assess key 
outcomes including level of intention and whether change occurred (Bauman et al., 2006). 
Efforts have included the use of simple-to-understand language, using audio-visual formats 
and to tailor or personalise content to minimise issues surrounding health literacy (Barry et al., 
2013; Mackert et al., 2014). Overall, it is important to consider how competent individuals in 
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terms of how able they feel to act on the health information being presented or provided to 
them. In an effort to support individuals with varying levels of competency, a broad range of 
health messages via number of modes (e.g. screen and non-screen based) are likely crucial to 
capture population-level attention. Consequently, it may be beneficial to deliver tailored 
messages (Appelboom et al., 2014) increasing resonance with the message. 
Personalised health messages relating to movement behaviours 
Pedometers have been the activity monitor of abundance in the past. However, with increasing 
sophistication, devices are increasingly able to quantify multiple aspects of activity with 
physical activity gaining recognition as a complicated behaviour (Thompson et al., 2015). 
Thompson and colleagues outlined that no single metric could truly classify level of physical 
activity and that tailoring of messages according to individual preferences as an optimal 
scenario (Thompson et al., 2015). Tailoring would encourage the presentation of specific 
metrics in relevant contexts and at specific times to help enhance the opportunity for behaviour 
change. Aligning with this approach, smartphone apps are a logical tool for behavioural 
interventions because they can monitor and classify behaviour almost immediately (Dennison 
et al., 2013). To date, step count has been rated as the most important metric by 74% of a 
national survey (n=1,349) with activity monitors considered helpful in promoting activity 
(Alley et al., 2016). Of the respondents, 63% stated that digital health technologies help 
individuals become more active (Alley et al., 2016). It must be acknowledged though that this 
sample of individuals may have been biased given that they have access to these devices and 
so may be more likely to be positive of their use. Another aspect is how messages are delivered 
to encourage a recommended quantity of behaviour. For instance, 41 people living with type 2 
diabetes were randomised into one of two groups; scheduled to either receive advice about 
walking 30 min/day (at any time) or to walk 10 minutes three times per day (after each meal) 
(Reynolds et al., 2016). The findings were interesting; highlighting that advice to walk after 
meals was more effective in lowering post-prandial glycaemia; suggesting that aligning bouts 
of achievable activity around routine events helped participants achieve their advice. 
Delivering personalised feedback offers many challenges but it has the potential to deliver 
useful outcomes. 
Personalised health messages relating to glucose  
Other personalised health messages may focus on the physiological feedback. A position 
statement published in 2015 outlined that personalised (but comprehensive) approaches are 
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necessary and that displaying glucose patterns is a useful form of feedback (Powers et al., 
2015). Encouraging regular monitoring is the crucial challenge with many life events or factors 
restricting the opportunity (e.g. diabetes severity, work commitments, physical activity and 
eating habits)  (American Diabetes Association, 2015b). Another major concern is that a 
sufficient level of literacy is needed to accurately interpret the values presented to the 
individual (International Diabetes Federation, 2009). An inadequate level of health literacy has 
been associated with worsened glucose control in those living with type 2 diabetes (Schillinger 
et al., 2003), which reflects a potential lost opportunity to deliver useful information. Rowsell 
and colleagues identified that those with a higher level of health literacy perceived the 
information as easier to understand and found certain features motivating (Rowsell et al., 
2015). This study investigated the use of a website which had participant accounts setup to 
access personalised information, restricting its reach for those who may have wanted greater, 
more immediate and easy access. The importance inflicted on having a sufficient literacy level 
to understand information means that education and training need to be provided (Battersby et 
al., 2010). It is important for healthcare professionals to understand the importance of 
individual understanding to optimise the opportunity to self-monitor. Healthcare professionals, 
such as specialist diabetes nurses, must consider individual literacy (International Diabetes 
Federation, 2009) because the transference of adequate knowledge is important (Klonoff, 2007) 
and, with individuals equipped with knowledge, patient empowerment can evolve 
(International Diabetes Federation, 2009). However, given the influx of technologies offering 
information on physiological markers, further consideration should be directed toward user 
knowledge and user comfort using mobile health (mHealth) platforms (Norman & Skinner, 
2006). For instance, healthcare professionals should be able to conduct initial assessments 
(Driscoll & Young-Hyman, 2014) to ensure that all patients are sufficiently equipped and, 
where needed, they receive the guidance they need (Jarvis et al., 2010). This allows for the 
accurate deployment of advice to maintain an appropriate level of digital health use for diabetes 
management. However, further investigation into how individuals living at risk of (and not 
diagnosed with) chronic disease deal with physiological feedback would be warranted. 
Temporal discounting 
Temporal discounting refers to how people tend to discount rewards that are temporally distant 
because the delay weakens the value of the reward (Critchfield & Kollins, 2001). It has often 
been linked to monetary reward investigations and involves a hyperbolic discount function; 
meaning that the subjective value of a reward is reduced when there is time before the reward 
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is received. For instance, participants are often asked to decide between receiving an immediate 
payment and a larger payment, but they would receive the larger payment in the future. 
Similarly, in a sample of current, never- and former-smokers, Bickel and colleagues 
investigated how participants differed in receiving a specific quantity of cigarettes immediately 
or a greater quantity of cigarettes at a delayed time (Bickel et al., 1999). The authors identified 
that cigarette smoking was characterised by a loss of subjective value for delayed outcomes; 
meaning that current smokers were more inclined to take a more immediate (albeit smaller) 
reward. When alcohol was compared with money in a sample of active alcoholics, currently 
abstinent alcoholics and controls, alcohol was discounted more rapidly; meaning that rapid 
discounting of delayed rewards was observed (Petry, 2001). Therefore, an individual can be 
either impulsive (immediate gain) or self-controlled (delayed reward) (Bickel et al., 1999) and 
still holds true today. Regardless of the task under consideration, individuals must actively 
sustain a feeling of value for the rewards. Temporal discounting is a crucial theory to consider 
when encouraging behaviour change because the reward (e.g. optimal cardiometabolic health) 
can often be experienced in the distant future but is affected by decisions in the present. More 
specifically, a major challenge to improving population health is encouraging people to change 
their lifestyle behaviours today to improve health decades later. Figure 1.6 illustrates the 
concept by suggesting that individuals prioritise (or more greatly value) behaviours that offer 
immediate gratification, and poorly disregard those events that may occur later. With 
individuals often seeking the immediate gratification or reward to fulfil their need for value, 
encouraging positive lifestyle behaviours can be difficult to challenge. Given the nature of 
available technologies for type 2 diabetes, novel sensors are increasingly capable of delivering 
information about behaviour and physiological markers in parallel. Consequently, with perhaps 
enhanced levels of user interaction as a result of this additional angle to personalised feedback, 
it may help improve understanding about the effects of acute decisions on long-term health to 
lower the risk of chronic disease onset. 
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Figure 1.6. A schematic displaying how subjective value is highest in the present and lowest 
for events that may occur in the future 
Assessing health messages 
Interviews, focus groups and surveys offer valuable qualitative insight into individual 
preferences and perceptions toward feedback (about both content and delivery). Personalising 
health messages is crucial moving forward given the advances in digital health technologies. 
Previous research (Kreuter et al., 1999), which appears to still hold true today in other domains 
(e.g. Noble et al., 2015), demonstrated that tailored weight loss materials were significantly 
better than untailored messages. The materials that were investigated were tailored to an 
individual according to their response of a questionnaire; thereby limiting its potential given 
that question may have been misinterpreted or incorrectly answered. A systematic review 
published in 2010, containing ten studies, demonstrated that tailored information resulted in 
greater increases in physical activity compared with untailored material (Latimer et al., 2010); 
perhaps attributable to the materials resulting in greater resonance. If we can retrieve rich 
information regarding preferences for feedback, then we may be better positioned to reveal 
information pertaining to health and behaviour in a resonant way. Other studies employing 
qualitative methods have focused on disseminating road safety messages (Lewis et al., 2007), 
smoking whilst pregnant (Lewis et al., 2010) and obesity (Naughton et al., 2013). Although 
self-report tools provide valuable information concerning behaviour, there remains a large 
portion of variance unexplained; in part attributable to respondents providing socially desirable 
answers (Booth-Kewley et al., 2007), unconscious influences (de Camp Wilson & Nisbett, 
1978), and a possible disconnect between responses provided in the laboratory and mental 
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processes that take place in the real world (Glassman et al., 2016; Klesges et al., 1990). Given 
these limitations, it is important to consider whether there is an opportunity to objectively 
assess how health messages are received. 
1.2.5. Neuroimaging 
One potential tool to objectively measure how health messages are received is neuroimaging 
under the umbrella of neuroscience. Neuroscience can be subdivided into several areas of 
interest. Communication neuroscience offers insight into understanding health communication 
(Falk, 2013) and helps bolster knowledge in nonverbal communication (Todorov et al., 2008); 
offering additional but supplementary information to traditional methods (e.g. focus groups). 
Communication neuroscience can be explored using an increasing number of available 
neuroimaging tools. These neuroimaging techniques can help identify what regions of the brain 
become activated whilst completing specific functions (or tasks) or processes; including 
emotion and affection, attention, social cognition, reasoning and language (Bookheimer, 2007; 
Cacioppo, 2002). The most commonly used neuroimaging techniques are 
electroencephalography (EEG), functional magnetic resonance imaging (fMRI), eye tracking 
and functional near infrared spectroscopy (fNIRS). 
Neuroimaging tools 
Electroencephalography, functional NIRS and event-related potentials 
Despite the abundance of neuroimaging tools available, each neuroimaging tool offers 
respective positive and negative attributes. Electroencephalography records brain signals from 
the scalp and identifies changes in these signals along the spectral bands of delta, theta, alpha, 
beta and gamma. Because people are often unable or unwilling to justify or explain preferences 
when prompted, in part attributable to human behaviours driven by unconscious awareness 
(Calvert & Brammer, 2012), neuroimaging techniques can be crucial. Eye tracking, in contrast, 
measure eye movements which are considered the most frequent human behaviour 
(Bridgeman, 1992). Because the visual system provides an enormous amount of information, 
eye tracking is a key tool to try and understand what motivates people to act in certain ways. 
In previous years, eye tracking relied on direct observation of eye movements; limiting the 
measurement accuracy to the memory and accuracy of the observer (Dodge, 1906). The need 
to implement a better, objective record of eye movements using non-invasive methods was 
acknowledged (Dodge & Cline, 1901) and subsequent efforts evolved (Taylor, 1971). EEG and 
eye tracking are considered the least invasive neuroimaging tools yet still provide high 
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temporal resolution. fNIRS, despite measuring brain activation in a different way, does offer 
greater portability and relatively lower costs which may encourage investigations in more 
naturalistic environments.  
Magnetic resonance imaging 
Magnetic resonance imaging (MRI) has made a substantial contribution to neuroscience by 
permitting imaging of the brain. Its history lies in nuclear magnetic resonance (NMR) 
spectroscopy which largely relies on the angular momentum possessed by subatomic particles 
(i.e. protons, neutrons and electrons). Over time, NMR produced images using detection coils 
to align with the resonance frequency of hydrogen which was used to calculate water density. 
Given the prevalence of water in the human body, hydrogen is the most commonly studied 
element with MRI. Sir Peter Mansfield subsequently developed this approach further, 
producing methods to analyse these images and the approach later became known as MRI. 
Magnetic field strengths are typically 0.1-10T (tesla) and apply a strong magnetic field to align 
the spinning proton. The MRI scanner, such as the one shown in Figure 1.7 (MR750w 3T 
scanner [General Electric Healthcare, Chicago, IL, USA]), then produces a series of radio 
frequency currents to create a varying magnetic field. The protons absorb this energy and flip 
their direction of spin, which is maintained until the radiofrequency field is switched off. Upon 
switching off, the protons return to their normal spinning motion, and in the process, produces 
a radio signal. This returning to normal phase can be measured and subsequently made into an 
image through radio frequency coils. In relation to imaging anatomy, the MRI scanner 
distinguishes between differing tissue types by the speed at which the protons return to their 
normal spins. The loud noise anecdotally aligned to MRI scans is due to the constant flipping 
motion of magnetic fields. Unfortunately, because MRI uses magnets, individuals who possess 
any metal implants cannot go inside as they are not magnetic resonance safe and pose a hazard. 
MR images can be acquired with a range of image contrasts, such as T1, T2, or diffusion 
weightings, which indicate underlying structure. They may also be acquired with contrast 
dependent on physiological processes, such as blood flow, which can be manipulated to reveal 
angiographic information or functional MRI via the BOLD effect, as described below.  
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Figure 1.7. An MR750w 3T scanner (left) with a participant being prepared to go inside (right) 
Functional magnetic resonance imaging 
fMRI is a non-invasive neuroimaging technique that studies the brain whilst an individual 
completes a cognitive task inside an MRI scanner (Figure 1.7). More specifically, fMRI 
provides images that show the location of magnetic resonance signal changes associated with 
neural activity. fMRI works on the basis that a vascular change occurs when neural tissue is 
activated (Ogawa et al., 1990). Using a method called blood oxygen level-dependent (BOLD) 
contrast imaging, fMRI provides an indirect measure of neuro-electric activity (Logothetis et 
al., 2001). An early observation advocated that changes in neural activity resulted in signal 
changes that can take seconds to develop and decay (Bandettini, 1993). The theory behind 
BOLD contrasts is supported because deoxyhaemoglobin is paramagnetic in nature meaning it 
causes reductions in signal strength in the vasculature and surrounding tissue. Cerebral blood 
volume and blood flow increase when an area of the brain is activated; resulting in a lower 
oxygen extraction fraction of the blood. Blood supply demand is subsequently exceeded which 
causes a reduction in deoxyhaemoglobin. As deoxyhaemoglobin decreases, the paramagnetic 
properties are removed which results in a greater signal intensity. Therefore, an activated region 
of the brain demonstrates a more intense signal which can reveal a temporal measure of neural 
activity. This occurs after a haemodynamic filter has smoothed the pattern of activation which, 
in the process, can slightly delay signal production (Aguirre et al., 1998). While arterial blood 
is similar in its magnetic properties to tissue, deoxygenated blood is paramagnetic and so 
induces in-homogeneities within the magnetic field in tissue. As a result, the magnetic 
resonance imaging signal decays faster but signals from activated regions of cortex increase as 
the tissue becomes more magnetically uniform. Dynamic increases in volume and flow of 
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blood to an activated region of the brain, accompanied by changes in oxygen consumption, 
occur shortly after cognitive stimulation (Leniger-Follert & Lübbers, 1976). To localise these 
neural activations, low resolution images are acquired in rapid succession to produce mapped 
brain volumes every few seconds. In combination, these volumes produce a time-series of 
activation intensities for each voxel. fMRI produces relatively good spatial resolution with 
whole brain coverage, but the technique suffers from poor temporal resolution and issues 
surrounding reverse inference. Reverse inference suggests that activations of specific brain 
regions infer the engagement of a specific cognitive process which is not fully valid (Poldrack, 
2006). There has been a recent expansion of interest in using fMRI as a neuroimaging tool 
bringing forward both scepticism and enthusiasm (Aue et al., 2009). However, having the 
capacity to measure specific cerebral structures in social cognition and behaviour has been 
noted as an outstanding achievement in contemporary neuroscience (Eisenberg, 1995).  
Functional MRI, health messages and behaviour change 
A systematic review conducted by Kaye and colleagues (Kaye et al., 2016) identified a variety 
of neuroimaging studies focusing on key human behaviours including smoking (Chua et al., 
2011), nutrition (Kessels et al., 2011), sun safety (Falk et al., 2010), narcotic substances (Weber 
et al., 2015), safe sex (e.g. Seelig et al., 2014) and blood donation (Falk et al., 2010). The 
review identified twenty studies that employed event-related potential, functional near infrared 
spectroscopy or fMRI and demonstrated a growing body of research assessing visual stimuli. 
However, expanding the scope of the review to identify studies on other lifestyle behaviours 
may have revealed further studies. Lifestyle behaviour health messages are often disseminated 
on packaging to deter individuals or billboards to highlight health implications. Studies to date 
have compared persuasive and unpersuasive messages (Falk et al., 2010), tailored and 
untailored messages (Noar et al., 2007) as well as images of lifestyle behaviour (Jackson et al., 
2014). Functional MRI studies often examine neural activation patterns in response to stimuli; 
offering insight into how people cortically respond. Understanding how messages can be made 
more potent (or persuasive) to encourage behaviour change is likely crucial. fMRI studies can 
also investigate human behaviour following exposure to a stimulus, such as health messages. 
For instance, after viewing anti-smoking advertisements, participants were subsequently 
measured at follow up for smoking consumption using exhaled carbon monoxide (a proxy 
indicator). Findings revealed that neural activity in response to anti-smoking advertisements 
accounted for 20% of the variance in how much exhaled carbon monoxide was recorded (i.e. 
how many were still smoking) (Falk et al., 2011). Moreover, the medial prefrontal cortex, a 
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region of the brain, acted as a surrogate marker for subsequent smoking cessation. In another 
study, using EEG, Versace and colleagues examined rates of smoking cessation and identified 
that neural patterns to emotional and smoking-related pictures had a role in predicting 
subsequent smoking cessation (Versace et al., 2011). More specifically, smokers with lower 
levels of neural activation in response to pleasant stimuli were less successful at ceasing 
smoking habits. These encouraging findings support the suggestion that social neuroscientists 
should examine new forms of media, such as social network sites and smartphones, to assess 
the role of technology in health communications (Cascio et al., 2013). The authors emphasise 
that people are affected differently by health message communications and subsequently act 
differently after exposure. However, in combination, neuroimaging tools (quantifying neural 
activity) and self-report surveys explain some variation related to behaviour change (Cascio et 
al., 2013). As a result, conducting more studies that employ objective measurements (using 
techniques such as fMRI) may be warranted. 
1.2.6. Behaviour Change 
Behaviour change framework 
Behaviours are multi-dimensional and highly complex. Therefore, understanding how 
behaviours are influenced by both external and internal sources is important to develop 
interventions targeting change (Michie et al., 2013). The capability, opportunity, motivation 
and behaviour (‘COM-B’) model developed by Michie and colleagues suggests that a change 
in behaviour requires a change in one of the following: capability, opportunity or motivation 
(Michie et al., 2011). The former refers to the physical and psychological attributes to perform 
a behaviour (e.g. skill level), for instance personal ability to perform the behaviour. 
Opportunity eludes to external sources and can be social or physical; influencing how an 
individual engages with behaviour. For instance, it must be accessible and socially acceptable. 
The latter component is crucial and is comprised of reflective and automatic processes such as 
emotion, beliefs and goals. Motivation confirms that people must be highly driven to complete 
the behaviour. These three components of the COM-B model are interlinked such that 
increasing opportunity or capability can increase motivation. The Behaviour Change Wheel 
comprises the COM-B model along with nine intervention functions, including: education (e.g. 
knowledge and understanding), training (e.g. imparting skills) and enablement (e.g. reducing 
barriers/increasing means) (Michie et al., 2011). It offers a systematic and theoretically-based 
approach to help identify successful intervention types for a given behaviour and population. 
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Together, these functions are crucial to appreciate how these factors can be addressed in 
interventions targeting positive behaviour change in different contexts and populations (Glanz 
& Bishop, 2010; Michie et al., 2011). Interventions are now widely recommended to 
incorporate frameworks to inform behaviour change within the design and development 
phrases of a trial (Campbell et al., 2000) despite inconsistent findings relating to the 
effectiveness of incorporating theory into intervention development (Ammerman et al., 2002; 
Bhattarai et al., 2013). Overall, it is recommended to incorporate structure by using frameworks 
such as COM-B when deliberating how to design and deliver interventions targeting behaviour 
change. 
Behaviour change techniques 
Michie and colleagues identified that published interventions were reporting insufficient details 
relating to the key components within interventions (Michie et al., 2011). As a result, 
subsequent interventions have not been able to appreciate what ingredients could or should be 
included or avoided when in the design phase. As a result, the Behaviour Change Taxonomy 
was developed to help identify and classify the active content of the intervention directly 
focusing on the promotion of physical activity (Michie et al., 2013). The taxonomy has since 
helped to guide the standardisation of terminology and content across interventions in the field 
of behaviour change, having identified 93 active ingredients (organised into sixteen groups). 
Following the development of the taxonomy, Michie and colleagues assessed the effectiveness 
of behaviour change interventions equipped with the newly developed taxonomy (Michie et 
al., 2009). Moderator analysis identified that intervention effectiveness was directly related to 
the number of self-regulation techniques (e.g. self-monitoring) incorporated within these 
interventions. Of the 93 active ingredients identified by the taxonomy, the behaviour change 
techniques of feedback, self-monitoring and goal setting are most pertinent to this thesis. 
Feedback and goal-setting 
Feedback, defined as the opportunity to ‘monitor and provide’ information on performance of 
the behaviour or outcome (Michie et al., 2013), can relate to several topics within various 
settings. For instance, feedback can be offered in a visual, auditory, or tactile manner (Stone et 
al., 2005). Within an occupational setting, for example, aircraft pilots expect to receive 
sufficient, informative feedback to maintain accurate navigation and control of an aircraft. The 
cockpit is also designed to accommodate the pilot to minimise pilot error and any accidents 
(Lintern et al., 1999). Perhaps more applicable to the wider population, smart devices are now 
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more frequently found within UK households. These devices monitor energy consumption with 
the suggested aim of reducing monthly bill outlays simply by revealing real-time consumption 
(e.g. £0.21/hour). It has been suggested that this information can enhance user engagement 
(Daae & Boks, 2014). However, feedback must be appropriately presented to avoid negating 
the potential benefits of behaviour change (Hargreaves et al., 2010); perhaps in part attributable 
to levels of literacy toward numerical outputs and graphs (Hargreaves et al., 2010; Van Dam 
et al., 2010). Technologies targeted health and behaviour also have a role to play in encouraging 
change (Allet et al., 2010). A review conducted by Lewis and colleagues identified that 
interventions deploying wearable technologies found significant post-intervention increases in 
physical activity (24 days to 6 months) and reductions in sedentary behaviour (at 4 weeks to 3 
months) (Lewis et al., 2015). However, how information is presented is crucial with level of 
motivation mediating the effect of the feedback received (Wood & Neal, 2007). 
Use of traffic light colours and health target ranges have been identified as key approaches to 
help interpret data (Western et al., 2015). More complicated forms of feedback impose greater 
cognitive load which may negate its impact and likely reduce engagement (Hargreaves et al., 
2010). The effect that feedback has on an individual and subsequent actions can be determined 
by personal intentions and goals set (Locke et al., 1968). If an individual lacks motivation to 
act upon the information or feedback received, then potency (or persuasiveness) can be 
reduced. However, receiving feedback can be a key technique because it provides information; 
previously demonstrated to surprise people or to reveal or misalign with what people think they 
achieve (Western et al., 2015). Feedback offered at an individual level is important, but it must 
be acknowledged there is no one-size-fits-all recommendation on how to present feedback on 
physical activity (Thompson et al., 2015). Integrating a dynamic but appropriate design is 
crucial for a successful behaviour change intervention. For instance, ensuring the graphic user 
interface (GUI) is interactive and resonates with the user. Related but independent to feedback 
is goal-setting, defined as to ‘set or agree on a goal’ to achieve a specific behaviour or outcome 
(Michie et al., 2013). As a key component of the widely recognised Control Theory (Carver & 
Scheier, 1982), goal-setting is a key ingredient to the action of self-management and control of 
behaviour. As a result, tailoring information has a crucial role in encouraging people to strive 
for, attain or exceed a target. However, ensuring that the target is dynamic is important as the 
user improves (or fails to reach) over time; minimising opportunity for de-motivation. Ideally, 
with increasing access to information from digital health technologies, there is a trend to move 
away from a physician-centred healthcare system (Battersby et al., 2010). 
Literature Review 
38 
 
Self-monitoring 
Michie and colleagues defined self-monitoring as a ‘method for the person to monitor and 
record’ behaviour and outcome(s) and as a key ingredient for behaviour change (Michie et al., 
2013). With advancing technologies, people are increasingly able to see how they behave (e.g. 
time spent sedentary) but more needs to be done to demonstrate how immediate behavioural 
decisions acutely influence health. Also, with increasing sophistication, people can be 
prompted (or nudged) at specific times (e.g. every 30 minutes to prevent prolonged sedentary). 
However, consideration should be made toward the source of the information and the perceived 
level of expertise because these can be important indicators for information persuasiveness 
(Petty & Cacioppo, 1986). Gardner and colleagues reviewed and identified the active behaviour 
change techniques within numerous sedentary behaviour interventions (Gardner et al., 2016). 
Findings were considered particularly promising, with self-monitoring offering the highest 
promise ratio (measured the contribution of a behaviour change technique to the intervention 
output) of all techniques investigated (Gardner et al., 2016). This finding has been supported 
more recently in a systematic review that highlighted seven out of 17 interventions using self-
monitoring of behaviour (Stephenson et al., 2017). 
Given that digital health technologies such as a Fitbit offer a wealth of information, presenting 
the information in various forms such as numbers and graphs may help alleviate difficulties in 
understanding the content (Van Dam et al., 2012). Sanders and colleagues identified that over 
90% of the 82 devices capable of self-monitoring sedentary time and/or physical activity 
revealed feedback in a numeric or graphic format (Sanders et al., 2016). Offering individuals 
with a visual representation of their behaviour and/or health can reinforce the information to 
the user (Kanfer & Goldstein, 1975). Previous pedometer-based study findings collated via a 
systematic review confirmed that simply providing users with a step count via a waist-worn 
device can increase physical activity levels (by 26.9%) from baseline levels (Bravata et al., 
2007). In other contexts, self-monitoring of home energy consumption has identified 7-10% 
reductions when consumers were provided with smart meters to monitor energy usage (Wood 
& Newborough, 2003). Providing users with a source of immediate information can increase 
personal awareness toward what has been done and what is perhaps left to achieve. In general, 
interventions that employ self-monitoring in a synergistic manner, by combining self-
monitoring with ≥1 other technique would result in greater effectiveness than when not 
incorporated in combination (Michie et al., 2009). Future studies should encourage accurate 
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reporting of behaviour change theories and how these were integrated in the intervention 
(Kitsiou et al., 2017). 
Mobile Health (mHealth) 
Consumer health wearables are considered the next ‘Dr Google’ (Piwek et al., 2016) whereby 
individuals often use devices to self-monitor and then visit healthcare professional equipped 
with personal information. These devices therefore offer the wearer direct access to personal 
analytics that can aid with prevention of chronic disease. There has been a recent rise in 
popularity for the use of both consumer activity or fitness monitors (Canalys, 2014) and 
smartphone apps (Pandey et al., 2013) contributing to the dynamic landscape of technology 
(Kelly, 2016; Patrick et al, 2016). These emerging tools allow continuous monitoring of 
movement behaviours (Case et al., 2015) but more could be done with regard to combining 
behavioural and physiological technologies. The rapid growth of digital technologies sector, in 
parallel with the evolving development of bite-sized technology and wearable devices, aims to 
deliver and supplement healthcare (Fiordelli et al., 2013) and subsequently promote behaviour 
change (Allet et al., 2010). The devices commonly make use of accelerometers (Preece et al., 
2009) and conform to the notion of mobile health (mHealth). Given the widespread presence 
of unhealthy behaviours, many mHealth technologies aim to help individuals attain healthier 
habits (Klasnja & Pratt, 2014) which have potential to prevent or delay chronic disease. 
Devices are often located on the person (e.g. wrist-worn activity tracker) or situated at home 
(e.g. blood pressure monitoring). A recent review of systematic reviews identified 15 papers 
(52 unique studies) that focused on the effectiveness of mHealth interventions for the self-
management of diabetes (Kitsiou et al., 2017); highlighting that diabetes has technologies 
available. Findings outlined a 0.8% improvement in Hba1c in the high quality reviews 
delivering mHealth interventions compared with standard care or non-mHealth approaches 
(Kitsiou et al., 2017). Further investigation is warranted to observe how these technologies may 
fare from a prevention perspective, for those living without (but at risk of) diabetes. Overall, 
these mHealth technologies align with the ‘Quantified Self’ movement (Swan, 2009) by 
enabling individuals to self-monitor behaviour and/or health. 
Purchasing appealing commercial devices has flourished in part because of the reduction in 
costs with advancing expertise and expanding consumer interest. Providing the user with 
immediate feedback about behaviour on a convenient platform could be a fundamental 
motivator (Rollo et al., 2016). There is also an ever-increasing number of features monitored; 
for instance, sitting time, heart rate, and time spent active are common (Sanders et al., 2016). 
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These devices are able to gather and present continuous data in a small physical package 
(Culhane et al., 2005) which have since managed to downsize further. However, medical-
related smartphone apps currently offer limited evidence (McCartney, 2013) and only 
borderline positive effects of technological interventions have been observed in over 8,000 
participants (Alkhaldi et al., 2016). Rollo and colleagues identified that web-based 
programmes, smartphone apps and wearable devices all contribute to the self-management of 
chronic disease (Rollo et al., 2016); but more needs to be done in those living without chronic 
disease to observe whether these technologies can help prevent chronic disease onset. 
Considering the position of the device (e.g. wrist, chest or waist) and the frequency of charging 
is crucial (Rollo et al., 2016) as this will likely impact user compliance (Murphy, 2009). 
Similarly, smartphone apps provide push notifications, offer capacity to sync (link to transfer 
data) with multiple devices and are highly portable; however, restrictions on the use of a 
specific platform (e.g. compatible with Apple iOS) and developer costs (Rollo et al., 2016) are 
largely ignored. Luijkx and colleagues suggested that, provided with appropriate support and 
guidance, the older generation are also highly amenable to adopting new technologies (Luijkx 
et al., 2015). In combination, these findings support the use of mHealth within the whole 
population but incorporating mHealth into mainstream efforts must be implemented more 
quickly to maximise their benefits (Riley et al., 2015). 
Engagement with mHealth 
Engagement introduced 
Engagement observes the quality of users’ experiences with technology (O’Brien & Toms, 
2008). Encouraging users to interact with mHealth or digital health technologies can often be 
a challenge. Considering there were an estimated 150,000 smartphone apps focused on health 
(Aitken, 2015), digital health technologies are increasingly promoted as a way to facilitate 
engagement with health (Steinhubl et al., 2013). Encouraging people to effectively engage with 
a tool can be viewed as more crucial than the act of engaging itself (Yardley et al., 2016); more 
specifically, engagement that leads to positive behaviour change is more important than the act 
of engagement itself. However, with only half of UK adults having immediate access to the 
internet via a personal mobile phone (McCartney, 2013) and greater engagement in those with 
higher education and income levels (Kohl et al., 2013), it is important to consider inequality 
divides. More recent evidence suggested that the proportions of households gaining internet 
access has been increasing annually, reaching an estimated 80% of coverage in 2013 (Dutton 
& Blank, 2015). Conflicting reports suggest that there are widening health inequalities 
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(indicator of socio-economic status) (McAuley, 2014) surpassing older research that recorded 
lower levels of health inequality (due to devices becoming more affordable and more 
accessible) (Muñoz, 2010). As a result, it is important to consider the digital divide and how 
varying levels of access to digital health (e.g. education, age, health status) impact how people 
access and engage with technology. However, it is also useful to acknowledge that all 
technologies tend to follow Gartner’s hyper cycle of innovation (Linden & Fenn, 2003). The 
life cycle of any technology has been conceptualised with fast-track technologies taking 
approximately two to four years to cycle through the five stages. It begins with a pattern of 
excitement that evokes a great level of expectation (Figure 1.8), but with time and continuing 
mass media hype, it is common to observe negative experiences (e.g. supplier failures and 
negative press). Counteracting this potentially inevitable cycle emphasises the importance of 
producing technologies that supersede current items. 
 
Figure 1.8. An illustration of the Hype Cycle of Innovation, adapted from Linden & Fenn, 2003 
Concerns about engagement 
Initial drive adoption and use of digital health technologies is complicated with questions raised 
about novelty (Ledger et al., 2014). A nine-item criteria has been produced to assess whether 
a device will be adopted and includes design, setup experience, form factor (how they fit), user 
experience and overall utility (Ledger et al., 2014). After overcoming the challenge of 
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accessing mHealth technologies, the subsequent hurdle involves encouraging long-term, 
sustained engagement. That said, it must be acknowledged that short-term use of these 
technologies may actually be appropriate for many (by being able to extract useful information 
quickly and not require longer-term wear) and so it would be inappropriate to expect long-term 
wear and engagement. Engagement can be evaluated using several tools, including: qualitative 
analyses, questionnaires, ecological momentary assessment, logs of system usage, sensors 
(within the technology) or by using psychophysiological measures such as fMRI (Yardley et 
al., 2016). There are a growing number of companies (e.g. Flurry Analytics) which, with 
permission, obtain data from the devices of interest (i.e. smartphone or wearable device) which 
can ease data capture and interpretation. Empirical evidence suggests that adoption and changes 
to motivation and behaviour are short-term (Klasnja et al., 2011). For instance, within a sample 
of 26 students aged 20-24 years, 65% of participants stopped using their Fitbit after only two 
weeks of use (Shih et al., 2015). Qualitative investigation identified that cessation of use was 
often attributed to: forgetting to put the device on, negative perceptions of device design as 
well as concerns for data management and accuracy (Shih et al., 2015). Poor long-term use has 
also been highlighted elsewhere with approximately one third of US consumers failing to 
continue using a device six months following purchase (Ledger et al., 2014). Conflicting 
findings were highlighted in a review conducted by Lewis and colleagues which identified that 
seven of eleven studies reported a retention rate of ≥80% (Lewis et al., 2015). This could be 
attributed to the context of having the devices deployed within a research setting (eluding to 
recruitment bias or heightened motivation to maintain adherence) rather than a real-world 
setting where perhaps there is minimal (or no) expectation for sustained use. Therefore, efforts 
to extend longevity of these devices in a real-world setting are warranted. Another concern 
relates to non-usage attrition where the use of mHealth is discontinued (i.e. users may still have 
access to the device but fail to use it). Eysenbach’s Law of Attrition supports that attrition can 
be common within the context of mHealth because users have flexibility and choice to choose 
their intervention dose. More specifically, users are able to decide when or when not to wear 
the device as well their frequency of looking at it; supporting that non-usage attrition should 
be monitored and better understood (Eysenbach, 2005). For instance, in an intervention 
enrolling 4,378 individuals, only 20% were classified as active users. Reasons for the lack of 
sustained use or attention could include the following factors: insufficient encouragement from 
healthcare professionals, insufficient evidence relating to effectiveness, concerns about 
security and privacy (Birnbaum et al., 2015) or that the information fails to resonate (Aitken, 
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2015). Simply put, many users are not likely making full use of these technologies (Birnbaum 
et al., 2015) and efforts to combat this are warranted moving forward. 
Measuring engagement 
O’Brien and colleagues proposed a model of engagement (Figure 1.9) which outlines the 
process starting from the initial point of engagement to disengagement (O’Brien et al., 2008). 
Items contributing at the point of engagement include aesthetics, novelty, interest and 
motivation. During engagement, factors include aesthetic and sensory appeal, attention and 
awareness (and can appear and disappear over wear) whilst the point of disengagement can be 
attributed to usability, challenge and positive/negative affect. These attributes are highly 
changeable over time which demonstrates that engagement is a dynamic process varying both 
between and within subjects. Measuring engagement will largely vary between studies because 
of the varying types of technology employed and so often proxy metrics are used. Proxy metrics 
could involve the number of visits (or uses), number of features used, time spent on the 
intervention item, number (and type) of pages visited, and/or response to alerts or reminders 
(Brindal et al., 2012). In parallel, qualitative insights may include perceptions toward how 
useful the information was perceived (Schneider et al., 2016). Engaging with digital health 
technologies could be enhanced by presenting information just in time by capitalising on 
embedded sensors (e.g. global positioning systems or GPS) (Spruijt-Metz et al., 2015), tailoring 
the information source or demonstrating clear boundaries (Rollo et al., 2016). Alternate 
approaches include increasing individuals’ involvement in the design of the technologies 
(Baker et al., 2014; Birnbaum et al., 2015) and encourage effective engagement, which has 
been defined as engagement sufficient to achieve intended outcomes (Yardley et al., 2016). 
Overall, it is crucial to gain insight into technology usage and user preferences in all activities 
to help identify how users interact with device interfaces which may encourage the release of 
more potent graphic user interfaces (Gero & Kannengiesser, 2009). 
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Figure 1.9. Proposed model of engagement, adapted from O’Brien & Toms, 2008 
1.2.7. Bio-behavioural Feedback 
Bio-behavioural feedback is a term coined to represent the simultaneous presentation of 
physiological and behavioural information. Examples of physiological streams include 
interstitial glucose, blood pressure and heart rate whilst examples of movement behavioural 
signals relate to physical activity and sedentary behaviour. It is becoming more feasible to 
measure physical activity in research focused on monitoring human physiology (Wright et al., 
2017). Bio-behavioural feedback aligns well with the approach of ‘teaching events’ outlined 
and researched by Allen and colleagues (Allen et al., 2009). Teaching events represent 
occurrences where a distinct stimulus has an identifiable effect. Having the opportunity to 
present real-time feedback about physiology and behaviour in parallel may help the user 
understand the consequences of movement behaviours on their health. Identifying these 
teaching events can, more specifically, allow individuals to recognise the benefits of the 
stimulus (e.g. the positive impact a short walk can have on post-prandial glucose response) 
which may enhance the likelihood of the positive behaviour being repeated in the future. 
Individuals who accurately identify and interpret these events can positively modify both their 
behavioural and psychosocial status (Jarvis et al., 2010). Therefore, given the advancement in 
digital health technologies, providing individuals with more comprehensive feedback about 
their health and behaviour concurrently is becoming more feasible. Of course, efforts to 
appreciate how this information is delivered and understood are certainly warranted. Strategies 
such as these are likely paramount to begin to understand and integrate this approach of self-
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monitoring into chronic disease management (Chiauzzi et al., 2015) and prevention of chronic 
disease. Given that current efforts to increase population level physical activity levels have 
been largely unsuccessful with insufficient levels recorded (Sport England, 2017), novel 
approaches to contribute to improvements should be encouraged. To date, an important 
limitation of the efforts to encourage people to be more physically active has been the 
assumption that we are willing to change our lifestyles today to reduce risk of developing 
disease 20 years from now (aligning with behavioural discounting). This means that it can be 
difficult for individuals to appreciate the health benefits from being physically active which 
are subsequently observed years, or even decades later. However, with the notion of providing 
complementary feedback streams in parallel, there may be potential to illuminate the 
relationship between behaviour and health consequences which may empower individuals to 
identify these events and adjust future decisions. Overall, investigating whether bio-
behavioural feedback could increase the persuasiveness (or potency) of the feedback by linking 
behaviours to acute health is a promising area for the prevention of chronic disease. 
1.2.8. Summary 
There is a global pandemic with physical inactivity and prolonged time spent sedentary evoking 
ill-effects on cardiometabolic health. Disseminating persuasive health messages is key to 
bolstering healthy lifestyle behaviours with a view to preventing and treating chronic diseases. 
With the ongoing influx of commercially available digital health technologies flooding the 
marketplace, it is crucial that the content that is being presented on smartphone apps (and the 
devices themselves) are critically assessed. Assessing these ‘at-a-glance’ health messages may 
help provide insight into how these forms of information (or feedback) are being received and 
whether they encourage positive lifestyle behaviour change. Neuroimaging techniques (such 
as fMRI) may offer a non-invasive, objective approach to measure how peoples’ brains respond 
to personalised feedback delivered by digital health technologies. In addition, given that digital 
health technologies often experience attrition, it is crucial for researchers and the industry to 
try and understand how to increase sustained device use. One way may be to increase the 
potency (resonance) of the feedback being presented to users, which may be achieved by 
delivering physiological and behavioural feedback in combination. Delivering this enhanced 
form of feedback may help highlight events where behaviour has a noticeable, acute effect on 
health which may translate into behaviour change. However, efforts to identify how users 
engage with this form of feedback are warranted. 
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1.3. Thesis Aims 
Study One 
To review research using functional magnetic resonance imaging to assess how people’s brains 
respond to health messages relating to physical activity, sedentary behaviour, diet, smoking 
and alcohol. 
Study Two 
To identify regions of the brain activated in response to personalised health messages relating 
to physical activity, sedentary behaviour and glucose control and subsequent behaviour change 
and how this relates to patterns of neural activation. 
Study Three 
To assess participant engagement, as a proxy for measuring potency, using novel physical 
activity and glucose technologies. 
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Chapter Two 
 
Study One: 
Can functional magnetic resonance imaging studies help 
with the optimisation of health messaging for lifestyle 
behaviour change? A systematic review 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Whelan, ME; Morgan, PS; Sherar, LB; Orme, MW; Esliger, DW. Can functional magnetic 
resonance imaging studies help with the optimisation of health messaging for lifestyle 
behaviour change? A systematic review. Preventive Medicine. 2017; 99, pp 185-196. 
Appendix A. Original publication has been adapted to fit within this thesis. 
DOI: 10.1016/j.ypmed.2017.02.004. 
Study One: Systematic Review 
 
48 
 
2.1. Introduction 
Chronic diseases such as cardiovascular disease, cancers and type 2 diabetes account for 60% 
of all deaths worldwide (Warburton et al., 2006). The onset of more than two thirds of all new 
cases of chronic disease is widely attributed to four modifiable risk factors; smoking, excessive 
alcohol consumption, poor nutritional intake and physical inactivity (Beaglehole et al., 2011). 
The prevalence for each of these risk factors is staggering with one in five UK adults current 
cigarette smokers (Office for National Statistics, 2016), over 85,000 alcohol-related deaths 
annually (Centers for Disease Control and Prevention, 2013), a rising global body mass index 
(NCD Risk Factor Collaboration, 2016) and only 5% of UK (Chaudhury et al., 2008) and US 
(Troiano et al., 2008) adults achieving national guidelines. This highlights that effective 
interventions to promote healthy lifestyles are needed. One approach that has been widely used 
is public health messaging which has the important advantage of reaching the population. 
Promoting lower sugar intake, regular physical activity (e.g. ‘Change4Life’), smoking 
cessation (e.g. ‘Smoke Free’) and minimising excessive alcohol consumption (e.g. ‘Know your 
limits’) are common aims of public health campaigns. In addition to these campaigns, point-
of-decision prompts (e.g. take the stairs) and on-product packaging (e.g. ‘Smoking Kills’) also 
present persuasive micro-level messages which can also reach a wide audience. In particular, 
pictures of tar-filled lungs and yellow teeth are now commonplace on cigarette packages 
(World Health Organisation, 2009). These prompts are attributed in part to the reductions in 
smoking prevalence (Emery et al., 2012; Wakefield et al., 2010). However, ensuring campaigns 
and the information or images provided are impactful and evidence-based is crucial when 
implementing these behaviour change approaches (Latimer-Cheung et al., 2013). Therefore, to 
help ensure public health campaigns and point-of-decision prompts are given the greatest 
chance to change behaviour, it is important to assess how people respond to them. 
Lifestyle behaviours are influenced not only by conscious choices (e.g. choosing to actively 
commute to work) but also by subconscious responses to the environment and stimuli (e.g. 
emotional responses to a television advertisement or billboard). For a decision to be made by 
the brain, self-related processing must occur which involves the evaluation of environmental 
stimuli with regards to its personal relevance. Given this, neuroimaging can provide valuable 
insight into subconscious responses to stimuli by examining regions of the brain and levels of 
brain activation when individuals view health-related messages. These insights may then be 
used to bolster the persuasiveness of health messages (Nisbett & Wilson, 1977) and as a result, 
increase the likelihood of changing behaviour (Kaye et al., 2016). Previous research has 
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highlighted that regions within the medial prefrontal cortex of the brain are associated with 
self-related processing (Lieberman, 2010) with people subsequently reducing time spent sitting 
when activations within the ventromedial prefrontal cortex were observed (Falk et al., 2015). 
Predicting behaviour change based on neural activity through functional magnetic resonance 
imaging (fMRI) offers an interesting brain-behaviour link (Falk et al., 2011); highlighting the 
importance of optimising the content of health messages as they have a direct effect on how 
people’s brains engage with the health message and whether they ultimately change their 
behaviour. By producing and disseminating health messages that activate brain regions linked 
with successful behaviour change, health campaigns may have greater population-level success 
and be more cost-effective (Falk et al., 2010, 2011). The present review aimed to review studies 
that used fMRI to examine brain activity in response to health messages pertaining to physical 
activity, sedentary behaviour, dietary intake, smoking and alcohol consumption. 
2.2. Aims and objectives 
The aims of the review were to (i) examine stimuli content and modality; (ii) identify activated 
brain regions in response to stimuli presented and (iii) assess the capacity of fMRI results to 
predict behaviour change.  
2.3. Methods 
Search Strategy 
The protocol of this systematic review was developed in accordance with the PRISMA-P 
guidelines (Moher et al., 2015). An electronic search was conducted using Medline/PubMed; 
Psych INFO; SPORT Discus; Web of Science (Core Collection); Cochrane Library; and Open 
Grey. The reference lists of included records were manually screened for identifying additional 
relevant records. The electronic database search was conducted on the 10th January 2017. The 
search strategy was identical across databases, but the affiliation field was adjusted for each 
database (Table 2.1). The search strategy used for all databases was: (“functional magnetic 
resonance imaging” OR “functional MRI” OR fMRI OR “blood oxygen level dependent” OR 
BOLD OR neuroimaging) AND (smoke* OR smoking OR cigarette OR tobacco OR alcohol 
OR drink OR “sedentary lifestyle” OR sedentary behavio* OR sedentar* OR sitting OR 
“physical activity” OR “physical inactivity” OR “activities of daily living” OR fitness OR 
exercise OR food OR snack OR diet OR eat OR eating OR calorie OR caloric OR campaign 
OR message OR messaging OR communication OR “mass media” OR PSA OR “public service 
announcement” OR graphic OR warning OR label OR image OR video). 
Study One: Systematic Review 
 
50 
 
Table 2.1. An outline of the electronic database search affiliations 
Electronic database Search criteria applied 
MEDLINE/PubMed Title and abstract 
Psych INFO Abstract only 
SPORT Discuss Abstract only 
Web of Science Title only 
Cochrane Library Title/abstract/keywords 
Open Grey No restriction applied 
Selection criteria and study selection 
To be included, identified records had to meet the following criteria: (i) published in English 
prior to January 2017; (ii) involved human participants aged ≥10 years; (iii) investigated 
physical activity, sedentary behaviour, dietary intake, smoking and/or alcohol consumption; 
(iv) assessed health messages; and (v) studied subjects using fMRI. We excluded all systematic 
reviews and meta-analyses. Record screening and data extraction were conducted using 
DistillerSR version 2.0 (Evidence Partners, Ottawa, Canada). After inspection for any 
duplicates, the titles and abstracts of all records were reviewed by one reviewer (MW). Where 
a decision to include or exclude was not attained based on the title/abstract, the full text was 
sourced. Full text records were examined by two reviewers (MW and MO). Conflicts were 
discussed and if consensus was not achieved, a third reviewer (DE) was consulted. 
Recorded variables, data extraction and analysis 
Data were extracted on standardised forms developed a priori by the lead author for the 
following variables: authors and year of publication; publication title, number of subjects 
included within analyses; number of subjects excluded from analyses; age; gender distribution; 
subject handedness; lifestyle behaviour investigated; fMRI task design; fMRI principle 
findings; presence of a follow up component and follow up principle findings. Further fMRI 
methodological variables were extracted (Appendix B and C). 
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2.4. Results 
Full details of the search results, including reasons for exclusion are summarised in Figure 2.1. 
Total search results obtained from each database are presented in Table 2.2. Of 13,836 records 
identified by the electronic database searches, 13,420 records (97%) were excluded based on 
title and abstract sifting. Of the remaining 416 records, 400 (96.2%) were excluded during full-
text sifting: 350 (87.5%) because they did not assess health messages, 20 (5%) due to 
inappropriate article type, 15 (3.8%) did not investigate fMRI and a lifestyle behaviour of 
interest in this review, 9 (2.3%) had no visual stimuli, 2 (0.5%) did not provide sufficient detail, 
2 (0.5%) studied subjects aged <10 years and 2 (0.5%) were duplicates. Reference lists of the 
16 included records yielded 2 additional records for inclusion; resulting in 18 identified studies 
for this review. 
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Figure 2.1. A flow diagram of how the studies were identified 
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Table 2.2. An outline of the search results from the electronic databases 
Electronic database Number of search results 
PubMed 5,859 
SPORT Discus/Psych INFO 5,342 
Web of Science (Core Collaboration) 3,178 
Cochrane Library 2,883 
Open Grey 82 
Total 17,344 
Characteristics of included studies 
Of the resulting 18 studies, studies investigated smoking (k=15), diet (k=2), physical activity 
and sedentary behaviour (k=1) and no studies were included for alcohol consumption (see 
Table 2.3). All studies were published between January 2009 and November 2015 (inclusive). 
The sample sizes of the included studies ranged from having 24 to 91 participants. Included 
studies recruited participants between the ages of 13 and 69 years. Fourteen (77.8%) studies 
recruited both males and females, 1 (5.6%) study recruited males only and 3 (16.7%) studies 
did not provide sufficient detail. 
Of the 18 studies, ten (55.6%) were cross-sectional and eight (44.4%) were longitudinal in 
design. The eight longitudinal studies followed up participants one to four months following 
fMRI and were conducted via telephone, appointment or email to assess level of smoking 
abstinence (k=6), objectively measure sedentary behaviour/physical activity (k=1) or intention 
to quit smoking (k=1). 
Fourteen (77.8%) of studies were conducted in the USA, specifically Michigan (k=6), 
Pennsylvania (k= 6), California (k=1) and South Carolina (k=1). The remaining studies were 
conducted in Germany (k=2) and Canada (k=2). Further characteristics are provided in Table 
2.3.
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Table 2.3. Characteristics of each of the studies included 
Title 
N included 
within 
analyses 
N excluded 
from 
analyses 
Mean age 
(SD) 
Gender 
Handed-
ness 
Author, 
year 
Physical Activity or Sedentary Behaviour 
Self-affirmation alters the brain’s response to health 
messages and subsequent behaviour change 
46 21 
Affirmed 
33.7 (13.5); 
control 
30.1 (13.1) 
27 F 19 M 45 R 
Falk et al., 
2015  
Diet 
Nutrition labels influence value computation of food 
products in the ventromedial prefrontal cortex 
25 10 
23.3 (4.4) 
 
14 F 11 M 
Detail 
not 
provided 
Enax et al., 
2015  
Relation of obesity to neural activation in response to food 
commercials 
30 
Detail not 
provided 
15.2 (1.1) 17 F 13 M 
Detail 
not 
provided 
Gearhardt et 
al., 2014  
Smoking 
Neural responses to elements of a web-based smoking 
cessation program 
41 
Detail not 
provided 
38.3 (11.5) 10 F 31 M 41 R 
Chua et al., 
2009  
Neural correlates of message tailoring and self-relatedness 
in smoking cessation programming 
24 
Detail not 
provided 
40 (11.2) 12 F 12 M 24 R 
Chua et al., 
2009  
Self-related neural response to tailored smoking-cessation 
messages predicts quitting  
91 
Detail not 
provided 
37.5 (11.5) 44 F 47 M 91 R 
Chua et al., 
2011  
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Title 
N included 
within 
analyses 
N excluded 
from 
analyses 
Mean age 
(SD) 
Gender 
Handed-
ness 
Author, 
year 
Brain activity in self- and value-related regions in response 
to online antismoking messages predicts behaviour change 
46 4 32.1 (12.6) 19 F 27 M 46 R 
Cooper et 
al., 2015  
Where there’s smoke, there’s fire: the brain reactivity of 
chronic smokers when exposed to the negative value of 
smoking 
30 
Detail not 
provided 
31.9 (9.4) 15 F 15 M 29 R 1 L 
Dinh-
Williams et 
al., 2014  
Executive-affective connectivity in smokers viewing anti-
smoking images: an fMRI study 
30 
Detail not 
provided 
31.8 (9.2) 15 F 15 M 
28 R 1 L 
1 A 
Dinh-
Williams et 
al., 2014  
FDA cigarette warning labels lower craving and elicit 
frontoinsular activation in adolescent smokers 
79  1 
Detail not 
provided 
Detail not 
provided 
79 R 
Do & 
Galvan, 
2015  
Neural activity during health messaging predicts reductions 
in smoking above and beyond self-report 
28 3 45 (10.1) 15 F 13 M 28 R 
Falk et al., 
2011  
Functional brain imaging predicts public health campaign 
success 
44 6 
Detail not 
provided 
Detail not 
provided 
Detail 
not 
provided 
Falk et al., 
2016  
Amygdala response to smoking-cessation messages 
mediates the effects of serotonin transporter gene variation 
on quitting. 
82 
Detail not 
provided 
Quitters 
36.4 (11.4); 
non-quitters 
38.4 (12.3) 
38 F 44 M 
Detail 
not 
provided 
Jasinska et 
al., 2012  
Study One: Systematic Review 
 
56 
 
Abbreviations: A, ambidextrous; AS, argument strength; F, female; L, left; M, male; N, number; R, right; SD, standard deviation
Title 
N included 
within 
analyses 
N excluded 
from 
analyses 
Mean age 
(SD) 
Gender 
Handed-
ness 
Author, 
year 
Reduced prefrontal and temporal processing and recall of 
high ‘sensation value’ ads 
15 3 
Detail not 
provided 
3 F 12 M 
Detail 
not 
provided 
Langleben 
et al., 2009  
Neural biomarkers for assessing different types of imagery 
in pictorial health warning labels for cigarette packaging: a 
cross-sectional study 
50 
Detail not 
provided 
27.6 24 F 26 M 
Detail 
not 
provided 
Newman-
Norlund et 
al., 2014  
Severity of dependence modulates smokers’ neuronal cue 
reactivity and cigarette craving elicited by tobacco 
advertisement 
43 5 
Non-
abstinent 
31.0 (7); 
never-
smokers 
29.0 (5) 
43 M 43 R 
Vollstadt-
Klein et al., 
2011  
Content matters: neuroimaging investigation of brain and 
behavioural impact of televised anti-tobacco public service 
announcements 
63 8 
High AS 
29.0 (1.6); 
low AS 
30.0 (1.9) 
High AS 
18F 15M; 
Low AS 
14 F 16 M 
Detail 
not 
provided 
Wang et al., 
2013  
Emotional reaction facilitates the brain and behavioural 
impact of graphic cigarette warning labels in smokers 
19 5 
Detail not 
provided 
Detail not 
provided 
19 R 
Wang et al., 
2015  
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Main findings 
Stimuli content and modality  
Identifying the content and modality of stimuli helps provide valuable insight as to what forms 
of health messages are being assessed using fMRI. Full details of the stimuli presented in the 
eighteen studies are presented in Table 2.4. Of the eighteen identified studies, nine studies used 
static images (k=8 smoking, k=1 diet), four studies used videos (k=3 smoking, k=1 diet) and 
five studies used text-based messages (k=4 smoking, k=1 physical activity/sedentary 
behaviour). Static messages included the presentation of images such as banner adverts 
(Cooper et al., 2015) and warning labels found on cigarette packaging (Do et al., 2015). Videos 
included food commercials (Gearhardt et al., 2014) and public service announcements 
highlighting the importance of smoking cessation (Langleben et al., 2009). Finally, text-based 
messages included the presentation of motivational messages that encouraged smoking 
cessation (Chua et al., 2009) or presented tailored/untailored/neutral statements (Chua et al., 
2011). 
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Table 2.4. An outline of the fMRI protocol and main findings of the included studies 
Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Physical activity or sedentary behaviour 
Falk et al., 
2015  
Visual 
Promote activity and emphasise 
risks due to being sedentary 
(n=10); 
reasons not to be sedentary 
(n=10) or more active (n=10); 
tips for how to become more 
active (n=10) or less sedentary 
(n=10). 
Affirmed participants showed 
greater activity within vmPFC 
during exposure to targeted 
health messages. 
Accelerometry 1 month. 
2 SMS messages per 
day: 1 value affirmation 
(either affirmation or 
control allocation) and 1 
health message. 
Activity within the vmPFC 
predicted sedentary behaviour 
in the subsequent month. 
Diet 
Enax et al., 
2015  
Visual 
Healthy TL (n=25); 
unhealthy TL (n=25); 
healthy GDA (n=25); 
unhealthy GDA (n=25) 
Unhealthy TL showed 
significantly increased 
activation in the left inf. front. 
gyrus/dlPFC. 
No follow up N/A 
Gearhardt et 
al., 2014  
Visual 
(presence 
of audio 
unknown) 
Food commercials (n=20); 
non-food commercials (n=20) 
Food commercials exhibited 
greater activation in bilateral 
post. cerebellar lobe (declive), 
bil. middle occipital gyrus, 
right precentral gyrus, right 
inf. temporal gyrus, bil. inf. 
parietal lobe, left postcentral 
gyrus, right precuneus and 
right sup. parietal lobe. 
No follow up N/A 
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Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Smoking 
Chua et al., 
2009 
Visual 
(presence 
of audio 
unknown) 
Personalisation/feedback; 
motivational; 
instructional; 
control messages (targeted and 
neutral) 
Personalisation/feedback 
messages activated the mPFC 
and precuneus/post. cingulate. 
Web-based tailored 
smoking-cessation 
program and a 10-week 
course of nicotine 
patches. 
 
Follow up at 4 months  
Detail not provided 
Chua et al., 
2009 
Audio-
visual 
High tailored messages; low 
tailored messages; generic 
statements 
High-tailored messages 
produced greater activity in 
rmPFC and precuneus/post. 
cingulate regions. 
No follow up N/A 
Chua et al., 
2011  
Audio-
visual 
 
Tailored messages (n=50); 
untailored messages (n=50); 
neutral messages (n=50).  
The dmPFC, precuneus, and 
angular gyrus were 
preferentially engaged by 
tailored messages. 
Web-based tailored 
smoking-cessation 
program. 
 
Follow up at 4 months. 
Greater activation in the 
dmPFC during tailored 
messages significantly 
predicted the odds of quitting 
smoking. Greater activation in 
the precuneus was marginally 
correlated. 
Cooper et 
al., 2015  
Visual Banner ads (n=23) Detail not provided Follow up at 40 days. 
Behaviour change was 
significantly related to activity 
in self- and value-related sub-
regions of the mPFC 
(replicated previous findings). 
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Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Dinh-
Williams et 
al., 2014  
Visual 
Aversive smoking-related 
(n=25); 
aversive non-smoking related 
(n=25); 
appetitive smoking-related 
(n=25); 
neutral (n=25). 
 
Aversive smoking-related 
elicited activations in the 
visual association cortex and 
ext. visual system, the 
temporal and parietal lobes, 
limbic system, lat. 
orbitofrontal cortex, inf. front. 
gyrus and mPFC. 
No follow up N/A 
Dinh-
Williams et 
al., 2014  
Visual 
Aversive smoking-related 
(n=25); 
aversive IAPS control (n=25); 
neutral IAPS control (n=25) 
Aversive smoking-related 
elicited significantly greater 
activations in regions of the 
occipital, temporal and 
parietal lobes, amygdala, lat. 
orbitofrontal cortex, inf. front. 
gyrus and mPFC. 
No follow up N/A 
Do et al., 
2015  
Visual 
FDA warning labels (n=9); 
non-graphic labels (control) 
(n=9) 
Smokers’ demonstrated 
blunted recruitment of insula 
and dlPFC relative to non-
smokers.  
No follow up N/A 
      
Study One: Systematic Review 
 
61 
 
Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Falk et al., 
2011  
Visual 
(presence 
of audio 
unknown) 
TV commercials relevant to 
smokers who were trying to 
quit (n=16). 
Detail not provided Follow up at 1 month. 
Neural activity in the mPFC 
significantly predicted 
behaviour change. The med. 
precuneus/post. cingulate and a 
region involved in motor 
planning supplementary motor 
area were also highly 
associated. 
Falk et al., 
2016  
Visual 
Anti-smoking images with a 
tag-line 
Negative images (n=10) 
Neutral images (n=10) 
Personal/control images (n=10) 
Detail not provided 
Population-level email 
campaign (n=400,000). 
 
Presented either anti-
smoking or neutral 
image with a tagline to 
stop smoking. 
 
Measured intention to 
quit via option to obtain 
free nicotine patches 
Activity within mPFC sub-
region predicted population-
level campaign responses 
Self-related neural processing 
predicted outcomes in response 
to graphic warning labels, but 
not in response to 
compositionally similar neutral 
images. 
Jasinska et 
al., 2012  
Audio-
visual 
Tailored messages (n=50); 
untailored messages (n=50); 
neutral messages (n=50). 
Detail not provided 
Web-based tailored 
smoking-cessation 
program and a 10-week 
course of nicotine 
patches. 
Follow up at 4 months. 
The mean amygdala response 
was a significant predictor of 
subsequent post-intervention 
quitting outcome. 
Study One: Systematic Review 
 
62 
 
Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Langleben 
et al., 2009  
Audio-
visual 
Anti-smoking PSAs (n=8); 
neutral videos (n=8) 
PSAs were associated with 
higher activity in the inf. and 
mPFC, the occipital cortex 
(fusiform and lingual gyri) 
and the temporal cortex 
(hippocampus and 
parahippocampus). 
No follow up N/A 
Newman-
Norlund et 
al., 2014  
Visual 
 
Graphic health warning label 
(n=19); 
suffering health warning label 
(n=19); 
symbolic health warning label 
(n=19) 
Stimuli elicited a significant 
neural response in the 
amygdala, insula and visual 
association cortex, front. 
gyrus, temporal gyrus, parietal 
lobe (inf.), suppl. motor area, 
parahippocampal gyrus and 
thalamus. 
No follow up N/A 
Vollstadt-
Klein et al., 
2011 
Visual 
Smoking-related (n=45); 
control (n=45) 
Moderately dependent 
smokers’ brain activity 
elicited by tobacco 
advertisement was higher in 
the amygdala, hippocampus, 
putamen and thalamus. 
No follow up N/A 
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Abbreviations: AS, argument strength; bil., bilateral; dmPFC dorsomedial prefrontal cortex; FDA, Food and Drug Administration; ext., extended; front., 
frontal; GDA, guideline daily amount; IAPS, International Affective Picture System inf., inferior; lat., lateral; med., medial; mPFC, medial prefrontal cortex; 
mid., middle; MSV, message sensation value; post., posterior; PSAs, public service announcements; rmPFC, rostral medial prefrontal cortex; sup., superior; 
suppl., supplementary; TL, traffic light; vmPFC ventromedial prefrontal cortex
Author, 
year 
Modality 
of fMRI 
stimuli 
Content of fMRI task 
Principle findings of fMRI 
task 
Presence of a follow up 
Principle findings of the follow 
up 
Wang et al., 
2013  
Audio-
visual 
Anti-smoking PSAs  
High AS/high MSV (n=8); 
high AS/low MSV (n=8); 
low AS/high MSV (n=8); 
low AS/low MSV (n=8) 
The interaction of AS and 
MSV was observed in the bil. 
inf. parietal lobule, left inf. 
front. gyrus, left fusiform 
gyrus, the right dmPFC, and 
the precuneus. 
Follow up at 1 month. 
Activation in the dmPFC 
predicted the urine cotinine 
levels. 
Wang et al., 
2015  
Visual 
High FDA graphic warning 
label (n=12); 
low FDA graphic warning label 
(n=12); 
control (n=12) 
Graphic warning labels 
evoked greater activation in 
the bil. occipitoparietal cortex, 
including visual and fusiform 
areas, cuneus and precuneus, 
bil. temporal and inf. front. 
cortices, amygdala, 
hippocampus and 
parahippocampus.  
No follow up N/A 
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Brain activations 
The most common brain regions activated in the studies are presented in Table 2.5. 
Static health messages 
Significantly more activation in the temporal and parietal lobes, lateral orbitofrontal cortex, 
inferior frontal gyrus and medial prefrontal cortex were consistently observed across two 
studies assessing aversive smoking versus control images (Dinh-Williams et al., 2014; Dinh-
Williams et al., 2014). Another study observed activations in other regions (e.g. amygdala and 
hippocampus) in response to tobacco advertisement images (Vollstadt-Klein et al., 2011). Of 
the three studies investigating graphic warning labels, two studies identified significant neural 
responses in the amygdala (Newman-Norlund et al., 2014; Wang et al., 2015). The two 
remaining smoking-related studies (Cooper et al., 2015; Falk et al., 2016) focused on the 
predictive capacity of neural activation therefore the results are not highlighted in this section. 
Only one study (Enax et al., 2015) examined neural activation toward static health messages 
restricting the opportunity for comparison. No studies were identified for physical activity or 
sedentary behaviour. 
Video health messages 
Of the three studies investigating smoking-related health messages presented by video, one 
study (Falk et al., 2016) focused only on the predictive capacity of brain activation on 
subsequent behaviour. The other two studies examined neural activation in response to anti-
smoking public service announcements but compared these stimuli with neutral videos 
(Langleben et al., 2009) or varying videos with varying levels of ‘message sensation value’ 
and ‘argument strength’ (Wang et al., 2013). This was reflected in the findings which 
highlighted no common brain regions between them. In addition, only one study (Gearhardt et 
al., 2014) investigated diet health messages delivered by video. No studies were identified for 
physical activity or sedentary behaviour. 
Text-based health messages 
Three of the four studies identified regions within the prefrontal cortex and precuneus as 
preferentially engaged in response to tailored/personalised text-based messages. These regions 
included the rostral medial prefrontal cortex (Chua et al., 2009), medial prefrontal cortex (Chua 
et al., 2009) and the dorso-medial prefrontal cortex (Chua et al., 2011). The fourth study  
instead focused on the predictive capacity of brain activation on subsequent behaviour 
(Jasinska et al., 2012). In contrast, only one study (Falk et al., 2015) investigated this form of 
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health message for physical activity/sedentary behaviour. No studies were identified for text-
based health messages relating to diet. 
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Table 2.5. An outline of how often activated brain regions were reported within the identified studies (criteria: ≥2 studies reported the brain region) 
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Inferior frontal gyrus              
Precuneus              
Amygdala              
Fusiform              
Inferior parietal lobe              
Middle temporal gyrus              
Precentral gyrus              
Lingual gyrus              
Medial prefrontal cortex              
Middle frontal gyrus              
Parra-hippocampal gyrus              
Posterior cingulate              
Superior frontal gyrus              
Caudate              
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Cerebellum              
Dorsolateral prefrontal cortex              
Dorsomedial prefrontal cortex              
Hippocampus              
Inferior occipital              
Insula              
Middle occipital gyrus              
Putamen              
Superior temporal gyrus              
 
Abbreviations: PA, physical activity; SB, sedentary behaviour.
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Predictive capacity of fMRI for behaviour change 
In total, eight studies assessed the predictive capacity of fMRI (k=7 smoking, k=1 physical 
activity/sedentary behaviour). Of the seven studies focused on smoking, six studies identified 
that the following activated brain regions were predictive of smoking abstinence: the 
dorsomedial prefrontal cortex (k=2), medial prefrontal cortex (k=2), amygdala (k=1) and the 
supplementary motor area (k=1). The physical activity/sedentary behaviour study (Falk et al., 
2015) identified the ventromedial prefrontal cortex as predictive of subsequent time spent 
sedentary. 
2.5. Discussion 
Summary 
The present review identified 18 studies; 15 relating to health messages about smoking, two 
relating to health messages about diet and one on health messages about physical 
activity/sedentary behaviour. Areas of the prefrontal cortex and amygdala were most 
commonly activated with increased activation of the ventromedial prefrontal cortex predicting 
subsequent behaviour change (e.g. smoking cessation). Most of the evidence on the utility of 
fMRI to facilitate behaviour change currently relates to smoking and there was a lack of RCTs; 
limiting findings to correlations rather than causal interpretation. More fMRI studies on health 
messages relating to physical activity, sedentary behaviour, dietary intake and alcohol 
consumption are needed that incorporate an RCT design. 
Stimuli content and modality 
The present review highlighted that a range of anti-smoking materials were investigating both 
pictorial and video stimuli such as US Food and Drug Administration (FDA) warning labels 
(Do & Galvan, 2015; Wang et al., 2015) and public services announcements (PSAs) 
(Langleben et al., 2009), respectively. Studies that compared neural responses to tailored and 
untailored messages observed activations in the dorsomedial prefrontal cortex and 
precuneus/posterior cingulate (e.g. Chua et al., 2009, 2011). Other studies demonstrated that 
aversive smoking stimuli, compared with neutral images, elicited greater activations in the 
amygdala (Dinh-Williams et al., 2014); often associated with emotion regulation (LeDoux, 
2003). With a range of anti-smoking materials currently advertised, it must be acknowledged 
that people respond and engage differently with them. For instance, Dos and Galvan identified 
that current smokers had a blunted response in the dorsolateral prefrontal cortex and insula 
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relative to non-smokers to cigarette warning labels (Do et al., 2015). This suggests that the 
health messages were not causing the same neural response in the smokers as in the non-
smokers and so perhaps multiple versions of health messages should be produced to target all 
people. For example, specific messaging materials could be developed to highlight the benefits 
of not starting a behaviour (proactive approach) and other materials to highlight the benefits of 
stopping a behaviour (reactive approach). Presenting pictures of people living with obesity, 
having limited mobility or other health issues such as diabetic foot on chairs and inside 
escalators (including sites that are likely to attract active individuals e.g. gyms and parks) could 
be a comparable approach to promote physical activity, within the community, across the entire 
population (i.e. active and inactive). 
As demonstrated in the present review, point-of-decision prompts such as pictures on cigarette 
packaging or traffic light coding systems found on food items are widely used in anti-tobacco 
and food industry communications, respectively, to deter purchasing. Other methods, such as 
billboard advertisements and videos (e.g. PSAs) enable similar but wider messages to reach 
the wider public and are often accompanied by graphic health messages; suggested to elicit 
stronger emotional responses than text-based messages alone (Kees et al., 2006). As previously 
mentioned, for physical activity and sedentary behaviour, point-of-decision prompts are placed 
at specific locations where people are forced to make a behavioural decision as to whether be 
active or sedentary, respectively. For instance, prompts that encourage people to take the stairs 
rather than the escalator have shown short-term promise (Webb & Eves, 2005). However, it is 
currently unknown whether these highlighted health messages activate brain regions associated 
with ‘the self’; previously suggested to motivate people to adjust behaviour (Wheeler et al., 
2007). Efforts to change behaviour generally result in short-term successes and a subsequent 
relapse or complete failure (Polivy & Herman, 2002). These failures are often aligned to the 
difficulty experienced when changing a habit and so rely on the use of cues and triggers to 
support the habit formation process (Neal et al., 2012). Therefore, more research using fMRI 
needs to be conducted to focus on alternative point-of-decision prompts that relate to promoting 
physical activity, minimising sedentary behaviour and improving dietary intake. Overall, this 
will likely inform the distribution of effective health messages across the different lifestyle 
behaviours in various locations to encourage positive behaviours.  
Activated brain regions 
The present review identified that the ventromedial prefrontal cortex, medial prefrontal cortex, 
and dorsomedial prefrontal cortex were activated in response to anti-smoking health messages 
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that were aversive or tailored. No studies explicitly stated whether the tailored messages were 
aversive or not. The medial prefrontal cortex is a well-established area of the brain associated 
with self-related processing (Lieberman, 2010); suggesting that individuals are self-reflecting 
whilst shown stimuli and are therefore potentially more likely to be engaging with the stimulus 
compared with an individual who does not have activation in that region. However, as with all 
fMRI research, caution is advised when interpreting findings; mainly attributed to the notion 
of reverse inference which suggests that brain activation infers the engagement of a specific 
cognitive process (Poldrack, 2006). Tailored health messages activated regions of the 
prefrontal cortex, precuneus and posterior cingulate regions which are associated with 
retrieving episodic autobiographical memories (Levine et al., 2004) as well as reflecting on 
one’s own traits (Johnson et al., 2002) and personal intentions (Den Ouden et al., 2005). The 
present review identified nine additional studies to those highlighted in a recent neuroimaging 
review (Kaye et al., 2016) which focused on wider health communication; including studies 
focusing on narcotic substance use, safe sex and sun safety. These studies investigated the 
perceived value of health messages and how greater neural activity was observed in certain 
populations (e.g. high risk cannabis users) (Kaye et al., 2016). 
Presenting caloric information activated the inferior frontal gyrus/dorsolateral prefrontal cortex 
region (Enax et al., 2015); a region implicated in self-control (Hare et al., 2011). The 
importance of this brain region is implicated in various domains of self-control, including 
compliance toward social norms (Maldjian et al., 2003) and controlling impulses in inter-
temporal choice (Figner et al., 2010). The ventromedial prefrontal cortex is implicated in 
simple-choice value computation (Enax et al., 2015). These findings suggest that health 
messages resonate with the individual and encourage them to self-reflect but it does not confirm 
that those individuals subsequently change their behaviour following exposure to the health 
message. Other studies, not eligible to be included in the present review, have begun to examine 
neural responses to pictures of individuals being physically active or sedentary (Jackson et al., 
2014; Kullmann et al., 2014). For instance, if an individual viewed a picture of someone else 
jogging, what brain regions are activated and does exposure result in desired changes to 
physical activity? Recent advances, such as the release of a new parcellation (mapping) tool 
identifying 97 further sub-regions within the cerebral cortex (Glasser et al., 2015), will help to 
further elucidate knowledge around the specific functions aligned with regions of interest 
which will help confirm findings obtained via studies using fMRI. 
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Predictive capacity of fMRI for behaviour change 
The present review identified that the brain regions that were identified as predictive (by 
association) of smoking cessation were the dorsomedial prefrontal cortex, amygdala, the 
supplementary motor area and the medial prefrontal cortex; associated with self-related 
processing (Lieberman, 2010). The other lifestyle behaviour study that conducted a follow up 
focused on changes in physical activity and sedentary behaviour. Interestingly, Falk and 
colleagues identified a different brain region as predictive of subsequent reductions in time 
spent sitting with activations observed in the ventromedial prefrontal cortex (Falk et al., 2015). 
Unfortunately, findings from the present review confirm that all studies that investigated the 
predictive capacity of fMRI for behaviour change conducted prospective, longitudinal studies 
and so report correlational data which cannot be causal. In addition, there appeared to be 
inconsistent findings such that there was not a single brain region that was activated across all 
of the health message stimuli due to the variety of health messages presented. 
Falk and colleagues also assessed the role of self-affirmation; in particular, how exposing 
individuals to their core values (e.g. friends and family, money and religion) prior to the task 
demonstrated that the stimuli was more self-relevant and valuable (Falk et al., 2011). The link 
between neural activity and behaviour change via self-processing is supported (Falk et al., 
2010) with findings suggesting that individuals more engrossed in anti-smoking advertisements 
report an increased benefit (i.e. are less likely to smoke or more likely to stop smoking) (Dunlop 
et al., 2008) and that self-relevant messages are likely more effective than generic messages 
(Dietz et al., 2008; Strecher et al., 2008). Findings from Kaye and colleagues confirmed that 
activation in the medial prefrontal cortex accounted for additional variance beyond that of self-
report measures (Kaye et al., 2016). Unfortunately, as highlighted by the present review, there 
is currently limited or a lack of evidence for changes in physical activity, sedentary behaviour, 
diet and alcohol following health message exposure. Future studies should consider 
implementing an RCT within their longitudinal studies to promote research assessing 
behaviour change across the different lifestyle behaviours. 
Future considerations 
With an increase in the application of digital technologies within healthcare systems for use in 
patients with chronic conditions, it is an important time to ensure that the health messages 
provided by these devices are effective (Driver, 2016). Presenting health messages via digital 
platforms such as wearable devices to promote standing and walking or via smartphone apps 
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to help monitor food, cigarette and alcohol consumption, given their omnipresence, could be 
very effective and not too dissimilar to the handheld health message platform of cigarettes or 
food packaging. That said, it must also be acknowledged that equivalent images (e.g. of yellow 
teeth for smoking) to reflect the physiological consequence of physical inactivity and sedentary 
behaviour are not as direct. These images could include foot amputations and atherosclerosis, 
as a couple of examples, but sadly these images could also be aligned to poor dietary intake; 
restricting our ability to capture peoples responses to their movement behaviours. Overall, 
future fMRI studies should aim to evaluate brain responses to different forms of health 
messages across the different lifestyle behaviours and incorporate longitudinal but controlled 
study designs to optimise the interpretation and consistency of study findings. 
Literature Methodology 
Of the 13 (72.2%) studies that stated their recruitment strategy, the majority presented 
advertisements in the community or via the internet; thus, recruiting self-selected and non-
randomised individuals. In addition, only two studies recruited adolescents despite the onset of 
an unhealthy lifestyle often beginning in the early-to-mid adolescent years. Most studies were 
conducted in either Michigan or Pennsylvania in the USA (k= 16); potentially attributable to 
the general limitations of fMRI such as restricted access and cost. In addition, nine studies 
either failed to report participant handedness or recruited a mixture of left, right and 
ambidextrous handed participants. The importance of reporting handedness is due to its clear 
link to cerebral dominance for activities such as language processing (Goodglass & Quadfasel, 
1954). Future research would benefit from standardising, and precisely measuring, the time 
between tobacco, food and alcohol consumption and exercise before the onset of the fMRI task. 
Limitations 
The present review acknowledges the following limitations. Firstly, there were only 18 studies 
identified by the electronic database search and reference lists and there was a lack of 
causational studies; therefore, it is difficult to draw any conclusions. Secondly, only eight 
studies examined behaviour change with seven (87.5%) of these conducted in relation to 
smoking cessation. In addition, there was a lack of studies identified for physical activity, 
sedentary behaviour, diet and alcohol. Studies published outside of the databases searched were 
not considered for inclusion. Future research is required to examine the utility of fMRI to 
examine health messaging relating to these lifestyle behaviours. 
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2.6. Conclusions 
This review highlights a skewed focus on the impact of health messages on brain activation 
relating to smoking behaviours and reveals gaps that need addressing in the physical activity 
messaging literature. Collating findings from multiple lifestyle behaviours could prove useful 
to begin producing more persuasive messages for population behaviour change; however, there 
is currently a deficiency of studies across the lifestyle behaviours to investigate this at this 
stage. Regardless of this, the review highlights that the prefrontal cortex and amygdala were 
most commonly activated in response to health messages and that the ventromedial prefrontal 
cortex was predictive (by association) of subsequent behaviour change. Future studies should 
focus on the assessment of point-of-decision prompts, PSAs and tailored messages (e.g. 
feedback notifications) across all lifestyle behaviours. Considering these findings, we are going 
to explore the use of fMRI to monitor brain activation in response to stimuli relating to 
personalised feedback often presented on digital health technologies. 
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Chapter Three 
 
Study Two: 
Brain activation in response to personalised behavioural 
and physiological feedback from self-monitoring 
technology: Pilot Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Whelan, ME; Morgan, PS; Sherar, LB; Kingsnorth, AP; Magistro, D; Esliger, DW. Brain 
activation in response to personalised behavioural and physiological feedback from self-
monitoring technology. Journal of Medical Internet Research. 2017;19(11): e384. 
Appendix D. Original publication has been adapted to fit within this thesis. 
DOI: 10.2196/jmir.8890 
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3.1. Introduction 
Physical inactivity, insufficient levels of physical activity, is attributable to 9% of premature 
mortality and 7% of type 2 diabetes cases (Lee et al., 2012). In addition, sedentary behaviour, 
defined as ‘any waking behaviour characterised by an energy expenditure ≤1.5 metabolic 
equivalents of task (METs) while in a sitting or reclining posture’ (Tremblay et al., 2017), has 
been strongly associated with poor cardiometabolic health (Henson et al., 2013). With adults 
spending an estimated 7 hours sedentary each day (Matthews et al., 2008) and the prevalence 
of type 2 diabetes expected to rise to 592 million by 2035 (Guariguata et al., 2014), it is critical 
to address the prevalence of physical inactivity and time spent sedentary for the prevention of 
type 2 diabetes and other important chronic, noncommunicable diseases. 
Over the last decade, wearable activity monitors have grown in popularity in consumer markets 
to help users track their movement behaviours (e.g. active minutes, step counts, distance 
travelled, time spent sitting) (Loveday et al., 2015; Sanders et al., 2016). Over the same period, 
wearable physiological sensing devices (e.g. heart rate monitors, continuous glucose monitors) 
have been evolving and are now venturing beyond the clinical domain into consumer-focused 
markets (Bonander & Gates, 2010). The allure of these wearable technologies is that they 
provide users with real-time, personalised health feedback that may encourage positive lifestyle 
behaviours (e.g. moving more, sitting less, eating more healthily) (Piwek et al., 2016). 
However, with 32% of individuals failing to continue using these devices beyond 6 months 
following purchase (Ledger et al., 2014), there is a need to optimise the feedback provided to 
the users to maintain adoption and sustain engagement with the information presented. Patel 
and colleagues suggest that providing explanatory feedback in an understandable manner is 
important to encourage sustained use (Patel et al., 2015). Given that sustained behaviour 
change is often poorly reported and not often achieved (Fjeldsoe et al., 2011), assessing how 
people respond to this feedback at a cortical level (by monitoring changes in brain activation) 
could reveal additional insight above traditional qualitative tools such as focus groups or 
interviews. 
Neuroimaging techniques are useful to recognise and identify the intricate relationships 
between cognitions, brain functions and behaviour (Lee & Harris, 2015). There has been 
growing interest in the community toward communication neuroscience, research that provides 
a deep understanding of attitude and behaviour change (Falk et al., 2010). Moreover, 
communication neuroscience research suggests that people’s intentions and behaviour are 
largely affected by the content and format of an advertisement (Fishbein & Cappella, 2006). 
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One key neuroimaging tool is functional magnetic resonance imaging (fMRI), which monitors 
neural responses as information is presented (Lieberman, 2010) (e.g. health messages and 
advertisements (Chua et al., 2011; Falk et al., 2010, 2011). Receiving personalised (or self-
related) feedback is often associated with activation within the rostral medial prefrontal cortex 
(mPFC), associated with decision making and mimicry behaviour (Euston et al., 2012; Wang 
& Hamilton, 2014), and the precuneus/posterior cingulate region, often associated with 
personal reflection (Johnson et al., 2002; Kelley et al., 2002; Phan et al., 2004). In particular, 
self-relevant messages elucidate more activation within the mPFC than untailored messages 
(Chua et al., 2009) and can predict behaviour change (Fishbein et al., 2000). Meta-analyses of 
fMRI studies also suggest that the mPFC and precuneus/posterior cingulate regions mediate 
self-related processing (Northoff et al., 2006). 
Functional MRI can improve our understanding of how cognitive processes vary between those 
who do change their behaviour following exposure to a stimulus and those who do not  (Cascio 
et al., 2013). The mPFC is positioned whereby activation in this region can predict individual 
behaviour change (Cooper et al., 2015; Falk et al., 2010, 2011). To date, research has largely 
focused on identifying neural responses to antismoking material (Cooper et al., 2015; Dinh-
Williams et al., 2014; Falk et al., 2011) rather than diet, alcohol consumption, physical 
inactivity, or sedentary behaviour (Whelan et al., 2017; Chapter Two). Investigating how 
people respond to personalised feedback relating to these lifestyle behaviours could offer 
crucial insight into how best to disseminate feedback to maximise effect; potentially helping to 
design materials that optimise population health (Vecchiato et al., 2011). For instance, 
observed reductions in smoking rates have been attributed to a number of influences, in part, 
by the dissemination of health message labels on cigarette packaging (Wakefield et al., 2008). 
Given that literature to date has largely assessed how people respond to antismoking materials, 
fMRI may help identify how people’s brains respond to information commonly presented on 
the screens of wearable devices and associated smartphone apps. We hypothesize that the 
mPFC and precuneus/posterior cingulate regions will be activated given the presentation of 
personalised (self-relevant) feedback (Johnson et al., 2002; Kelley et al., 2002; Northoff et al., 
2006; Northoff & Bermpohl, 2004; Phan et al., 2004). 
3.2. Aims and objectives 
The aims of this study were to (i) identify regions of the brain activated in response to 
personalised behavioural and physiological feedback messages and (ii) examine behaviour 
change and associations with levels of brain activation. 
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3.3. Methods 
Participants 
A total of 33 participants were recruited from a university in the UK via advertisement posters 
and email. Participants were aged 30 to 60 years, had no mobility-related musculoskeletal 
problems, had no confirmed diagnosis of diabetes, were willing and able to comply with the 
study protocol, met standard fMRI safety criteria (no metal in body, not claustrophobic, not 
pregnant), and were right-handed (self-reported). All participants completed a physical activity 
readiness questionnaire (Warburton et al., 2011) prior to participation with positive responses 
assessed by a clinician. 
Experimental procedures were approved by the Loughborough University Ethics Advisory 
Committee (R15-P142). 
Procedure 
Data were collected between June and September 2016. The study design is presented in Figure 
3.1. During the first appointment, participants provided informed consent; answered questions 
relating to age, sex, ethnicity, and education; and completed a selection of health measures 
(body composition, blood pressure, and blood sample). Following the identification of a gap 
within the fMRI literature (Chapter Two), physical activity and sedentary behaviour health 
messages were partly employed alongside glucose feedback, as the stimulus for Study Two. 
As a result, participants were fitted with three devices to monitor their physical activity, 
sedentary behaviour, and glucose levels for 14 days. In addition, participants were provided an 
education booklet to take away with them prior to baseline to read approximately one week 
before their fMRI appointment (Appendix E). This booklet included definitions and UK 
national recommendations (e.g. 150 minutes of moderate-to-vigorous physical activity per 
week and target glucose range) to help minimise any variations in knowledge. The fMRI took 
place at the second appointment (on average 32.4±10.5 days following the first appointment); 
following this, participants continued to wear two devices to monitor physical activity and 
sedentary behaviour for 8 days. Participants were not informed about the true reason why they 
were wearing the devices again (i.e. to monitor behaviour change), only to monitor their 
behaviour once final time. At the end of the follow-up period, participants returned the devices 
and received a comprehensive personalised health report. 
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Figure 3.1. An illustration of the study design 
Measures 
Physical health 
Weight and body fat percentage were measured using the MC 780 MA scale (Tanita) following 
the removal of shoes and socks. Body mass index was calculated as weight (kg) divided by 
height (m) squared (weight/height2). Glucose and haemoglobin A1c (HbA1c) were analysed 
using a Cholestech LDX system and Afinion AS100 Analyzer (both Alere Inc), respectively. 
Participants arrived fasted for ≥8 hours prior to the collection of a capillary blood sample. 
Accelerometry 
A wGT3X-BT accelerometer (ActiGraph, Pensacola, FL) (Figure 3.2) was worn on a 
waistband (on the right anterior axillary line) to objectively measure physical activity. 
Participants were asked to wear the validated device (Aadland & Ylvisåker, 2015) during 
waking hours and to remove for any water-based activities (e.g. showers or bathing). The 
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accelerometry data were collected at 100 Hz resolution and integrated into 60 second epochs 
using ActiLife version 6.13.2 (ActiGraph LLC) and processed using Kinesoft version 3.3.80 
(Kinesoft). Data were classified as stationary time (≤100 counts per min [cpm]), light activity 
(101 to 2019 cpm), or MVPA (>2019 cpm) (Troiano et al., 2008). Nonwear was identified by 
an interval of at least 60 consecutive minutes of zero activity intensity counts, with allowance 
for up to 2 minutes (Troiano et al., 2008). Participants who had <4 valid days were excluded 
from analyses. A valid day was defined as having ≥10 hours of monitor wear. Accelerometers 
were initialised to begin monitoring at the end of appointments, which meant participants had 
a variable amount of possible wear on the first day. As a result, to standardise the opportunity 
for participants to adhere to device wear, days 2 through 8 were analysed for both baseline and 
follow-up. A global wear time variable was calculated as the mean of wear time at baseline and 
follow-up. 
 
 
 
 
   
Figure 3.2. Images of the ActiGraph (left), Lumo (middle) and Freestyle Libre (right) 
Inclinometry 
A Lumo (Lumo Bodytech Inc, Palo Alto, CA; Figure 3.2) posture sensor was worn on a 
waistband (in the lumbosacral region) in contact with the skin to measure sedentary behaviour 
(time spent sitting, driving, lying, standing, stepping, and number of sit-to-stand transitions) 
during baseline and follow-up. Devices were calibrated to the wearer using the Lumo app 
which offers a default calibration process and was used as a way to check it was detecting 
various postures. Participants were asked to walk for 30 seconds before doing at least two sit-
to-stand transitions. Whilst doing this, the researcher checked the app’s avatar was replicating 
the participant’s movements. Participants were asked to wear the device only during waking 
hours, remove it for any water-based activities (e.g. showers or bathing), and place the device 
on charge overnight each day. The Lumo has been found to produce valid measurements of 
sedentary behaviour, with a mean absolute percent error of 9.5% for time spent sedentary 
compared with the ActivPAL (PAL Technologies Ltd) (Rosenberger et al., 2016). Data from 
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the Lumo devices were analysed in 5-minute epochs (highest resolution) using Excel 
(Microsoft Corp). Nonwear was defined by 1 of 2 criteria: (1) device removal for sleep which 
was automatically detected if the device was placed on charge or (2) prolonged periods of the 
same posture deemed to be biologically unlikely (i.e. ≥60 minutes in the position ‘sit bad 
forward’). Prior to follow up device deployment, participants were asked to wear the devices 
(i.e. no emphasise was made about them having been exposed to their feedback). Again, the 
Lumos were set up to begin monitoring at the end of appointments and days 2 through 8 were 
analysed for both baseline and follow-up. 
Flash glucose monitoring 
The Freestyle Libre flash glucose monitor (Abbott Diabetes Care, Alameda, CA, Figure 3.2) 
measures interstitial glucose levels via a minimally invasive 5 mm flexible filament inserted 
into the posterior upper arm. The sensor works based on the glucose-oxidase process by 
measuring an electrical current proportional to the concentration of glucose. Tegaderm 
transparent film dressing (3M Health Care) was applied on top of the sensor to maintain its 
position. Participants were informed not to remove the sensor and to scan at least once every 7 
hours (a conservative decision as the manufacturer states 8 hours to avoid data loss). As a result, 
participants were able to see their real-time glucose levels during baseline wear. An indication 
of how many times participants viewed this information (level of exposure) was identified by 
the frequency with which they scanned. Missing data were obtained because of a fault (sensor 
last <14 days) or the participant failed to scan at least once every 8 hours. The Freestyle Libre 
has been previously validated against venous sampling with an overall mean absolute 
difference of 11.4% with consistent accuracy throughout the 14 days (Bailey et al., 2015). 
Glucose data were downloaded in 15-minute epochs (highest resolution possible) using 
Freestyle Libre version 1.0. The raw data were used to calculate the number of high glucose 
events (defined as ≥8.8 mmol/L) and to identify valid days. Days were defined as valid if they 
met the prespecified threshold of ≥90% of data points (96 expected based on 4 readings each 
hour across each 24-hour period). All 14 days were analysed from baseline wear. Area under 
the curve was calculated from the mean area of the positive peaks across the valid days using 
Graph Pad Prism version 7.0.0 (GraphPad Software) and participants’ fasting glucose level 
were used as the baseline. 
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Functional MRI stimuli 
Twenty personalised feedback messages were created for the purposes of this study and 
covered 4 topics: MVPA, light physical activity, sedentary behaviour, and glucose levels (all 
presented in Figure 3.3 with example data). They intended to reflect feedback metrics presented 
on wearable technologies, but it was challenging to identify what specific metrics were 
included that would be meaningful to participants. Data obtained via accelerometry, 
inclinometry, and flash glucose monitoring were analysed and then incorporated into the 
feedback messages. Therefore, the values presented on the messages were personalised so that 
the numbers varied between participants, but the image and text remained consistent. The 
images were matched in visual complexity, colour, and text font using Axure RP Pro version 
7.0.0.3190 (Axure Software Solutions Inc) to standardise stimuli across participants. Picture 
icons were identified and downloaded from an icon resource website (www.flaticon.com). 
 
Figure 3.3. An example of the personalised feedback stimuli images displayed to participants 
inside the MRI scanner 
Stimuli were presented on a monitor located 2.8 m behind the centre of the scanner bore and 
viewed by a mirror mounted on the head coil. Adjustments to the positioning of the mirror were 
made for participants to ensure that the full monitor screen could be seen. We examined neural 
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activity while participants were presented with feedback and were requested to maintain 
attention throughout. Prior to the start of the fMRI task, there was an initial period of 40 seconds 
of dummy scans which were immediately discarded. The fMRI task is outlined in Figure 3.4. 
In total, 24 blocks (12 active, 12 rest) were presented during the protocol. Each active block 
consisted of stimulus presentation of 5 back-to-back trials (referred to as images from this point 
forward) of 8 secs each, totalling 40 secs, followed by a rest period of 40 secs, during which 
participants viewed a fixation cross and were instructed to clear their minds. The order of the 
blocks and back-to-back images (within the blocks) were not presented in a counterbalanced 
or randomised order. 
 
Figure 3.4. An outline of the trial setup including 8 of the 24 blocks presented 
Functional MRI data acquisition 
Brain imaging data were acquired on a 3T Discovery MR750w scanner (General 
Electric) using a 32-channel head coil at the National Centre for Sport and Exercise Medicine, 
Loughborough University, United Kingdom. Structural images (T1-weighted) were acquired 
using a fast-spoiled gradient echo (FSPGR) Bravo sequence (3D volume, FSPGR; TR=8.2 ms; 
TE=3.1 ms; matrix size 240×240; 160 sagittal slices; FOV=240 mm; 1 mm thick). One 
functional scan lasting 16 minutes (480 volumes) was acquired during the task (2D gradient 
echo EPI; TR=2000 ms; TE=30 ms; flip angle=75 degrees; matrix size 64×64; 35 axial slices; 
FOV=205 mm; 3 mm thick). Stimulus presentation and synchronisation to scanner acquisition 
were performed using the software program Presentation version 18.1 (Neurobehavioral 
Systems Inc). 
Behaviour change techniques 
During the fMRI appointment, participants will be presented personalised feedback about their 
physical activity levels, sedentary behaviour and interstitial glucose levels. In line with Michie 
et al’s taxonomy, this study encompassed the following behaviour change techniques: self-
monitoring of behaviour, self-monitoring of outcome(s) of behaviour and biofeedback. 
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Data analysis 
Functional MRI 
Functional MRI data analysis 
Functional data were pre-processed and analysed using statistical parametric mapping (SPM12, 
Wellcome Department of Cognitive Neurology). All data reported are from scans that exhibited 
≤3 mm in translational movement. Data were processed using a standard statistical parametric 
mapping approach, which consisted of scan realignment, co-registration, segmentation, 
normalisation, and smoothing. Data were spatially aligned to the first functional image using 
4th degree B-spline interpolation. Scans were then co-registered (mean functional image 
aligned with T1 then parameters applied to all functional images). Functional images were 
normalised into the Montreal Neurological Institute (MNI) standard stereotactic space with 
parameters applied to all functional images. A final smoothing step with a Gaussian Kernel 
with full width half maximum of 8 mm was applied to improve signal-to-noise ratio. The onsets 
and durations of each of the conditions of interest were modelled according to the block design 
described in the protocol. For each participant, brain activation was estimated using a general 
linear model (GLM) and included movement parameters (3 translations, 3 rotations) and a 
session constant as regressors. All regressors were convolved with SPM12’s canonical 
difference of the hemodynamic response function. Data were high-pass filtered with a cut off 
of 128 seconds to remove low-frequency noise and slow drifts in the signal. Family-wise error 
(FWE) correction was used to correct for multiple comparisons at PFWE<.001 and PFWE<.05 for 
the initial contrasts of interest and the additional contrasts, respectively. At the first level for 
each participant, contrasts were computed using a series of univariate analyses of covariance 
(ANCOVAs), averaging activity across the topics compared with baseline (i.e. (1) 
MVPA>baseline, (2) light physical activity>baseline, (3) sedentary>baseline, (4) 
glucose>baseline, and (5) behaviour>baseline). Additional contrasts were computed using a 
series of univariate ANCOVAs, averaging activity between the different blocks of stimuli (i.e. 
MVPA>light physical activity and glucose>sedentary) and reverse contrasts also computed 
(i.e. light physical activity>MVPA and sedentary>glucose). 
Second level random effects models for each task were constructed that averaged across 
participants and were subjected to further region of interest (ROI) and between-group analysis. 
Exploratory whole brain searches were conducted for each contrast with a threshold set at 
P<.001 and P<.05 for the baseline contrasts and intergroup contrasts, respectively (cluster 
threshold of k=0 voxels). Between-group analyses were conducted to compare gender 
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differences and differences between those least (<150 minutes of bouted MVPA/week) and 
most (≥150 minutes of bouted MVPA/week) active. Using independent samples t test analysis, 
brain regions were labelled according to the MNI anatomic labelling tool in the Wake Forest 
University Pickatlas (WFU Pickatlas) (Tzourio-Mazoyer et al., 2002). The average beta 
parameter estimates of activity during the presentation of information compared with other 
information blocks were extracted using MarsBaR, an ROI toolbox. All models controlled for 
centred demographic variables (centred age and sex). An additional centred variable (number 
of daily glucose scans) was included within the additional contrasts conducted. 
Statistical analysis 
To examine demographic and self-report data, we conducted descriptive analyses using SPSS 
version 22.0 (IBM Corp). Repeated measures ANCOVAs were conducted to assess changes in 
behaviour (levels of MVPA, light physical activity, and sedentary behaviour) from baseline to 
follow-up, controlling for global wear time (average wear time). Tests of statistical significance 
conducted with alpha set to 0.05. 
Correlation analysis 
Parameter estimates corresponding to each significantly activated region, identified via fMRI 
analysis, were extracted for each participant. Linear regressions provided partial correlation 
coefficients between the parameter estimates from the significant regions of interest and 
subsequent behaviour at follow-up (i.e. time spent in MVPA, light physical activity, and 
sedentary), controlling for wear time. The relationships between behaviour change and activity 
from the ROIs were examined in separate models for each ROI and the analyses were repeated 
to assess behaviour via both accelerometry and inclinometry data.  
3.4. Results 
Participant characteristics 
A flow chart of individuals through the study and the characteristics of the sample are presented 
in Figure 3.5 and Table 3.1, respectively. Four participants were excluded from fMRI analyses 
due to incorrect scanner parameter setup, poor participant vision (without glasses), and 
presence of an unsafe magnetic resonance implant. One participant fell asleep, and an 
additional participant was excluded due to incorrect accelerometry initialisation. This resulted 
in a final sample of 28 participants. 
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The 28 participants (43% male) had a mean age of 45.1±9.4 years (range 30 to 59 years). 
Twenty (71%) received a bachelor’s degree or higher, 3 (11%) participants completed 
secondary school and 5 (18%) completed some additional training. Twenty-five (89%) were 
White, 2 (7%) were Chinese, and 1 (4%) was Asian or Asian British. Males were significantly 
taller (178.7 versus 167.5 cm), had a lower body fat percentage (18.8% versus 32.6%), and 
scanned the Freestyle Libre more frequently (11.7 versus 9.1 scans/day). 
 
 
Figure 3.5. A flow chart of how participants progressed through the study 
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Table 3.1. Participant baseline characteristics, reported as mean±SD 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abbreviations: HbA1c, glycated haemoglobin; HDL, high-density lipoprotein; mmol/L, millimoles per 
litre. † n=23 as n=5 measures were outside of measuring range. a No participants reported 100% of 
target range for glucose levels so the threshold was brought down to 90%. 
Activated brain regions 
First, we contrasted each of the four topics with a fixation cross. The brain regions significantly 
activated in response to the initial contrasts of interest are presented in Table 3.2. Regions 
 Whole Sample (n = 28) 
Body composition 
Height (cm)  172.3±10 
Weight (kg) 75.2±15.3 
Body mass index (kg/m2) 25.2±4.3 
Body fat (%) 26.7±9.3 
Waist circumference (cm) 85.7±11.3 
Cardio-metabolic 
Systolic blood pressure (mmHg) 119.1±11.4 
Diastolic blood pressure (mmHg) 72.8±7.2 
Resting heart rate (bpm) 60.3±11.2 
HbA1c (%) 5.4±0.4 
Glucose (mmol/L) 5±0.6 
Total cholesterol (mmol/L) 4.8±0.9 
Triglycerides (mmol/L)† 0.9±0.2 
HDL cholesterol (mmol/L) 1.5±0.4 
Glucose monitoring 
Average glucose (mmol/L) 5±0.5 
Area under the curve (units) 37.2±27.9 
Time in range (%) 88.3±8.1 
Scan count (per day) 10.3±4.3 
Feedback – attainment of targets  
Number of participants achieving ≥100% 
of the MVPA guidelines N(%) 
11 (39.3) 
Number of participants achieving ≥100% 
of the steps guidelines N(%) 
9 (32.1) 
Number of participants achieving ≤100% 
of the sedentary guidelines N(%) 
4 (14.3) 
Number of participants achieving ≥90%a 
of glucose target range N(%) 
13 (46.4) 
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include the middle and inferior occipital gyrus, middle frontal gyrus, lingual gyrus, subgyral, 
and thalamus (P<.001). No significant voxels were identified between those most and least 
active or between males and females. 
Table 3.2. Average contrasting differencesa compared with baseline 
Region Hem x y z Voxels Z t PFWE 
MVPA > Baseline         
Middle Occipital Gyrus L -38 -74 -14 178 6.29 9.99 <0.001 
Lingual Gyrus L -14 -94 -10  6.25 9.89 < 0.001 
Inferior Occipital Gyrus L -22 -90 -14  6.21 9.76 < 0.001 
Sub-Gyral R 36 -62 -16 11 6.06 9.29 < 0.001 
Fusiform Gyrus L -36 -54 -16 9 5.97 9.03 < 0.001 
Sub-Gyral R 34 -84 -6 93 5.95 8.97 < 0.001 
Lingual Gyrus R 24 -92 -10  5.86 8.74 < 0.001 
Lingual Gyrus R 16 -90 -8  5.63 8.11 0.001 
Inferior Occipital Gyrus R 44 -76 -12 2 5.62 8.09 0.001 
Middle Occipital Gyrus R 30 -88 4 1 5.57 7.97 0.001 
Light PA > Baseline         
Cuneus L -16 -96 -2 101 6.47 10.61 <0.001 
Middle Occipital Gyrus L -32 -84 -14 119 6.23 9.80 <0.001 
Middle Occipital Gyrus L -38 -72 -14  6.05 9.28 <0.001 
Sub-Gyral R 34 -84 -6 83 6.05 9.26 <0.001 
Middle Occipital Gyrus R 30 -84 -14  5.68 8.24 0.001 
Middle Occipital Gyrus R 46 -76 -10 23 6.01 9.14 <0.001 
Sub-Gyral R 36 -62 -16 23 5.90 8.83 <0.001 
Middle Occipital Gyrus R 28 -98 6 19 5.77 8.48 <0.001 
Fusiform Gyrus L -36 -54 -16 3 5.77 8.47 <0.001 
Fusiform Gyrus L -34 -50 -18 2 5.70 8.30 <0.001 
Inferior Frontal Gyrus L -54 18 20 4 5.69 8.27 <0.001 
Lingual Gyrus R 16 -90 -10 10 5.65 8.18 0.001 
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Region Hem x y z Voxels Z t PFWE 
Sedentary > Baseline         
Middle Occipital Gyrus L -36 -72 -16 19 5.99 9.11 <0.001 
Inferior Occipital Gyrus L -38 -82 -10 46 5.95 8.98 <0.001 
Sub-Gyral L -20 -94 -6 36 5.87 8.77 <0.001 
Middle Occipital Gyrus R 36 -84 -4 4 5.78 8.50 <0.001 
Inferior Frontal Gyrus L -48 14 22 3 5.65 8.16 0.001 
Middle Occipital Gyrus R 48 -76 -10 3 5.59 8.02 0.001 
Sub-Gyral R 28 -88 -6 1 5.57 7.97 0.001 
Glucose > Baseline         
Cuneus L -16 -96 -6 218 6.69 11.38 <0.001 
Middle Occipital Gyrus L -36 -74 -16  6.13 9.50 <0.001 
Middle Occipital Gyrus L -20 -90 -14  5.90 8.83 <0.001 
Sub-Gyral R 36 -62 -16 13 5.99 9.10 <0.001 
Lingual Gyral R 14 -90 -8 28 5.97 9.05 <0.001 
Sub-Gyral R 28 -84 -6 56 5.88 8.78 <0.001 
Middle Frontal Gyrus L -40 10 30 6 5.69 8.27 <0.001 
Middle Occipital Gyrus R 44 -76 -14 1 5.60 8.05 0.001 
Middle Occipital Gyrus R 30 -84 -14 2 5.58 8.00 0.001 
Behaviour > Baseline         
Middle Occipital Gyrus L -38 -72 -16 272 6.44 10.49 <0.001 
Cuneus L -16 -96 -6  6.33 10.12 <0.001 
Middle Occipital Gyrus L -32 -84 -14  6.07 9.33 <0.001 
Sub-Gyral R 36 -62 -16 27 6.16 9.61 <0.001 
Sub-Gyral R 34 -84 -6 135 6.14 9.53 <0.001 
Lingual Gyral R 22 -92 -10  5.85 8.69 <0.001 
Middle Occipital Gyrus R 30 -84 -14  5.75 8.42 <0.001 
Superior Parietal Lobule L -32 -62 58 5 6.06 9.28 <0.001 
Middle Occipital Gyrus R 46 -76 -12 24 5.96 9.00 <0.001 
Middle Occipital Gyrus R 48 -66 -14  5.88 8.79 <0.001 
Fusiform Gyrus L -36 -54 -16 8 5.95 8.98 <0.001 
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Abbreviations: L, left; hem, hemisphere; MVPA, moderate-to-vigorous physical activity; PA, physical 
activity; R, right. a threshold set to p<0.001, cluster threshold of k = 0 voxels. Hem relates to which 
hemisphere the brain region was identified (i.e. left or right). X, Y and Z relate to the Montreal 
Neurological Institute (MNI) coordinates that relate to the brain region listed. Voxels refers to the total 
number of voxels identified as significant in that brain region. Z reflects the z-score and t reflects the t-
statistic whilst PFWE is the p-value after accounting for family wise error (i.e. multiple comparisons). 
Behaviour refers to the inclusion of light physical activity, MVPA and sedentary behaviour. 
We then proceeded to the main analysis that contrasted the topics between themselves. The 
brain regions identified as significantly activated are presented in Table 3.3. Of the additional 
contrasts of interest, the glucose>behaviour contrast highlighted significant activation in the 
middle frontal gyrus (–32, 36, –12, z=5.60) and left subgyral (–26, 48, 4, z=5.33). The 
glucose>sedentary contrast revealed significant activation in the cuneus (–2, –80, 4, z=5.05), 
middle frontal gyrus (–32, 36, –12, z=4.95; –20, 34, 42, z=4.94), superior frontal gyrus (–26, 
50, 4, z=4.79), and right subgyral (28, –52, 24, z=4.66) (Figure 3.6, Table 3.3). 
Table 3.3. Average contrasting differences between blocks of stimuli (controlling for age, 
gender and daily scans)a 
Abbreviations: L, left; hem., hemisphere; MNI, Montreal Neurological Institute, MVPA, moderate-to-
vigorous physical activity; R, right. a threshold set to p<0.05, cluster threshold of k = 0 voxels. Hem 
relates to which hemisphere the brain region was identified (i.e. left or right). X, Y and Z relate to the 
Montreal Neurological Institute (MNI) coordinates that relate to the brain region listed. Voxels refers 
Region Hem x y z Voxels Z t PFWE 
Middle Frontal Gyrus L -52 26 26 9 5.73 8.38 <0.001 
Thalamus R 22 -28 -2 2 5.69 8.27 0.001 
Region Hem x y z Voxels Z t PFWE 
Glucose > Behaviour 
Middle Frontal Gyrus L -32 36 -12 25 5.60 8.17 < 0.001 
Sub-Gyral L -26 48 4 16 5.33 7.48 < 0.001 
Glucose > Sedentary 
Cuneus L -2 -80 4 34 5.05 6.85 < 0.001 
Middle Frontal Gyrus L -32 36 -12 8 4.95 6.63 < 0.001 
Middle Frontal Gyrus L -20 34 42 11 4.94 6.61 < 0.001 
Superior Frontal Gyrus L -26 50 4 3 4.79 6.29 < 0.001 
Sub-Gyral R 28 -52 24 1 4.66 6.04 < 0.001 
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to the total number of voxels identified as significant in that brain region. Z reflects the z-score and t 
reflects the t-statistic whilst PFWE is the p-value after accounting for family wise error (i.e. multiple 
comparisons). Behaviour refers to the inclusion of light physical activity, MVPA and sedentary 
behaviour. 
 
Figure 3.6. An illustration of group activation for glucose>behaviour at (a) -32, 36, -12 and (b) 
-26, 48, 4 
Behaviour change 
The behavioural characteristics obtained via accelerometry and inclinometry are presented in 
Table 3.4. Among the 28 participants, 100% provided ≥4 days for accelerometry during 
baseline and follow-up. In contrast, only 15 (54%) and 20 (71%) participants provided ≥4 valid 
days at baseline and follow-up with the inclinometer, respectively, revealing a reduced sample 
(13 vs 28). As a result, the criteria for the Lumo was adjusted to ≥1 valid days (hereby 
identifying the limitation for using the LUMO as a data logger). From baseline to follow-up, 
wear time and sedentary time reduced while minutes of MVPA and counts per minute 
increased. After controlling for global wear time, only time spent sedentary remained 
significant for both the accelerometry and inclinometry (589±13.9 min vs 560±11.7 min, 
P=.014 and 602.2±19.4 min vs 554.5±18.1 min, P=.001, respectively). Despite a lack of change 
at the whole sample level for time spent in light physical activity, MVPA, and step count, 9 
(32%), 17 (61%), and 16 (57%) participants, respectively, positively increased the amount of 
steps, light physical activity, and MVPA at follow-up (unadjusted for global wear time). Males 
accumulated significantly more vigorous physical activity compared with females at baseline 
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and follow-up (P=.029 and P=.026, respectively) and also significantly more minutes of 
MVPA (P=.033) at follow-up. No significant associations were observed between number of 
scans and changes in behaviour via accelerometry or inclinometry (controlling for global wear 
time). 
Table 3.4. Behavioural characteristics, reported as mean±SD 
Abbreviations: CPM, counts per minute; LVPA, light-to-vigorous physical activity; MVPA, moderate-
to-vigorous physical activity. *, p<0.05 
Functional MRI correlations 
To investigate the relationship between brain activation and subsequent behaviour, parameter 
estimates were calculated for the patterns of neural activation. Of these, only glucose feedback 
was positively associated with subsequent minutes of MVPA (r=0.392, P=.043). No significant 
associations were observed for the inclinometry data. 
 
 
 
 Accelerometry (n=28) Inclinometry (n=23) 
 Baseline Follow Up Baseline Follow Up 
Number of Valid Days 7±0 7±1 4.2±2.1 5.5±1.7 
Wear Time 903.5±67.7 868.2±70.4* 924.3±61.9 884±61.6* 
Step Count 9065±3456 9634±3699 8661±2996 9580±4326 
CPM 388.1±174.7 410±182.8* - - 
Sedentary (min) 589.0±84.7 560±75.6* 602.2±91.1 554.5±89.4* 
Light PA (min) 265±69 254.2±71.1 - - 
Moderate (min) 45.8±31 50.7±33.2 - - 
Vigorous (min) 3.6±6.6 3.2±6.2 - - 
MVPA (min) 49.4±34.2 53.9±35.5* - - 
LVPA (min) 314.4±66.4 308.1±72.1 - - 
Stepping (min) - - 93.5±26.7 103.2±44.1 
Standing (min) - - 228.5±98.5 226.5±67.8 
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3.5. Discussion 
Summary 
As recent neuroimaging work has highlighted value in analysing individual responses to 
feedback relating to lifestyle behaviours (Falk et al., 2010), we used fMRI to examine neural 
responses to personalised feedback relating to physical activity, sedentary behaviour, and 
interstitial glucose levels. We also investigated associations between neural activity and 
subsequent behaviour. This study lies at the intersection of 3 rapidly evolving areas of interest: 
wearables, lifestyle behaviours, and neuroimaging. Our study identified that presenting people 
with personalised feedback relating to interstitial glucose levels resulted in significantly more 
brain activation when compared with personalised behavioural feedback. 
Activated regions of the brain 
Our findings identified activations within regions of the prefrontal cortex, in particular the 
middle frontal gyrus, subgyral, cuneus, and superior frontal gyrus upon comparison of 
personalised glucose feedback with behavioural feedback. Previous studies have also identified 
regions within the prefrontal cortex following exposure to antismoking images (Cooper et al., 
2015), messages encouraging sunscreen use (Falk et al., 2010), and informative nutritional 
labels (Enax et al., 2015). The authors hypothesized that the mPFC and precuneus/posterior 
cingulate regions would be activated in our study given the presentation of personalised 
feedback (Johnson et al., 2002; Northoff et al., 2006; Northoff & Bermpohl, 2004; Phan et al., 
2004; Wang & Hamilton, 2014). Other fMRI studies have identified alternate activated regions 
including the ventromedial prefrontal cortex, inferior frontal gyrus, and amygdala when 
presented information about other lifestyle behaviours (e.g. smoking) (Dinh-Williams et al., 
2014; Falk et al., 2015; Newman-Norlund et al., 2014). The findings suggest that the 
personalised feedback did not offer identical regions of interest when compared with the 
literature; however, some activation did overlap with the mPFC. Neuroimaging studies impose 
additional complexity because identical neural patterns can result after exposure to different 
stimuli (Tognoli & Kelso, 2015). However, the identified regions of brain activation may also 
differ because the stimuli differ between fMRI studies. Our study used a combination of text 
and images to inform participants about their physical activity, sedentary behaviour, and 
interstitial glucose levels. In comparison, Falk and colleagues presented images with text and 
numbers in a sentence (multiple lines of text) (Falk et al., 2015). Overall, our findings suggest 
that it is possible to identify what brain regions are activated in response to personalised 
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feedback and that glucose-related feedback evoked more brain activation. As a result, wearable 
technologies presenting personalised glucose feedback may be useful to employ in future 
interventions. 
Investigating how individuals responded to personalised health-related feedback was an 
important component of this study as it has been well documented that receiving tailored 
feedback can result in greater resonance and consequently result in desirable health behaviours 
(Brug et al., 1996; Skinner et al., 1994; Strecher et al., 1994). Our study demonstrated that 
presenting feedback pertaining to an individual’s glucose levels elicited significantly more 
brain activation within the middle frontal gyrus and subgyral compared with the behavioural 
feedback. These regions, anatomically positioned within Brodmann areas 9/10 and 47, 
respectively, have previously been associated with the actions of making personal moral 
judgments (Greene & Haidt, 2002) and working memory (d’Esposito et al., 1998), respectively. 
Previous studies have investigated messages promoting child vaccinations against measles-
mumps-rubella and identified that highlighting the dangers of not vaccinating may actually be 
counterproductive (Nyhan et al., 2014); therefore, findings are often highly dependent on the 
topic investigated. Future studies could investigate the role of self-affirmation, a construct 
suggested to increase individual sensitivity to health-risk information and incorporated in prior 
neuroimaging studies (Cooper et al., 2015; Falk et al., 2015). Self-affirmation essentially 
investigates how neural activity patterns vary to information after being exposed to personally 
important values (e.g. friends, family, and religion). Given that the desirable outcome is for 
people to positively respond to health-related information, exposing a person to their personal 
values may provoke attention and enhance the importance of the information being given. 
Therefore, future investigation into whether self-affirmation could contribute to increasing the 
level of resonance toward personalised feedback and encourage positive behaviours may be 
crucial. 
Behaviour change and associations with brain activation 
Our study identified a significant reduction of 29 minutes (or 47 minutes using inclinometry) 
in time spent sedentary from baseline to follow-up. Previous findings support this finding, 
having observed a 39.6 min/day reduction in time spent sedentary (Chu et al., 2016). However, 
no significant differences were observed for time spent in MVPA, light physical activity, or 
step count. Wearable technologies research to date has offered the suggestion that people can 
increase their activity levels having received feedback about behaviour (Bravata et al., 2007; 
Stephenson et al., 2017). However, it must be acknowledged that physical activity, for example, 
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has been categorised as a very complex behaviour and no single metric can encapsulate a 
person’s level of physical activity (Thompson et al., 2015). According to the literature, changes 
in behaviour most likely occur when personalised health messages are presented in moments 
when action can be taken (e.g. at midday to promote a walk following the consumption of 
lunch) (Patel et al., 2015). Despite participants being presented personalised feedback, there 
are a multitude of reasons as to why they may or may not have changed their behaviour during 
the follow-up period. Therefore, determining whether their behaviour (change or no change) 
was because of the exposure to health-related information is truly unknown. However, 
emphasising that the feedback was only briefly presented and within an unusual situation (i.e. 
inside an MRI scanner) is warranted when comparing how people normally receive 
personalised feedback through wearable technologies. Further investigation could quantify or 
contextualise the follow-up period to try and account for extraneous variables (e.g. weather, 
holiday, illness) or consider the inclusion of a control group to provide more definitive findings. 
In regard to the relationship of activation and subsequent behaviour during the follow-up 
period, findings identified a positive partial correlation with minutes of MVPA. Previous 
studies have investigated behaviour change subsequent to fMRI and have demonstrated 
positive associations between neural response (e.g. to aversive smoking-related images) and 
smoking cessation (Falk et al., 2011; Jasinska et al., 2012). For example, Falk and colleagues 
identified that greater reductions in sedentary behaviour aligned with greater activity in the 
ventromedial prefrontal cortex, suggesting that if people exhibited greater levels of activation 
in response to the visual stimuli, those individuals were subsequently more likely to be less 
sedentary (Falk et al., 2015). On a larger scale, identifying what stimuli (i.e. health messages) 
evoke positive behaviours (e.g. being less sedentary or more active) can inform the provision 
of effective public health messages. It could be suggested that, despite the observed association, 
being presented personalised feedback about health and behaviour while inside an MRI scanner 
is not a normal environment. Consequently, alternate neuroimaging tools could be useful for 
future investigation within a free-living setting. For instance, individuals could obtain 
personalised feedback via a wearable device or a smartphone app while their neural activity is 
recorded by a portable electroencephalogram system via functional near infrared spectroscopy 
or by eye tracking (to monitor gaze patterns and fixations). Interestingly, eye tracking has 
previously been conducted on various health communication materials including both cigarette 
advertising (Krugman et al., 1994) and nutrition labels (Oliveira et al., 2016). 
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Strengths and limitations 
Positioned at the intersection of several evolving interest areas, this interdisciplinary study 
offers a number of strengths. One strength was presenting personalised feedback pertaining to 
both movement behaviours and physiology to participants. These components were objectively 
measured during baseline and follow-up using novel digital health technologies, obtaining data 
to directly inform the feedback. In addition, some of the information that was presented in the 
fMRI tasks were designed based on feedback commonly presented via wearable devices or 
smartphone apps, reflecting what could be received in real-time in a real-world setting. Future 
efforts should consider how best to ensure the feedback metrics are meaningful (i.e. standalone) 
and truly encapsulate physical activity, sedentary behaviour and glucose regulation. It may be 
worthwhile considering the incorporation of public engagement to co-produce and design these 
materials. Objective quantification of behaviour at follow-up permitted the assessment of 
behaviour following exposure and associations between neural activation and behaviour. 
Limitations of our study include the situation that participants viewed their glucose levels 
during baseline wear, an unavoidable situation given intentions to minimise data loss. This 
protocol confirms that participants had prior exposure to the glucose-related feedback 
subsequently presented during fMRI. However, to help try and account for this, analysis 
included the number of scans as a covariate because we thought the number of scans suggested 
the frequency with which participants viewed their glucose levels (e.g. more scans equalled 
more exposure and so a greater awareness of their glucose levels). Another limitation was that 
participants were provided a copy of the education booklet prior to baseline. Despite being 
instructed to access this resource one week prior to their fMRI appointment, it is possible that 
participants read this material prior to baseline. In addition, there was a delay between 
participants completing baseline and attending the fMRI appointment which may have 
impacted the potential perceived relevancy of the feedback. Following the composition of our 
sample, it would have been beneficial to exclude individuals who self-reported themselves as 
active to enhance the opportunity for individuals to feel able to increase their levels of physical 
activity. Furthermore, our unpowered sample size was another limitation, as we are unable to 
offer definitive interpretation of the findings. Finally, the pattern of neural activity observed 
and related psychological processes should be interpreted with caution due to the nature of 
reverse inference (Poldrack, 2006). Future studies could investigate neural activity in polar 
groups of people classified by activity or time spent sedentary and to repeat fMRI, so patterns 
of brain activation are quantified before and after exposure to the feedback. 
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3.6. Conclusions 
This multidisciplinary study highlighted that fMRI can be used to assess the neural response to 
personalised health feedback. In particular, greater activation in the prefrontal cortex during 
exposure to glucose compared with behavioural feedback was observed. A reduction in time 
spent sedentary and a positive association between the parameter estimates and subsequent 
minutes of MVPA were observed. Future research deploying behavioural feedback in parallel 
with physiological feedback to encourage positive behaviour change is warranted. 
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Chapter Four 
 
Study Three: 
Sensing Interstitial Glucose to Nudge Active Lifestyles 
(SIGNAL): Feasibility of combining novel self-
monitoring technologies for persuasive behaviour 
change 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N.B. Study protocol has been published (Appendix F). 
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4.1. Introduction 
In England, the prevalence of type 2 diabetes has increased from 2.3 million in 2013 to 3 
million in 2016 (NHS Digital, 2016). More alarming still, the prevalence of prediabetes, a 
preclinical stage comprising impaired glucose tolerance and impaired fasting glucose, has 
increased more than three-fold from 2003 to 2011, burdening more than one-third of UK adults 
(Mainous et al., 2014). These trends are global in reach and as a result, 592 million individuals 
worldwide are projected to be diagnosed with type 2 diabetes by 2035 (Guariguata et al., 2014). 
Given this, developing successful interventions to prevent type 2 diabetes is a crucial public 
health priority (Barry et al., 2017) given that 5-10% of people living with prediabetes progress 
to develop type 2 diabetes annually (Bansal, 2015). To date, structured lifestyle interventions 
have shown promise in both the prevention and delayed onset of diabetes (e.g. Diabetes 
Prevention Group, 2002; Norris et al., 2005); however, implementing these interventions into 
routine clinical settings has proven difficult (Cardona-Morrell et al., 2010).  
Over the last decade digital health technologies, most notably wearable activity monitors, have 
flooded the consumer market and are recognised as a leading trend by industry experts 
(Ferguson et al., 2015). Smartphone applications (apps) commonly connect with digital health 
technologies to provide feedback to the user. In 2017 alone, 78,000 new apps were added (16% 
higher than 2016) bringing the total to 325,000 available health apps (Research2Guidance, 
2017). Health apps are becoming increasingly sophisticated most often with a primary function 
of presenting goal-oriented feedback to offer guidance to the user (e.g. daily step count in 
relation to 10,000 steps/day). With increasing technological advancement, wearable digital 
health technologies have evolved to provide feedback not only on movement behaviours but 
also the physiological consequences of behaviours (e.g. sensors measuring continuous glucose, 
heart rate and blood pressure). Continual improvements in the sensing elements in digital health 
technologies provide an opportunity to examine whether coupling these two feedback elements 
(i.e. movement behaviours and their physiological consequences) could lead to more potent 
behaviour change messaging and thus warrants further investigation. 
A previous study provided thirteen pre-diabetics and type 2 diabetics with information on their 
glucose concentrations in relation to prescribed bouts of exercise (Bailey et al., 2016). 
Participants were enrolled into standard care (i.e. self-monitoring exercise using a logbook) or 
the intervention (standard care plus self-monitoring of glucose using a continuous glucose 
monitor). Findings highlighted that self-monitoring both exercise and glucose led to greater 
adherence to the exercise programme over eight weeks compared with individuals self-
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monitoring exercise only. Another study provided fifty-two inactive type 2 diabetics ‘role 
model’ graphs of glucose levels that identified activity-related reductions in glucose to 
illustrate the benefits of physical activity (Allen et al., 2008). All participants received 90 
minutes of individualised education including topics about diabetes physiology, glucose testing 
and diet, but the intervention group also wore a continuous glucose monitor for three days at 
baseline. The intervention group demonstrated a five-minute increase in moderate physical 
activity at the expense of sedentary time at eight weeks. Collectively, these findings support 
the potential for providing users with coupled physiological and behavioural feedback. 
However, to the authors’ knowledge, no study has provided individuals with digital health 
technologies that provide coupled (i.e. simultaneous) feedback on both physical activity and 
glucose in free-living conditions.  
Before large-scale studies providing physiological and behavioural feedback to individuals at 
risk of developing type 2 diabetes are conducted, the extent to which individuals engage with 
the intervention needs to be understood. This is important not only for researchers but clinicians 
and industry alike. With the provision of combined physiological and behavioural feedback in 
its infancy (i.e. immature), it is important to examine how these individuals engage with digital 
health technologies and health apps providing this feedback. For example, in a study of over 
12 million adult users of a weight loss app ‘Lose It!’, authors found that those who customised 
the app to their personal preferences engaged for a longer period of time compared to those 
who kept the default configuration (Serrano et al., 2017). Such insights into how people 
naturally engage with digital health technologies may help optimise the delivery of future 
interventions and promote their incorporation into existing national prevention programmes. 
Objectively measuring how long people spend on health apps and how they use digital health 
technologies may permit the identification of sub-groups requiring different levels of support 
to lead a more physically active lifestyle. Therefore, the present study examined how 
individuals at moderate-high risk of developing type 2 diabetes naturally engaged with 
wearable digital health technologies and associated health apps providing continuous, objective 
physical activity and glucose feedback over six weeks. 
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4.2. Aims and objectives 
Primary aim 
To examine participant engagement with physical activity and glucose self-monitoring 
technologies over 6 weeks; assessed by app usage, scan frequency (glucose), sync frequency 
(physical activity) and changes to physical activity goals. 
Secondary aims 
To (i) assess the acceptability and practicality of the intervention trial, (ii) establish levels of 
physical activity and glucose at baseline, 1, 2, 3, 4, 5, and 6 weeks; (iii) inform the development 
of a full-scale RCT. 
4.3. Methods 
Study design 
A detailed description of the study protocol has been published (Whelan et al., 2017; Appendix 
F). Briefly, the seven-week protocol consisted of a baseline period (one week) and an 
intervention period (six weeks). Following baseline, participants were randomised into one of 
three groups (described further below) and all participants wore an activity monitor and a 
glucose sensor during the intervention period (regardless of group allocation). The 
Loughborough University Ethics Advisory Committee provided ethical approval for the study 
in April 2017 (Research Proposal R17-P049). 
Inclusion criteria 
Adults aged ≥40 years, who recorded a moderate-to-high risk of developing Type 2 diabetes 
on Leicester Risk Assessment screening tool (i.e. ≥16 points out of 47) (Gray et al., 2010) and 
owned a compatible Android smartphone were eligible to take part. Compatible smartphones 
were defined as having the following characteristics: An Android operating system of ≥4.0, 
Near Field Communication (NFC) capability, a screen resolution of 480x800 to 1080x1920 
and a screen size of 8.9-14.5cm. These requirements were in place to ensure participants could 
install the LibreLink app on their smartphone; thereby preventing iOS smartphone owners from 
taking part. However, it is likely that with continuing app development the need to implement 
strict smartphone criteria will disappear in the near future. As per LibreLink app guidance, 
known smartphones (at the time of recruitment) that duly meet the above compatibility criteria 
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but for some reason do not work were the Samsung Galaxy 7, Samsung S8, Nexus 5X and 
Nexus 6P. 
Exclusion criteria 
Individuals were excluded if they had been diagnosed with any form of diabetes, presented 
with a HbA1c of ≥6.5% at baseline, had suspected/confirmed pregnancy, who were unable or 
unwilling to provide informed consent, who could not or were unwilling to adhere to the study 
protocol or could not read and write English.  
Recruitment 
Interested individuals were recruited between May and September 2017. Participants were 
initially recruited via community organisations through the distribution of posters, letters and 
emails sent to existing participant databases within Leicestershire, UK. To further boost 
recruitment, recruitment efforts (using posters and emails) were also directed toward local 
businesses and local social media channels (i.e. Facebook and Twitter). Interested individuals 
were directed to complete a brief online survey to determine level of risk for type 2 diabetes 
(Gray et al., 2010) via Qualtrics (Qualtrics, Provo, UT). The questions related to sex, age, ethnic 
background, familial history of diabetes, waist circumference, body mass index and blood 
pressure (Gray et al., 2010). The waist circumference question was modified to instead ask 
participants about their clothing size and fit rather than a direct measurement of their waist 
circumference (in cm). Their responses to these two clothing fit questions were used to 
calculate an estimated waist circumference value (Battram et al., 2011) which was 
subsequently used to determine level of risk. Upon completion, moderate (16-24 points out of 
47) and high-risk (≥25 points out of 47) individuals self-reporting ownership of a compatible 
smartphone were contacted and sent a participant information sheet via email. Ineligible 
individuals were informed of their risk and directed to Diabetes UK risk prevention 
documentation. Individuals who continued to express an interest in taking part (having read the 
study material and confirmed eligibility) were contacted about scheduling the baseline 
appointment.  
Intervention groups 
Participants were block randomised (3, 6 and 9 block sizes) using a 1:1:1 study allocation ratio 
into one of three groups (Figure 4.1). Group allocations were concealed from the researcher 
until participants completed baseline wear in an effort to minimise the introduction of any bias. 
Participants were informed of their group allocation after completing baseline wear. Group 1 
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were offered glucose feedback for 4 weeks (G4) followed by glucose plus physical activity 
feedback for 2 weeks (GPA2) (hereon referred to as G4GPA2). Group 2 were offered physical 
activity feedback for 4 weeks (PA4) followed by glucose plus physical activity feedback for 2 
weeks (GPA2) (hereon referred to as PA4GPA2). Group 3 were offered glucose plus physical 
activity feedback for six weeks (hereon referred to as GPA6).  
It should be acknowledged at this stage that the derivation of these groups followed substantial 
discussion around which study design would best meet the research question and study budget. 
We arrived at the conclusion of the study protocol outlined in Figure 4.1 in part by the following 
factors: the lifespan of the glucose sensors were 2 weeks; intentions to maximise data on 
participant engagement with the technologies (i.e. decided against a true control group); 
intended to ensure participant engagement was captured using both devices simultaneously 
across all participants; two weeks was likely insufficient for initial exposure and total duration 
appeared long enough to identify behaviour change but not too long for financial outlay. 
 
Figure 4.1. An outline of the study protocol. G4GPA2 represents glucose feedback (4 weeks) 
followed by glucose and physical activity feedback (2 weeks); PA4GPA2 represents physical 
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activity feedback (4 weeks) followed by glucose and physical activity feedback (2 weeks) and 
GPA6 represents glucose and physical activity feedback (6 weeks). Abbreviations: G, glucose 
feedback; PA, physical activity feedback; GPA, glucose plus physical activity feedback. 
Wearable technologies 
Fitbit 
Physical activity feedback was provided by a Fitbit Charge 2 (Fitbit Inc., San Francisco, CA) 
(Appendix G). Participants were asked to wear the Fitbit on their non-dominant wrist during 
waking hours; removing it for sleep and any water-based activities. Participants were asked to 
charge the Fitbit overnight every night and to sync the device at least once every five days to 
minimise data loss. In an effort to monitor participant adherence to charging and syncing, the 
research team sent participants reminder emails to either charge (if battery level reached <25%) 
or to sync (if it had been ≥5 days since the previous recorded sync). Battery level was remotely 
monitored with Fitbit sending emails automatically to the research team when the Fitbit battery 
reached a critical level (<25%). Fitbit syncs were remotely monitored via the Fitabase 
dashboard (Small Steps Labs LLC., San Diego, CA) which ordered participant Fitbit accounts 
by time since last sync; allowing easy identification of participants who had not synced their 
Fitbit for >5 days. No syncs were extracted for G4GPA2 during intervention weeks 1 to 4 to 
minimise participant interaction with the technology. Devices were initialised using the Fitbit 
app and the data were downloaded via Fitabase. The raw 60-second epoch data were re-
structured to present 1,440 epochs/day. Data were analysed by Kinesoft version 3.3.80 
(Kinesoft, Lougborough, UK).  
Physical activity feedback was displayed on both the Fitbit screen (wrist) and the participant’s 
smartphone (via the app). The following metrics were viewable: daily step count; floors (flights 
of stairs) climbed; number of active minutes; number of calories burned (kcal); heart rate and 
number of hours achieving ≥250 steps. The Fitbit app also provided historical information and 
more comprehensive information for all of the metrics (e.g. hourly graphs).  
Freestyle Libre 
Feedback on glucose levels during the intervention period was provided by a Freestyle Libre 
flash glucose monitor (Abbott Diabetes Care, Alameda, CA) (Appendix G). In total, 
participants wore three Freestyle Libre sensors (one every two weeks) during the intervention 
period. These minimally-invasive, disposable sensors were worn on the non-dominant 
posterior brachium. Participants were asked to scan the sensor using the LibreLink app once 
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every seven to eight hours (three times per day) as a minimum to avoid data loss. Participants 
were not prompted at all about their scanning frequency and were able to set reminders to scan 
via the LibreLink app. No charging or calibration of the sensors was required. Glucose levels 
were captured by the LibreLink app and extracted in 15-second epochs using Diasend (Diasend 
Inc., Chicago, IL). No data were recorded for PA4GPA2 during the intervention weeks 1 to 4 
as participants were not set up with the Freestyle Libre app or asked to scan the device but this 
will likely become void in future iterations. A valid day was defined as having ≥90% of glucose 
data and only valid days were carried forward for analyses.  
Interstitial glucose levels were categorised as: normal (4.0-5.9 mmol/L), above range (≥6.0 
mmol/L) or below range (<4.0 mmol/L) (International Diabetes Federation, 2007). Each 
participant scan was characterised by the following metrics: glucose level (mmol/L), rate of 
change (i.e. rising quickly, rising, changing slowly, falling, falling quickly or no trend arrow; 
thresholds for these metrics not provided by the manufacturer), target zone (normal, above 
range or below range) and a 24-hour graph of glucose. Glucose feedback was displayed on the 
LibreLink app only and the following metrics were viewable: glucose levels (value at the time 
of scanning and a graph of the previous 24 hours); an arrow to suggest rate and direction of 
change; time spent in target range; number of low glucose events and historical data (e.g. 
glucose levels on previous days). 
Primary outcomes 
User engagement 
An assessment of participant engagement was conducted to help determine if this unique 
intervention of coupled feedback warrants further investigation. Participant engagement with 
the self-monitoring technologies was assessed by time spent on the smartphone apps, the 
frequency the Freestyle Libre was scanned and the frequency the Fitbit was synced and any 
changes to the set physical activity goals. The duration of time spent on the study-related apps 
(Figure 4.2) was recorded in minutes, as either a summary of total time per day or time per visit 
to the app, dependent on participants’ smartphones. As a result, time per day on each app was 
calculated for all participants. App usage was monitored and extracted using Ethica Data 
(Kitchener, Ontario, Canada). The frequency the glucose sensor was scanned by the 
participant was collected by LibreLink app (compulsory number of scans: once every eight 
hours). The frequency that participants synced the Fitbit was collected by Fitabase (compulsory 
number of syncs: once every five days). Prior to deployment, all participants received verbal 
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and written information about how to scan the Freestyle Libre and how to sync the Fitbit. 
Default physical activity goals were 10,000 steps, 30 active minutes, 2,500kcal, 10 flights of 
stairs and 8km per day. Participants were informed how to change these values, if they wished, 
using verbal instructions and a brief demonstration. To record if, when and how the activity 
goal settings were changed, the research team accessed the Fitbit account associated with each 
participant at the end of each day. 
 
Figure 4.2. Screenshots of the Fitbit app (left) and LibreLink app (right) 
Secondary outcomes 
Feasibility 
Feasibility was also assessed to help identify whether the intervention was suitable using 
indicators of recruitment, uptake, retention and device wear. The assessment of feasibility 
focused on the practicality and acceptability of the self-monitoring technologies as outlined by 
Bowen and colleagues (Bowen et al., 2009). 
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Practicality 
Researcher-produced project records documented the number of additional glucose sensors 
provided to participants (minimum of three per participant) and reasons why additional sensors 
were needed (e.g. faulty or displaced sensors). Missing glucose data (reported as percentage 
data capture, number of missing data events and minutes of missing data) were quantified using 
raw interstitial glucose data downloaded from Diasend. Missing glucose data occurred if 
participants failed to adhere to scanning at least once every eight hours. The amount of missing 
physical activity data was recorded and quantified using Fitabase (Small Steps Labs LLC., San 
Diego, CA). Missing data for the Fitbit would result in obtaining a truncated daily summary of 
activity data rather than minute-level data.  
Acceptability 
Uptake and retention 
The number of participants who (a) completed the survey, (b) were eligible, (c) decided to take 
part (uptake) and (d) completed the study (attended follow-up assessment) were recorded. Non-
usage attrition (failure to comply with compulsory engagement but no study withdrawal) and 
dropout attrition (withdrawn or not attending the final appointment) were assessed (Alkhaldi 
et al., 2016).  
Wear adherence 
Fitbit wear time and undirected overnight wear were quantified using minute-level data 
extracted from Fitabase. Wear time for each epoch was defined by the combined presence of a 
heart rate signal (>0 beats/min) and not classified as sleep according to Fitbit’s default 
proprietary algorithm. 
Smartphone usage 
The number of participants consenting to having their phone use monitored via Ethica Health 
app (Kitchener, Ontario, Canada) were recorded. Of these participants, the number who 
consent for full coverage (all 14 data sources; location sensors, motion sensors, contact network 
sensors, digital footprint and exit survey) and restricted coverage (3 data sources; digital 
footprint and exit survey) were recorded. The full coverage option was the default decision 
presented to participants and if any participants expressed concerns then they were offered the 
option of the restricted coverage.  
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Baseline physical activity assessment 
ActiGraph 
To assess and compare baseline physical activity levels of our participants against nationally 
representative studies (Chaudhury & Esliger, 2008; Troiano et al., 2008), participants were 
asked to wear an ActiGraph wGT3x-BT accelerometer (ActiGraph, Pensacola, FL, USA) for 
seven consecutive days. Participants were instructed to wear these accelerometers around the 
waist (over the right anterior iliac spine) with an elastic belt during all waking hours and only 
removed for water-based activities. Initialisation, downloading and conversion of 
accelerometer files into 60-second epoch were conducted using ActiLife version 6.13.1 
(ActiGraph, Pensacola, FL, USA). Kinesoft version 3.3.80 (Kinesoft, Loughborough, UK) was 
used to batch analyse the 60-second epoch files. Non-wear was defined as 60 minutes of 
consecutive zeros with up to two minutes of non-zero interruptions allowed (Troiano et al., 
2008). Valid files had ≥4 valid days defined as having ≥10 hr/day (Troiano et al., 2008). 
Stationary time was classified as <100 counts per minute (cpm), light physical activity as 100-
2019 cpm and MVPA as ≥2020 cpm (Troiano et al., 2008). 
Fitbit 
All email accounts and password combinations were manually generated and managed by the 
research team. During baseline assessment, Fitbits were masked for all participants using black 
tape and participants were asked not to tamper with it. Settings on the Fitbit app were adjusted 
to remove the feedback metrics and notifications restricted (Appendix H). Participants had 
access to the app to allow automatic syncs to occur thereby ensuring minute-level data were 
obtained. 
Levels of technology readiness, health status and attitude 
Questionnaires were completed by participants electronically using Bristol Online Surveys 
(Bristol, UK) at baseline and at the final appointment. Quality of life was assessed via the 26 
item EQ-5D-5L (Herdman et al., 2011), technology readiness via the 16 item Technology 
Readiness Index (TRI 2.0) (Parasuraman & Colby, 2015), diabetes knowledge via the revised 
diabetes knowledge test (DKT) (Collins et al., 2011) and attitude toward developing diabetes 
using the general attitudes section of the Risk Perception Survey for Developing Diabetes 
(RPS-DD) (Walker et al., 2003). The maximum score for the DKT was 18. The TRI2.0 
questionnaire classified individuals as either a Skeptic, Explorer, Pioneer, Hesitator or Avoider. 
Skeptics offered low levels of optimism, discomfort and insecurity but moderate levels of 
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innovativeness; Explorers offered high levels of optimism and innovativeness but low levels 
of discomfort and insecurity; Avoiders revealed low levels of optimism and innovativeness but 
high levels of discomfort and insecurity; Pioneers revealed high levels of optimism, 
innovativeness, discomfort and insecurity; whilst Hesitators demonstrated high levels of 
optimism, low levels of innovativeness and moderate levels of discomfort and insecurity.  
Other measures 
Participant demographics 
Self-reported age, sex, ethnic background, employment status, household income, home 
postcode (used to derive index of multiple deprivation (IMD)) and highest level of education 
were recorded. 
Cardiometabolic health 
Participants removed shoes and socks prior to having height measured using a Seca stadiometer 
(Seca, Hamburg, Germany) and weight and body fat percentage measured using Tanita scales 
(Tokyo, Japan). Two measures of waist circumference were taken at the midpoint between the 
lowest rib and top of the iliac crest with an additional measure taken if the difference exceeded 
1cm. Glycated haemoglobin (HbA1c) was assessed using an Afinion AS100 Analyser (Alere 
Inc., Waltham, MA). Three measures of resting blood pressure were recorded using an Omron 
digital monitor (Omron Corporation, Kyoto, Japan) after participants were seated for ≥10 
minutes, with at least 2 minutes rest between measurements. Participants were classified as 
having hypertension if their resting blood pressure was ≥140/90mmHg (National Institute for 
Health and Care Excellence, 2011) and as pre-diabetic if their HbA1c reading was 6.0-6.4% 
(National Institute for Health and Clinical Excellence, 2012). 
Physical functioning and aerobic fitness 
Upper body strength was assessed by hand grip strength using a handheld Takei dynamometer 
(Takei Scientific Instruments, Tokyo, Japan). The Canadian Physical Activity, Fitness and 
Lifestyle Approach grip strength protocol was used (Canadian Society for Exercise Physiology, 
2004). Lower body strength was assessed on the dominant leg by the quadriceps maximal 
voluntary contraction (QMVC) using the DAVID G200 knee extension machine (David Health 
Solutions Ltd., Helsinki, Finland). Aerobic fitness was assessed using the modified Canadian 
Aerobic Fitness Test (mCAFT) (Canadian Society for Exercise Physiology, 2004). Participants 
were excluded from the mCAFT if they were aged ≥70 years, if their blood pressure was more 
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than 140/95mmHG, if they reported sufficient mobility-related problems or any other 
contraindications to exercise testing according to the Physical Activity Readiness 
Questionnaire (Warburton et al., 2011). Stage achieved on the mCAFT was converted to an 
estimate of O2 cost, entered alongside age and weight, into an algorithm to calculate predicted 
VO2max (Weller et al., 1993). 
Behaviour change techniques 
Prior to starting the intervention, the researcher will implement the default settings for levels 
of physical activity (BCT 1.1: Goal setting [behaviour]) (i.e. 10,000 steps and 10 floors 
climbed) and glucose (BCT 1.3: Goal setting [outcome]) (i.e. 4.0-5.9 mmol/L). Participants 
will also receive haptic feedback (BCT 7.1: Prompts/cues; i.e. a gentle vibration) as a reminder 
to move by the Fitbit 10 minutes prior to the end of each hour (default 09:00-18:00) if 250 steps 
have not been taken. In relation to the other behaviour change techniques, participants will be 
able to monitor physical activity levels using the Fitbit Charge 2 (BCT: 2.3 Self-monitoring of 
behaviour) and glucose levels using the Freestyle Libre (BCT: 2.4: Self-monitoring of 
outcome(s) of behaviour) which is a minimally-invasive device that presents feedback about 
glucose (BCT: Biofeedback).  
Statistical analyses 
Descriptive statistics were reported as mean (SD) for continuous variables and frequency (%) 
for categorical variables. Identification of any statistical differences did not necessarily result 
in their inclusion as covariates within the main analysis (due to small sample size). Analysis of 
variance (ANOVA) were conducted to compare between intervention groups for continuous 
variables and chi-square tests for between group comparisons for categorical, unpaired 
variables. If a significant chi-square statistic was revealed, unadjusted standardised residuals 
were computed to identify significant pairwise differences. If the unadjusted standardised 
residuals were >1.96 or <-1.96 then the z-score was classified as significant. McNemar tests 
were used to assess changes in categorical, paired variables over time. Two-way repeated 
measures ANOVAs were used to compare between groups over the intervention period. 
Mauchly’s test of sphericity was examined to assess sphericity of the data, with Greenhouse-
Geisser statistics used when the assumption of sphericity was violated. Participant engagement 
metrics were entered as the dependent variable whilst time (within-subject), group (between-
subject) and time*group interactions were examined. Two-way repeated measures analysis of 
covariance (ANCOVA) was used to assess changes in step count over the intervention period 
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between groups, controlling for global wear time (average wear min/day over seven weeks). 
Pairwise differences were identified using a post-hoc Bonferroni correction. All data were 
analysed using Statistical Package for Social Sciences Version 24.0 (SPSS Inc. Chicago, IL) 
with alpha set to 0.05. 
4.4. Results 
Participant recruitment 
Between 16th May and 30th August 2017, there were a total of 525 visitors to the SIGNAL 
Study risk assessment website tool. Of these, 340 (64.8%) completed the survey and 58 (17.1% 
of those who completed the survey) identified as eligible (Figure 4.3). Forty-five individuals 
(77.6% of those eligible and 13.2% of those completing the survey) consented to take part and 
no participant withdrawals were recorded. The forty-five participants were recruited via 
participant databases (n=12), local businesses (n=11), social media (n=10), university 
employees/alumni (n=8) and word of mouth (n=4). 
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Figure 4.3. A flow diagram of recruitment, enrolment and allocation for the study. G4GPA2 
represents glucose feedback (4 weeks) followed by glucose and physical activity feedback (2 
weeks); PA4GPA2 represents physical activity feedback (4 weeks) followed by glucose and 
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physical activity feedback (2 weeks) and GPA6 represents glucose and physical activity 
feedback (6 weeks). 
Participant characteristics 
Forty-five participants (60% female) had a mean age of 56±8.7 (range: 40-77 years) and most 
reported themselves as White British (88.9%) (Table 4.1 and Table 4.2). Seven participants 
(15.6%) were identified as being at high-risk of developing Type 2 diabetes and 3 participants 
(6.7%) were classified as living with prediabetes. Seventeen (37.8%) were overweight, 13 
(28.9%) had obesity and 10 (22.2%) had severe obesity. Seventeen participants (37.8%) were 
classified as hypertensive. Thirty-nine participants (86.7%) did not comply with the UK 
physical activity guidelines at baseline. 
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Table 4.1. Participant baseline demographics stratified by group, reported as mean±SD or N 
(%) 
 Whole 
Sample 
(n=45) 
G4GPA2 
(n=15) 
PA4GPA2 
(n=15) 
GPA6 
(n=15) 
Demographics     
Age (yrs) 56±8.7 58.8±9.8 55.3±8.8 53.9±7 
Female gender N (%) 27 (60) 9 (40) 9 (60) 12 (80) 
Employment status N (%)     
     Employed 30 (66.7) 9 (60) 10 (66.7) 11 (73.3) 
     Retired 10 (22.2) 4 (26.7) 4 (26.7) 2 (13.3) 
     Other 5 (11.1) 2 (13.3) 1 (6.7) 2 (13.3) 
Education level N (%)     
    Undergraduate or higher 24 (46.7) 12 (80)* 3 (20) 9 (60) 
    Lower than Undergraduate 21 (46.7) 3 (20)* 12 (80) 6 (40) 
Household income N (%)     
      ≥£52,000 19 (42.2) 6 (40) 5 (33.3) 8 (53.3) 
     £18,000-£51,999 18 (40) 7 (46.7) 7 (46.7) 4 (26.7) 
     <£18,000 6 (13.3) 2 (13.3) 2 (13.3) 2 (13.3) 
      Unknown 2 (4.4) 0 1 (6.7) 1 (6.7) 
Postcode deprivation N (%)     
     ≤8.49 (least deprived) 20 (44.4) 6 (40) 7 (46.7) 7 (46.7) 
     ≥34.18 (most deprived) 3 (6.7) 0 1 (6.7) 2 (13.3) 
Diabetes knowledge     
    DKT test score 10.7±3 11.1±2.5 9.7±3.5 11.3±2.8 
 
Table notes: G4GPA2 represents glucose feedback (4 weeks) followed by glucose and physical 
activity feedback (2 weeks); PA4GPA2 represents physical activity feedback (4 weeks) followed 
by glucose and physical activity feedback (2 weeks) and GPA6 represents glucose and physical 
activity feedback (6 weeks). Abbreviations: DKT, Diabetes Knowledge Test. *, significant 
difference between G4GPA2 and PA4GPA2 (p=.004). Postcode deprivation offers ten categories 
but only the two most extreme categories have been included in this table for presentation 
reasons. 
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Table 4.2. Participant baseline characteristics stratified by group, reported as mean±SD or N 
(%) 
 Whole Sample 
(n=45) 
G4GPA2 
(n=15) 
PA4GPA2 
(n=15) 
GPA6 
(n=15) 
Body composition 
Height (cm) 168.4±9.5 171.2±9.4 167±9.6 167±9.6 
Weight (kg) 89.6±19.7 86.7±16.1 96.6±23.3 85.5±18.3 
BMI (kg/m2) 31.6±6.9 29.6±4.9 34.8±9.4 30.4±4.3 
Waist circumference 
(cm) 
101.5±14.8 98.8±14.3 108.4±15.2 97.4±13.3 
Cardio-metabolic health 
Prediabetic (%) 3 (6.7) 1 (6.7) 0 2 (13.3) 
HbA1c (%) 5.6±0.3 5.6±0.3 5.5±0.3 5.6±0.3 
SBP (mmHg) 132±15.8 135.9±15.1 131.7±16.3 128.5±16.2 
DBP (mmHg) 81.7±10.4 82.7±10.6 79.9±9.4 82.3±11.5 
Physical function 
Grip strength 
(combined, kg) 
69.1±22.2 75.8±23.1 64.6±21.1 67±22.4 
Quadriceps strength 
(dominant leg, Nm) 
124.3±64.1 137.1±73.8 109.4±39.4 125.5±73 
Calculated VO2max 
(ml/kg/min)a 
36.7±6.7 37.4±8.2 35.5±5.0 37±6.8 
ActiGraph physical activityb 
Number of valid days 6.6±0.7 6.8±0.8 6.5±0.7 6.5±0.6 
Valid day, N (%, c%)     
     7 days     31 (68.9, 68.9) 14 (93.3, 93.3) 9 (60, 60) 8 (53.3, 53.3) 
     6 days 10 (22.2, 91.1) 0 (0, 93.3) 4 (26.7, 86.7) 6 (40, 93.3) 
    5 days 3 (6.7, 97.8) 0 (0, 93.3) 2 (13.3, 100) 1 (6.7, 100) 
    4 days 1 (2.2, 100) 1 (6.7, 100) 0 (0, 100) 0 (0, 100) 
Wear time (min/day) 861.5±86.9 911.4±88.5* 833.2±74 839.8±80 
Step count 6905±3776 7331±3433 5637±1963 7748±5148 
CPM 328.7±144.6 342.2±107.6 281.3±123.1 362.5±187.5 
Sedentary (min/day) 540.1±95.3 569.9±90.1 536.6±89.9 513.9±103.2 
Light PA (min/day) 288.2±83.4 304.4±97.1 271.4±77.3 288.7±76.7 
MVPA (min/day) 33.1±28.4 37.0±21.2 25.2±18.6 37.2±40.5 
MVPA in bouts ≥10 
minutes (min/day) 
10.1±21.9 9.6±14.4 5±6.2 15.8±34.5 
Met physical activity 
guidelinesc N (%) 
5 (11.1) 2 (13.3) 1 (6.7) 2 (13.3) 
Fitbit physical activityb 
Number of valid days 6.7±0.7 6.8±0.8 6.5±0.8 6.8±0.4 
Valid day, N (%, c%)     
     7 days     36 (80, 80) 14 (93.3, 93.3) 10 (66.7, 66.7) 12 (80, 80) 
     6 days 7 (15.6, 95.6) 0 (0, 93.3) 4 (26.7, 93.4) 3 (20, 100) 
    5 days 0 (0, 95.6) 0 (0, 93.3) 0 (0, 93.4) 0 (0, 100) 
    4 days 2 (4.4, 100) 1 (6.7, 100) 1 (6.7, 100) 0 (0, 100) 
Wear time (min/day) 865.1±69.6 912.4±63.3 832±61.1 851±60.7 
Step count 8575±4530 9329±4251 7650±4007 8747±5367 
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Table notes: G4GPA2 represents glucose feedback (4 weeks) followed by glucose and physical 
activity feedback (2 weeks); PA4GPA2 represents physical activity feedback (4 weeks) followed 
by glucose and physical activity feedback (2 weeks) and GPA6 represents glucose and physical 
activity feedback (6 weeks). Abbreviations: c, cumulative; CPM, counts per minute; DBP, 
diastolic blood pressure; MVPA, moderate-to-vigorous physical activity; PA, physical activity; 
SBP, systolic blood pressure. aN=32, N=13 excluded (n=6, self-reported mobility issues; n=4, 
resting diastolic blood pressure ≥95 mmHg; n=3, aged ≥70 years); fitness score based on age 
and sex of each participant. bunadjusted values are presented. c150 min/week of moderate-to-
vigorous physical activity in bouts of ≥10 minutes (using MVPA in bouts of ≥10 min/day * 7) 
or 75 min/week of vigorous-intensity physical activity. *, significant difference between 
G4GPA2 and PA4GPA2 (p=.035). 
Primary outcomes 
User engagement 
Freestyle Libre – scan frequency and characteristics 
A key engagement metric for the LibreLink app was how often participants scanned the glucose 
sensor. The average number of scans each day did not differ significantly between G4GPA2 
and GPA6 groups (7.5±4.9 versus 7.7±4.3 scans/day, p=.883; Figure 4.4). However, it was 
noted that the number of scans/day significantly decreased over the six weeks on average for 
these groups (9.2±5.1 scans/day in week 1 to 5.9±3.4 scans/day in week 6, p=.016). 
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Figure 4.4. Average daily number of Freestyle Libre scans across the intervention period. 
Figure notes: Point of unmasking glucose feedback at (a) for G4GPA2 and GPA6 and (b) for 
PA4GPA2. Note that the compulsory engagement threshold was 3 scans/day. G4GPA2 
represents glucose feedback (4 weeks) followed by glucose and physical activity feedback (2 
weeks); PA4GPA2 represents physical activity feedback (4 weeks) followed by glucose and 
physical activity feedback (2 weeks) and GPA6 represents glucose and physical activity 
feedback (6 weeks). 
Figure 4.5 illustrates when participants scanned the glucose monitor across an average 24-hour 
period. Participants scanned their glucose sensor significantly more often in the morning, 
afternoon and evening periods compared with overnight (27.9±4.8% vs. 31±4.8% vs. 
33.6±6.2% vs. 7.6±7.4%, respectively, p<.001) and most frequently between 21:00-22:00. No 
other significant differences between times of day were observed. 
 
Figure 4.5. Scan frequency across the 24-hour period. G4GPA2 represents glucose feedback (4 
weeks) followed by glucose and physical activity feedback (2 weeks); PA4GPA2 represents 
physical activity feedback (4 weeks) followed by glucose and physical activity feedback (2 
weeks) and GPA6 represents glucose and physical activity feedback (6 weeks). 
In an effort to describe what information participants were presented with on the LibreLink 
app when they scanned the glucose sensor, the characteristics of the glucose feedback are 
presented in Table 4.3. Of all the scans conducted by participants during the study period 
(n=10,582), the majority of scans presented a changing slowly (i.e. ‘→’) trend arrow (80%) 
and were most often in the normal range (59%). Participants saw that their glucose level was 
rising on 10% of scans and that their glucose was above the normal range on 36% of scans. 
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Participants in GPA6 saw a significantly greater proportion of scans classified as falling quickly 
compared with PA4GPA2 (1% versus 0.2% of scans, p=.015). No other significant differences 
were observed between groups. 
Table 4.3. Scan information displayed to users as a proportion (%) of total scans accumulated, 
reported as mean±SD 
Table notes: G4GPA2 represents glucose feedback (4 weeks) followed by glucose and physical 
activity feedback (2 weeks); PA4GPA2 represents physical activity feedback (4 weeks) followed 
by glucose and physical activity feedback (2 weeks) and GPA6 represents glucose and physical 
activity feedback (6 weeks). *, significant difference between PA4GPA6 and GPA6 (p=.015). 
Freestyle Libre – app usage 
To see whether participant engagement reduced over time, it was reported that time spent on 
the LibreLink app decreased over the six weeks among participants who had access to glucose 
feedback throughout the whole intervention. G4GPA2 and GPA6, on average, reduced their time 
spent on the LibreLink app from 20.2±20 min/day in week 1 to 9.4±14.6min/day in week 6 
(p=.007). When comparing these two groups, it was noted that G4GPA2 spent significantly 
more time on the LibreLink app than GPA6 over the six weeks (16.1±11.9 versus 
8.4±8.7min/day, p=.026). 
Fitbit – app usage 
The amount of time spent on the Fitbit app decreased significantly over the six weeks among 
participants that had access to feedback for the whole intervention (7.1±3.8min/day in week 1 
to 3.8±2.9min/day in week 6, p=.003). However, the average amount of time spent on the Fitbit 
app did not significantly differ between PA4GPA2 and GPA6 (14.8±11.3 versus 
5.2±3.1min/day, respectively, p=.468). 
 Whole sample 
(n=45) 
G4GPA2 
(n=15) 
PA4GPA2 
(n=15) 
GPA6 
(n=15) 
Glucose Rising Quickly ↑ 1.9±1.8 1.7±1.4 2.3±2.6 1.7±1 
Glucose Rising ↗ 8.2±3.8 8.3±3.2 7.8±5.5 8.5±2.1 
Glucose Changing Slowly → 80.3±8.4 79.9±5.5 81.7±12.5 79.3±5.4 
Glucose Falling ↘ 5.6±2.3 6.3±1.7 4.8±2.9 5.8±1.9 
Glucose Falling Quickly ↓ 0.7±0.8 0.8±0.9 0.2±0.6 1±0.7* 
No trend arrow 3.2±3.3 2.7±1.9 3.2±5 3.7±2.3 
Above range (≥6.0 mmol/L) 36.2±14.3 38±13 36.8±16.9 33.8±13.2 
Normal range (4.0-5.9 
mmol/L) 
59.2±12.8 56.7±9.5 59.8±16.5 61.3±11.8 
Below range (<4.0 mmol/L) 4.6±6.2 5.3±7.5 3.5±6 4.9±5 
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Fitbit – syncs 
Despite participants spending less time on the Fitbit app, the number of syncs per day did not 
change significantly during the intervention period (i.e. week 1: 6.9±7.8 syncs/day versus week 
6: 6.5±10.2 syncs/day, p=.752) and did not differ significantly between PA4GPA2 and GPA6 
(11.6±12.5 versus 10.7±15.8 syncs/day, p=.098). 
Fitbit – changes to default goal settings 
Given that goal-setting is often incorporated in behavioural interventions, it was important to 
record whether participants changed the default settings. In total, 13 participants (28.9%) 
changed at least one of the five physical activity goals on the Fitbit app (daily step count, kcal 
burnt, distance, active minutes or floors). Within the specific groups, G4GPA2 altered steps 
(n=3, 20%), calories (n=3, 20%), distance (n=2, 13.3%), active minutes (n=2, 13.3%) and 
number of floors (n=3, 20%). Steps were increased from 10,000 to 11,500 and 15,000 and 
reduced to 6,000, active minutes were increased from 30 to 40 min and reduced to 20 min and 
floors increased from 10 to 15 and 25 and reduced to 5 and 1 per day. In PA4GPA2, only steps 
(n=3, 20%) and active minutes (n=1, 6.7%) were changed; with steps reduced to 7,000, 6,000 
and 3,000 whilst active minutes increased to 200 min. In GPA6, three participants (20%) 
changed their steps and one participant (6.7%) changed the number of floors. Step count goal 
was increased to 14,000 and reduced to 8,000 steps/day whilst floors reduced from 10 to 8 per 
day. 
Secondary outcomes 
Feasibility (practicality) 
Freestyle Libre – deploying sensors 
To assess the practicality of deploying the glucose sensors, the number of excess deployed 
monitors were examined. 157 sensors were deployed in total; 22 more than the intended 
number of sensors and averaging 3.5±1.4 sensors/participant. Only 17 participants (37.8%) 
completed the study using the minimum (expected) three sensors. In total, 16 participants 
(35.6%), 7 (15.6%), and 1 (2.2%) required one, two or three additional sensors, respectively. 
Additional sensors were required due to being faulty (29.3%) or displaced whilst worn (70.7%). 
Freestyle Libre – compliance to minimum scanning requirement 
Compliance to scanning data revealed that 27 participants (60%) set the LibreLink app to offer 
reminders to scan the glucose sensor if seven to eight hours had lapsed since the preceding scan 
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(via a smartphone notification). Of these individuals, only two participants (4.4%) (from 
G4GPA2) adjusted the reminder; changing it to remind them five or six hours after the preceding 
scan. Participant compliance to scanning was important because it impacted data capture, with 
missing data a key indicator of how much time lapsed before the participant scanned (Table 
4.4). No significant differences in the number of missing minutes, number of missing events 
or data capture of glucose levels were revealed between the groups and the amount of missing 
data did not change significantly over the intervention.  
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Table 4.4. An outline of data capture from the Freestyle Libre, reported as mean±SD 
Table notes: G4GPA2 represents glucose feedback (4 weeks) followed by glucose and physical activity feedback (2 weeks); PA4GPA2 represents 
physical activity feedback (4 weeks) followed by glucose and physical activity feedback (2 weeks) and GPA6 represents glucose and physical 
activity feedback (6 weeks). 
At time of writing no guidance was available for the missing data threshold but to date, flash glucose monitoring is mainly purchased privately 
and is only in use by selected NHS patients (NICE, 2017). In comparison, continuous glucose monitoring is also not routinely provided to people 
at risk, nor diagnosed with Type 1 or Type 2 diabetes (NICE, 2015a, 2015b) but can be in Type 1 diabetics if individuals are willing to commit to 
using it ≥70% of the time. 70% of the time refers to minimising missing data to <432 min/day. 
 Total data capture  
(%) 
Number of missing data events  
(per day) 
Amount of missing data  
(min/day) 
 
G4GPA2 PA4GPA2 GPA6 G4GPA2 PA4GPA2 GPA6 G4GPA2 PA4GPA2 GPA6 
Week 1 87.6±2.7  86.7±4.8 0.5±0.5  0.7±0.5 27.4±6.5  28.0±9.8 
Week 2 87.4±15.7  93.7±4.5 0.6±0.6  0.8±0.7 27.1±31.7  13.0±9.2 
Week 3 87.2±16.5  91.9±6.5 0.6±0.4  0.8±0.7 26.8±33.6  17.1±13.0 
Week 4 82.0±21.5  91.1±9.1 0.7±0.5  0.7±0.6 37.7±44.0  18.8±18.6 
Week 5 85.8±14.7 80.2±11.7 89.0±11.6 0.8±0.7 0.8±0.6 0.9±0.6 29.8±30.0 41.6±23.3 22.7±23.8 
Week 6 83.1±17.5 73.2±28.6 89.6±10.8 0.9±0.7 0.7±0.6 0.9±0.5 35.1±35.7 55.3±58.5 21.6±22.1 
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Fitbit – compliance to minimum syncing and charging requirement 
To monitor participant compliance with syncing and charging the Fitbit, it was recorded that 
24 participants (53.3%) did not receive any reminder email prompts to sync the Fitbit. Of the 
participants who received an email prompt, 12 (50%) received a single prompt whilst 5 
(20.8%), 3 (12.5%), 2 (8.3%) and 2 (8.3%) received 2, 3, 4 or 5 prompts, respectively. It was 
noted that all participants responded because new syncs were identified after the email prompt 
had been sent. For Fitbit charging compliance, 35 participants (77.8%) had at least one 
occurrence of a battery status of 25-75% whilst nine participants (20%) recorded a battery 
status of <25%. Despite the need to deliver email prompts, no losses in data were recorded.  
Feasibility (acceptability) 
Smart phone usage tracking 
All participants consented to the full coverage option for Ethica Data (all 14 data sources 
recorded, including app usage, GPS and screen state). However, despite consenting to having 
their app usage monitored, it was noted that seven participants (15.6%) had no LibreLink app 
usage data and nine participants (20%) had no Fitbit app usage data available. 
Fitbit – wear compliance 
To determine the acceptability of wearing a Fitbit, it was noted that 36 participants (80%) 
provided seven valid days of Fitbit data, seven participants (15.6%) provided six valid days 
and two participants (4.4%) provided four valid days (6.7±0.7 valid days/person). Number of 
valid days did not differ significantly between groups. However, on average, G4GPA2 wore the 
Fitbit significantly longer each day than PA4GPA2 and GPA6 (912.4±63.3 vs. 832±61.1 vs. 
851±60.7 min/day, respectively, p=.002). During the intervention period, 22 participants 
(48.9%) provided the full 42 days of valid Fitbit wear; averaging 40.1±3.2 valid days/person. 
No significant differences in the number of valid days (p=.175) nor wear time (p=.508) were 
observed between groups. Furthermore, wear time did not differ significantly through the 
intervention period (p=.245). 
Behaviour Change 
Despite participants gaining access to their physical activity feedback, no group differences 
(p=.593) nor differences over time (p=.373) were revealed for step count (Figure 4.6); 
therefore, step count was maintained throughout the intervention. Albeit not significant, 
meaningfully increases in step count were observed from the fourth to the fifth week of the 
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intervention for G4GPA2 (+1071 steps) and PA4GPA2 (+1214 steps) but not for GPA6 (-12 
steps). These noticeable increases reflected the point of unmasking physical activity and 
glucose feedback, respectively. Glucose levels also did not differ significantly between groups 
(5.6±0.5 versus 5.5±0.4 mmol/L, p=.719) and did not change significantly over the six weeks 
(from 5.6±0.7 mmol/L in week 1 to 5.5±0.6 mmol/L in week 6, p=.724). 
 
Figure 4.6. Step count from baseline to week 6 of the intervention, reported as EMM±SE. 
Figure notes: G4GPA2 represents glucose feedback (4 weeks) followed by glucose and physical 
activity feedback (2 weeks); PA4GPA2 represents physical activity feedback (4 weeks) 
followed by glucose and physical activity feedback (2 weeks) and GPA6 represents glucose 
and physical activity feedback (6 weeks). Error bars represent standard error. Point of 
unmasking physical activity feedback occurred at (a) for PA4GPA2 and GPA6 and (b) for 
G4GPA2. 
Changes in technology readiness, health status and attitudes toward health 
Baseline and follow-up questionnaires were completed to observe whether participants 
changed their technology readiness, health status and risk perception of diabetes. No significant 
differences between baseline and follow-up nor between groups were observed. Table 4.5 
outlines key frequency data for technology readiness and perceived risk of developing diabetes 
questionnaires. Although not statistically significant, four fewer participants (-8.9%) were 
classified as Skeptic (high optimism, moderate innovativeness and low levels of discomfort and 
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insecurity) about technology in general and five more participants (+11.1%) were classified as 
Pioneer (high levels of optimism, innovativeness, discomfort and insecurity). 
At baseline, to profile the health status of the sample, it was recorded that 14 participants 
(36.8%) reported mobility problems, two participants (5.3%) reported problems relating to self-
care, nine (23.7%) reported problems performing usual activities, 25 (65.8%) reported 
discomfort/pain and nine (23.7%) reported problems relating to anxiety/depression. From 
baseline to follow-up, participants reported a similar perceived overall health score (81±13.5 
versus 79.2±17.1 (out of 100), respectively, p=.340). 
Table 4.5. Descriptives for questionnaire responses relating to general technology readiness 
and perceived risk for developing diabetes, reported as N (%). 
 Whole sample (n=45) 
Baseline Follow up 
TRI 2.0a   
     Skeptic 17 (37.8) 13 (28.9) 
     Explorer 14 (31.1) 13 (28.9) 
     Avoider 2 (4.4) 3 (6.7) 
     Pioneer 2 (4.4) 7 (15.6) 
    Hesitator 10 (22.2) 9 (20) 
RPS-DD, number of respondents who agreed   
I feel that I have little control over risks to my health 4 (8.9) 3 (6.7) 
If I am going to get diabetes, there is not much I can do about it  1 (2.2) 1 (2.2) 
I think that my personal efforts will help control my risks of getting 
diabetes 
43 (95.6) 43 (95.6) 
People who make a good effort to control the risks of getting diabetes 
are much less likely to get diabetes 
44 (97.8) 41 (91.1) 
I worry about getting diabetes  30 (66.7) 27 (60) 
Compared to other people of my same age and sex (gender), I am less 
likely than they are to get diabetes 
12 (26.7) 12 (26.7) 
Compared to other people of my same age and sex (gender), I am less 
likely than they are to get a serious disease  
13 (31.1) 11 (24.4) 
Worrying about getting diabetes is very upsetting 15 (33.3) 16 (35.6) 
aSkeptic: low levels of optimism, discomfort and insecurity but moderate levels of 
innovativeness; Explorer: high levels of optimism and innovativeness but low levels of 
discomfort and insecurity; Avoider: low levels of optimism and innovativeness but high levels 
of discomfort and insecurity; Pioneer: high levels of optimism, innovativeness, discomfort and 
insecurity; and Hesitator: high levels of optimism, low levels of innovativeness and moderate 
levels of discomfort and insecurity. Abbreviations: TRI, Technology Readiness Index; RPS-
DD, Risk Perception Survey for Developing Diabetes 
 
Study Three: SIGNAL Results 
 
124 
 
4.5. Discussion 
Summary 
The aim of the present study was to examine participant engagement with two digital health 
technologies presenting physical activity and glucose feedback over six weeks and observe 
how feasible the intervention was to implement. The primary findings revealed that participant 
engagement (app usage as well as glucose scan frequency) was initially high upon receiving 
the devices and decreased over time but was sustained above minimum levels at six weeks (i.e. 
above the level of ‘compulsory engagement’ as required), and more than a quarter of 
paticipants changed at least one of their physical acivity goals. That said, there were hurdles to 
study recruitment given the imature nature of the glucose sensing technology and companion 
feedback apps (i.e. need for compatible smartphone); however, this will likely be overcome in 
the very near future as iOS support becomes available. Despite this, the study was feasible to 
implement with high participant adherence to device wear, low amounts of missing data and 
no participants withdrew from the intervention.  
User engagement 
App usage with the Fitbit and LibreLink apps  
In the present study, app usage was used as a proxy indicator for participant engagement. 
Findings demonstrated an initial flurry of interest in accessing the LibreLink and Fitbit apps 
(20 min/day and 7 min/day, respectively). By the final week of the intervention, participants 
were still spending an encouraging amount of time on the apps (9 min/day on the LibreLink 
app and 4 min/day on the Fitbit app). This decline in engagement over time was expected given 
that initial novelty of technologies can fade over time (Lazar et al., 2015). Also, reductions in 
app usage does not necessarily imply a reduction in engagement; instead, becoming 
increasingly familiar with navigating the app interface to digest feedback may have led to users 
becoming more efficient. Despite this, it has been shown elsewhere that apps can experience 
fewer than three visits per week (Flurry Analytics, 2009), that only 16% of users access a health 
app more than twice after downloading it (Pramis, 2013) and that 43% of users stop accessing 
weight-loss apps after four weeks (Laing et al., 2014). That said, our observation that 
participants were continuing to access both apps into the sixth week was an encouraging 
finding. Other particularly interesting findings were that app usage for the LibreLink app was 
slightly greater than Fitbit app usage (11 min/day versus 8 min/day, respectively). In the present 
study, Fitbit app usage may have been lower because up-to-date physical activity feedback was 
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also displayed on the wrist-worn device; perhaps limiting participant interest in accessing the 
more comprehensive (and historical) physical activity feedback on the smartphone app. 
Together, these findings demonstrate that objective monitoring of participant engagement 
provided valuable insight into how participants used the digital health technologies deployed. 
Scanning and syncing frequency 
In addition to a reduction in time spent on the health apps, glucose scanning frequency reduced 
from approximately 9 scans/day in the first week to 6 scans/day in the last week. Similarly to 
app usage, participant engagement may have been at its greatest at the start of the intervention 
period because the opportunity to receive glucose feedback was likely interesting and novel 
(Lazar et al., 2015). That said, it was promising to find that participants were maintaining an 
average daily number of scans that was double the compulsory level of engagement of three 
scans/day. This finding suggests that participants may have found the glucose feedback (or 
simply the act of scanning) to be sufficiently interesting six weeks later. However, it was 
surprising to observe that PA4GPA2 participants did not scan the glucose sensor as often as 
G4GPA2 and GPA6 did upon the day of unmasking (3.9 versus 8.8 scans/day, respectively). 
This may be because PA4GPA2 participants became accustomed to wearing the glucose sensor 
over the four weeks and having to wait to access its feedback may have brought down its initial 
‘wow’ factor, whereas G4GPA2 and GPA6 had immediate access upon applying the sensor, 
bringing with it greater levels of engagement. In addition, the suggestion that participants 
scanned most often whilst in the ‘target range’ brings with it complexity as participants were 
very likely to go above/below this range. Moving forward, with increasing technological 
sophistication, perhaps a dynamic target range would be more suitable for all users of this 
technology; regardless of presence of a diabetes diagnosis. Participants tended to scan most 
often between 21:00-22:00, which may infer a potential key opportunity to deliver summative 
end-of-day feedback to users (in addition to real-time feedback). 
In contrast, the frequency with which participants synced the Fitbit did not change over the six 
weeks (7 syncs/day). This high observed frequency of syncing was unlikely reflective of 
participants accessing the Fitbit app seven times per day. Instead, the author acknowledges that 
the automatic ‘all day sync’ feature may have been disenabled, either by technical error 
(settings reverting to default configuration) or participants adjusting the settings (via the app). 
Therefore, labelling number of syncs as a reliable metric of engagement is hindered by not 
knowing with certainty whether the sync was performed by the participant opening the app, 
because they were interested in their feedback, or whether it was an automatic sync. Therefore, 
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the present study recommends that syncing frequency may instead be better applied as a metric 
to monitor data transfer. 
Changing physical activity goals 
In the present study, participants were instructed how to change their goals via the Fitbit app 
and informed they could change them if they wished to (but did not have to). Interestingly, 
almost a third of participants in the present study decided to change at least one of five physical 
activity goals. Most (69%) of the participants who changed a physical activity goal changed 
their step count goal which may in part be because it was the primary goal displayed via device 
and Fitbit app. Moreover, step count is an easily understood metric, a characteristic that may 
partly explain why pedometers (or step counters) have an important role to play in physical 
activity interventions (Bravata et al., 2007). It was noted that six of the nine changes to step 
count were reductions. Personalising goals to be more achievable for individuals (by increasing 
or decreasing the target) have previously been shown to encourage greater feedback 
engagement (Laing et al., 2014). The author acknowledges that participants may not have 
personalised the goals because they had uncertainty navigating the app, were unsure of what 
these values should be for them, or they may have been content with the default values. 
Intervention feasibility and behaviour change 
Feasibility of the recruitment strategy 
Given the intention of recruiting individuals at risk of developing type 2 diabetes, who have 
been prioritised to prevent disease onset (Bansal, 2015), it is important to assess the feasibility 
of the recruitment strategy implemented. The inclusion criteria revealed that only 17% of 
individuals who expressed an interest were eligible to take part. Almost two-thirds of interested 
individuals were ineligible because their level of diabetes risk was ‘low’. In addition, 
approximately one-fifth of adults were ineligible because they did not own a compatible 
Android smartphone. Despite more smartphone sales in 2017 (Statistica, 2018) and having 46% 
of the UK market share (Statistica, 2017), this was a significant contributor to ineligibility. The 
authors expect the technologies to soon be accessible on iOS and were only a concern in the 
present study due to the companion app being immature. The final sample revealed that only 
7% were confirmed as living with prediabetes. The risk assessment tools, as employed in the 
present study, can identify individuals with multiple risk factors of developing type 2 diabetes. 
These multiple risk factors can increase an individual’s likelihood of being pre-diabetic, but 
may not necessarily be at that moment in time, pre-diabetic (Cowie et al., 2009). Previous 
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larger studies, with in excess of 3,000 participants, have identified 17.5-26.5% of screened 
individuals presenting impaired glucose regulation (Gray et al., 2012; Webb et al., 2011). As a 
result, future screening efforts are encouraged to target individuals at greatest risk of 
developing type 2 diabetes by also using a confirmatory HbA1c reading.  
Feasibility of deploying these technologies 
Given the novel approach of deploying digital health technologies to present behavioural and 
physiological feedback simultaneously, it was important to assess its feasibility. With all 
participants attending appointments and no non-usage attrition or participant withdrawals 
recorded, the study is deemed feasible. Data capture from the Fitbit and Freestyle Libre also 
demonstrated great feasibility (40 valid days of physical activity data and 80-94% glucose data 
capture). Previous studies have, however, demonstrated high wear compliance (more than ten 
hours on 95% of days) for the Fitbit (Cadmus-Bertram et al., 2015) which highlights wear-
ability. An important limitation was the frequency of accidental displacement of the glucose 
sensors which saw only 38% of participants using three (expected) glucose sensors. Previous 
studies have reported mild incidences of skin irritation, bruising and bleeding in <9% of cases 
and were considered typical cases for medical-grade adhesives (Bailey et al., 2015; Bolinder 
et al., 2016). Given the resulting cost implications of providing replacements (£57.95/sensor), 
efforts are needed to minimise sensor displacement. Displacements in the present study may 
be in part because of positioning or it may be that participants forgot they were wearing the 
sensors because participants were very unfamiliar with wearing a glucose sensor. Given other 
digital health technologies are largely worn elsewhere on the body (e.g. activity monitors on 
the wrist similarly to watches) (Sanders et al., 2016), it is an important point to consider 
whether the sensor may be better positioned in a more protected location (e.g. abdomen). 
Overall, the present study supports the feasibility and potential of these two digital health 
technologies for continuous health monitoring. 
Changes in physical activity and glucose 
It was envisaged that the conduit through which people may reduce their risk would be via 
monitoring their lifestyle behaviours and the physiological consequences of those behaviours. 
In the present study, no significant increases in step count were observed (averaging 8589 and 
9267 steps at baseline and week 6, respectively). However, despite no significant increase in 
step count, it is important to highlight that participants in G4GPA2 did increase their step count 
by approximately 1,000 steps upon unmasking physical activity feedback after four weeks. 
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Similarly, and an even more intriguing finding, was that participants in PA4GPA2 also 
increased their step count by approximately 1,000 steps upon unmasking of glucose feedback. 
By comparison, GPA6 participants (i.e. those having access to both physical activity and 
glucose feedback throughout) had reduced their step count by 12 steps at the same week 
timepoint. The introduction of ‘new’ feedback may have driven the results of these formed 
mentioned participant groups; however, it may also be partially due to these participants having 
contact with the research team which may have reignited motivation or perhaps desire to please 
the researchers. 
Another finding of interest was the fact that despite no guidance being offered by the research 
team as to when or why to scan the glucose sensor, 36% of scans were when glucose levels 
were above the target range. This interesting finding may suggest that participants may have 
had some understanding about when and why glucose levels may fluctuate (e.g. to observe the 
effects of dietary intake and/or physical activity or prolonged sedentary time). To help 
encourage this from the outset, previous studies have incorporated education to illustrate 
activity-related reductions in glucose to inform participants of the health benefits of physical 
activity (Allen et al., 2008; Bailey et al., 2016). Moving forward, it is important to consider not 
only how to present information but also how to facilitate understanding (Pagliari, 2007) so 
incorporating personalised education may be a key addition to encourage behaviour change. 
Moreover, such educational strategies may benefit from employing a form of gamification as 
a way to gradually expose users to feedback by having users complete challenges (Piwek et al., 
2016). 
Strengths and limitations 
The strengths of this study include the use of novel, minimally-invasive digital health 
technologies to present feedback about physical activity and glucose levels. Deploying these 
two technologies in combination offered valuable insight into how individuals at moderate-to-
high risk of developing type 2 diabetes engaged with the devices and apps. For the 
quantification of participant engagement, multiple platforms were used to objectively and 
remotely monitor non-usage and dropout attrition. Furthermore, using Ethica Health allowed 
the research team to capture participant preference toward data sources (i.e. if any of them 
raised concern) and permitted a dynamic consent strategy by allowing participants to remotely 
withdraw from the study at any time. 
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The limitations of the present study include not obtaining glucose levels at baseline (for any 
participants) and from PA4GPA2 participants who were masked to this feedback for the first 
four weeks of the intervention period. Technological restrictions meant that, despite 
quantifying time spent on the apps, we were unable to identify what specific features and pages 
were viewed on the apps. Given that participants used their personal smartphones, phone and 
app updates occurring during their participation restricted our confidence in gleaning insight 
about the frequency that participants chose to sync the Fitbit (as an indicator of engagement). 
4.6. Conclusions 
The present study demonstrated that adults at moderate-to-high risk of developing type 2 
diabetes engaged with physical activity and glucose feedback presented by digital health 
technologies. Several important improvements to the study have been highlighted: (a) the need 
to explore the technology in individuals presenting prediabetes; (b) expand the inclusion 
criteria to include individuals with non-Android smartphones; (c) provide detailed instructions 
and/or training on how to navigate the apps; and (d) provide education sessions to help 
participants understand, interpret and act on the behavioural and physiological feedback 
presented by the digital health technologies. Overall, the findings suggest it is feasible to 
provide individuals with feedback on movement behaviours and the physiological 
consequences of those behaviours through digital health technologies in the context of type 2 
diabetes prevention. 
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5.1. Summary 
The present thesis is comprised of three studies which contribute to research on physical 
activity and health feedback and the use of digital health technologies in the prevention of 
chronic diseases, particularly type 2 diabetes. The overall purpose of the thesis was to 
investigate the associations between brain activation and personalised feedback and to 
determine whether coupled feedback presented by digital health technologies could influence 
behaviour change in an at-risk population. 
Firstly, a systematic review was conducted in Study One to identify studies that used functional 
magnetic resonance imaging (fMRI) to assess how people’s brains responded to health 
messages pertaining to key lifestyle behaviour risk factors for chronic diseases; namely, 
physical inactivity, sedentary behaviour, smoking, diet and alcohol consumption. Hereon Study 
One is referred to as the systematic review. Having identified that only one study had 
investigated brain responses to physical activity or sedentary behaviour information, Study 
Two assessed the neural responses of adults when they were presented with personalised 
feedback relating to movement behaviours (physical activity, sedentary behaviour) whilst 
inside an MRI scanner. In addition, individuals were presented feedback relating to the 
physiological consequence of these behaviours (glucose) to align with our interest of moving 
toward providing coupled feedback. Study Two found that the glucose health messages resulted 
in a greater neural response in the prefrontal cortex compared with the behavioural health 
messages, providing support for an intervention incorporating physiological feedback in 
addition to behavioural feedback. Hereon Study Two is referred to as the brain activation pilot 
study. Therefore, Study Three was a randomised feasibility trial investigating participant 
engagement with digital health technologies that presented personalised behavioural and 
physiological feedback to individuals living with moderate-to-high risk of developing type 2 
diabetes. Results showed that it was feasible to conduct an intervention offering both 
behavioural and physiological feedback through digital health technologies and participants 
engaged with the feedback over the six weeks. Hereon Study Three is referred to as the 
feasibility intervention. Overall, this thesis has shown that lifestyle interventions deploying 
digital health technologies presenting physiological and behavioural feedback have potential 
to enhance participant engagement, which is an essential step in successful and prolonged 
behaviour change. 
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5.2. Key discussion points 
5.2.1 Health messaging: Can we learn from smoking cessation? 
Having identified in the systematic review that a large amount of the health messaging fMRI 
literature focuses on smoking cessation, there is a need to consider whether the lessons learnt 
can be applied to other behaviours, including physical activity. Having said that, it must be 
clearly acknowledged that these behaviours require individuals to make very different 
decisions. As a brief example, individuals should ‘stop’ smoking but ‘do’ activity. If a person 
intends to stop smoking, they can be referred to stop smoking services and are encouraged to 
undergo nicotine replacement therapy during the initial 8-12 weeks (NHS Choices, 2016). To 
reduce the chance of relapse, individuals are offered weekly face-to-face (or telephone) 
contacts for the initial four weeks then less frequent contacts in the subsequent eight weeks 
with regular carbon monoxide readings conducted to monitor adherence (NHS Choices, 2016). 
It remains unclear what an effective equivalent may be for individuals at risk of developing 
type 2 diabetes. As a similar lifestyle related disease, the same support should be given to 
individuals who wish to become more physically active. Even though physical activity 
promotion has largely been unsuccessful with the majority of the population obtaining 
insufficient levels of physical activity (Chaudhury et al., 2008), perhaps the information 
provided has not been potent enough to initiate behaviour change. The findings presented in 
this thesis suggest that the provision of feedback demonstrating the physiological consequence 
of movement behaviours (e.g. glucose levels) are encouraging but it is still early days for the 
application of changing behaviour. 
The brain activation pilot study identified that fMRI can be used to quantify people’s response 
to personalised health messages. Having also highlighted that fMRI may not be the most 
practical or feasible tool to capture naturalistic exposure to feedback presented by digital health 
technologies, further lessons may be learnt from the smoking cessation literature. For instance, 
much of the smoking cessation literature has explored the presentation of threatening messages 
to motivate people to refrain from smoking. This has in part been substantiated by studies using 
eye-tracking technology which quantifies visual attention and is likely a more practical 
neuroimaging tool to use. Findings have revealed that the addition of graphic warning labels to 
cigarette packages, which demonstrate the negative health consequences of smoking, are often 
met with ‘defensive avoidance’ but they can promote better recall of the health risks (Kessels 
et al., 2010; Strasser et al., 2012). Similar research has also investigated visual attention to food 
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and beverage advertising (Velazquez & Pasch, 2014) as well as beer and cigarette advertising 
(Krugman et al., 1994). Therefore, it may be worthwhile exploring whether eye tracking can 
be applied within the context of physical activity health messages. For instance, eye-tracking 
technology may allow us to objectively monitor overt visual attention to feedback delivered 
via wearable technologies and their companion smartphone apps. This may help us better 
understand users and their varying, complex patterns of use that cannot be gleaned from self-
report measures or fMRI alone. 
5.2.2 Education on the stimulus-response relationship between physical activity 
and glucose: A key ingredient? 
Despite growing evidence for the stimulus-response between physical activity and glucose 
levels in individuals living with and without diabetes (Buckley et al., 2014; Dunstan et al., 
2012; Fritschi et al., 2016; Healy et al., 2008; Henson et al., 2013; Thorp et al., 2010), only a 
couple of studies (to the authors knowledge) have capitalised on this relationship as an 
educational tool to demonstrate the health benefits of physical activity (Allen et al., 2008; 
Bailey et al., 2016). Allen and colleagues presented ‘personal’ and ‘role model’ glucose graphs 
to individuals living with diabetes which depicted activity-related reductions in glucose (Allen 
et al., 2008). Findings revealed a 5 min/day increase in moderate-intensity physical activity at 
the expense of sedentary time. In addition, Bailey and colleagues taught individuals living with 
prediabetes how to set goals, monitor their exercise and glucose levels, and how to observe 
their interaction using continuous glucose monitoring; improving adherence to a home-based 
exercise programme (Bailey et al., 2016). Knowing how best to incorporate education into a 
free-living setting will be a future direction from this thesis. 
The feasibility intervention investigated the use of both physiological and behavioural data and 
the effect they had on behaviour change in individuals at risk of type 2 diabetes. Despite 
sufficient engagement with the technologies, participants did not significantly increase their 
physical activity or reduce their sedentary behaviour which could be attributed to participants 
observing a stronger stimulus-response coupling between glucose and diet rather than physical 
activity. This study did not incorporate an education session about interpreting the feedback 
provided by the technologies or the stimulus-response relationship. There were also no 
instructions provided regarding when or why to scan the glucose sensors. Nevertheless, 36% 
of glucose scans occurred when glucose levels were above the target range. Whilst individuals 
were informed about the purpose of the study, not all would have been equipped with the 
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knowledge of the acute responses of glucose levels from being physically active. Incorporating 
an education session could therefore improve the potency of an intervention and should be 
tested in future study iterations. 
The National Diabetes Prevention Programme (NDPP), in its current form, also focusses 
heavily on in-person education sessions, during which diet and physical activity are key topics. 
However, in-person education sessions, and particularly laboratory-based education sessions, 
can be costly and require people to travel and commit time. It may be that as digital health 
technologies integrate multiple health measures within a single form (e.g. physical activity and 
glucose measured by the same device), education on the stimulus-response relationships may 
also become integrated within the technology. Showing people via feedback devices could be 
more effective than telling people why they should be more active and/or less sedentary 
(Latimer-Cheung et al., 2013). For example, an app which continually receives glucose levels 
and steps taken may be able to alert the user when they should go for a walk (e.g. if glucose 
reaches hyperglycaemic levels). If the user then completes the walk, the app may positively 
reinforce the decision by showing their glucose level returning to baseline quicker than if they 
had remained seated (e.g. “Well done, by going for that walk your glucose returned to normal 
22 minutes quicker than if you had remained sat down. Walking on most days will reduce your 
risk of developing diabetes by 8%”). That said, this message may need to be framed in an 
alternate way to capture the attention of other individuals; therefore, it is important to try and 
have flexibility in how messages are presented so that individuals can resonate and feel 
competent to act on the information shown. However, until technology enables this concept to 
be tested, in-person education sessions on stimulus-response relationships followed by free-
living exposure to behavioural and physiological feedback seems to be the next step on the 
journey of digital health technologies to elicit sustained increases in physical activity. 
5.2.3 Targeting the right people for interventions 
Given the high prevalence of multiple negative lifestyle behaviours in today’s society, such as 
‘hyper-sitting syndrome’ (Gray, 2016), and with 5-10% of adults developing diabetes (Bansal, 
2015), it is vital to target the right people. Objectively measuring how people engage with 
digital health technologies, as done in the feasibility intervention, may help to identify 
individuals most suitable for these types of interventions and who may require greater levels 
of support (Serrano et al., 2017). It is not only what education support is needed but also the 
type and level (i.e. some may need more support than others). The feasibility intervention 
revealed variations in the level of engagement between participants, which may suggest that 
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some were more engaged with technology than others. It may also be that some people were 
able to access and interpret information quicker than others. By stratifying individuals who 
might benefit from diabetes prevention interventions by the level of support or education they 
require, future interventions may better optimise resources to give participants an equal chance 
of making positive lifestyle changes such as increasing their physical activity. 
It is important for type 2 diabetes prevention interventions to target those who would benefit 
most from lifestyle changes; given that 592 million individuals are likely to be diagnosed by 
2035 (Chapman & Elstein, 1995) and prediabetes burdening more than one-third of adults in 
England (Green et al., 1996). That said, targeting individuals who need support will be crucial 
to ensure effective allocation of available resources. The feasibility intervention recruited 45 
individuals living at moderate-to-high risk of developing type 2 diabetes from the community 
within a four-month period. Screening individuals from the community is important given that 
many people (e.g. low income, unemployed and less well educated) do not attend NHS health 
checks and thus do not have up-to-date medical records (Dryden et al., 2012). However, 
community-based recruitment comes with its own challenges that must be overcome before 
such strategies are implemented. Firstly, despite screening as moderate-to-high risk, only 7% 
of participants in the feasibility intervention had prediabetes. Similar to the limitations of other 
screening initiatives, the one used in this thesis identified individuals who presented multiple 
risk factors but this can only be suggestive of prediabetes (Patel et al., 2015). Targeting 
individuals living with prediabetes has been declared a priority for diabetes prevention efforts 
(Barry et al., 2017). Previous studies in the UK have been able to identify prediabetes in 17.5-
26.5% of screened individuals using GP practice databases (Gray et al., 2012; Webb et al., 
2011). Consequently, efforts to improve the way in which individuals with undiagnosed 
prediabetes are identified, particularly in community settings, are needed. Difficulties 
recruiting from community settings are also highlighted by our finding that almost two-thirds 
of individuals interested in taking part in the feasibility intervention were ineligible because 
their level of diabetes risk was too low. Also, as previously highlighted, current technological 
limitations may provide significant barriers to reaching people in need of interventions, as one-
in-five individuals were ineligible for the feasibility intervention because they did not own or 
use a compatible smartphone. With 7.8 million individuals in the UK identified as non-users 
of the internet (Good Things Foundation & Yates, 2017) and 24% of adults not using a 
smartphone (Ofcom, 2017), ensuring that interventions are not too technologically restrictive 
is important. 
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5.2.4 Digital health technologies: Ready for real-time but are they ready for 
prime-time? 
The prevalence of digital health technologies (and their companion smartphone apps) has 
continued to grow over the last decade (Research2Guidance, 2017). With an estimated 2.3 
billion smartphone users (Statistica, 2018) and smartwatch ownership increasing in the UK 
from 5% in 2016 to 9% in 2017 (Ofcom, 2017), digital health technologies appear to be here 
to stay. More specifically, the growing marketplace for health-related apps 
(Research2Guidance, 2017) has brought with it increases in smartphone ownership and 
improvements in app quality (Research2Guidance, 2016). These statistics are quite compelling, 
but they do not necessarily mean that digital health technologies will be the answer to chronic 
disease burden. Devices often become unused items ‘left in a sock drawer’ never to be used 
again. Previous work has found that 65% of users abandon Fitbit devices within two weeks 
(Shih et al., 2015), 43% of people no longer access MyFitnessPal apps after one month (Laing 
et al., 2014) and 33% of American users no longer use their activity monitor within six months 
of purchase (Ledger et al., 2014). Indeed, some individuals do not use the technology for its 
intended purpose (Kelders et al., 2012). In comparison, the feasibility intervention observed a 
reduction in time spent on the LibreLink and Fitbit apps (20 min/day and 7 min/day reducing 
to 9 min/day and 4 min/day, respectively over six weeks) and participants complied well with 
wearing and scanning the minimally-invasive glucose sensor for six weeks (80-94% data 
capture). However, a problem with this glucose sensor was that 62% of participants required 
additional sensors, resulting in a higher than expected cost per participant, predominantly 
because these sensors were accidentally displaced. Therefore, it is unlikely that such 
technologies, in their current form, will be incorporated into routine clinical services if they 
need to be frequently replaced or if patients do not engage with them sufficiently to evoke the 
required health improvements. That said, future iterations of these technologies will likely 
evolve with greater, more enhanced functionality. Therefore, efforts to sustain user interest in 
digital health technologies are needed.  
This thesis provides evidence for the potential of providing behavioural feedback with 
physiological feedback to help sustain use and engagement with the digital health technologies. 
It is perhaps the increased functionality of the technologies that delays this ‘sock drawer effect’. 
In the feasibility intervention, participants wore both the Fitbit and Freestyle Libre for the full 
six weeks and maintained engagement above the ‘minimum ask’; scanning the Freestyle Libre 
at least twice as often as they were asked to. However, the digital health technologies used in 
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this thesis have important limitations that should be overcome before they can be deemed ready 
for prime-time. Two wearable technologies were needed (one for behavioural feedback and 
one for physiological feedback), each worn in a different location, with a different attachment 
mechanism, different charging requirements, different memory storage capabilities and 
different apps. To provide truly combined behavioural and physiological feedback, this 
information must be harmonised within a single digital health technology/app. There are also 
more short-term problems, with recruitment to the feasibility intervention restricted to users of 
certain Android smart phones; leading to approximately one-fifth of screened adults being 
ineligible for the study. Whilst the Abbott Freestyle Libre is likely soon accessible via iOS 
smartphones given other devices (e.g. Dexcom G5) are already available on both smartphone 
operating systems, these issues will greatly hinder the potential for such technologies to gain 
mass adoption. However, this should not deter investigations into the utility of these 
technologies to facilitate the adoption of healthier lifestyles, including increasing physical 
activity. Digital health technologies will continue to improve by solving the problems of 
previous generations and explore the integration of multiple health measures within a single 
wearable module. For example, Medtronic, a major competitor to Abbott, issued a press release 
in 2017 that eluded to a collaboration with Fitbit to integrate glucose and physical activity data 
via their smartphone app (Medtronic, 2017). Multi-functional apps are likely to continue 
advancing in the coming years. Therefore, whilst prime-time in the sense of implementation 
into clinical pathways may still be on the horizon, the digital technologies are making 
promising strides. For now, it is important to ensure that the health messages provided by these 
digital health technologies are effective (Driver, 2016). 
5.2.5 Finding a suitable home for digital health technologies for type 2 diabetes 
prevention 
An existing prevention programme in England refers individuals identified via GP databases 
or NHS health checks to a nine-month educational programme. Forming part of the Five Year 
Forward Plan (NHS England, 2014), the NDPP delivers a structured lifestyle intervention. 
Between June 2016 and March 2017, the programme had over 43,000 referrals (4,000 in the 
East Midlands) (Barron et al., 2017) which exceeded expectations set by the expert reference 
group (NHS England, 2016). However, preliminary findings suggest that only 49% of those 
referred attended the initial assessment (ranging from 16-86% across England) (Barron et al., 
2017). The NDPP has begun to pilot the use of digital health technologies in the form of 
weighing scales, activity monitors and online counselling (NHS Digital, 2017). This is a 
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promising development and aligns well with the present thesis which supports the use of digital 
health technologies presenting personalised feedback in the context of diabetes prevention. 
As interventions such as the NDPP increasingly incorporate digital health technologies and 
with the ongoing expansion of NHS Digital, efforts to widen digital participation are ongoing. 
For example, the NHS Digital ‘Widen Digital Participation programme’ aims to offer 
individuals skills to better manage their condition (NHS Digital, 2016b). Digital technologies 
offer great potential in improving the delivery and reach of healthcare (Michie et al., 2017) and 
with the ongoing growth of NHS Digital, the NHS seeks to maximise the integration of digital 
solutions within patient healthcare. Consequently, the present thesis helps inform how 
personalised behavioural and physiological feedback can be deployed for the prevention of 
chronic disease. 
5.3. Challenges and potential in this area of research 
5.3.1 Challenges 
In addition to the challenges already mentioned, the following section acknowledges further 
challenges faced in this area of research. A major challenge facing researchers is that digital 
health technologies are regularly superseded in the consumer marketplace. Within the present 
thesis, both the Lumoback and Fitbit Charge 2 have been superseded since their deployment in 
the brain activation pilot and feasibility intervention, respectively, by the Lumo Lift and Fitbit 
Alta and Ionic, respectively. This is due to the increasing consumer demand for more 
sophisticated functionality and design (Sanders et al., 2016). In addition, the flash glucose 
monitor used in the brain activation pilot and feasibility intervention was deployed soon after 
market release in 2016. Consequently, the device did not permit masked measurement of 
glucose levels, so participants had to have access to feedback to capture data. Previous studies, 
which have been financially supported by Abbott, have had access to the Pro model which has 
a masked (logging) mode (e.g. Bolinder et al., 2016). Increasing competition in the 
physiological sensors market will likely bolster efforts to become more amenable to research 
applications, until then slight adjustments to devices will be actioned to fit within protocols. 
A major challenge to utilising interstitial glucose sensors is the invasiveness of the devices. 
Despite being marketed as minimally-invasive, individuals not accustomed to these devices 
may not be comfortable applying and wearing these devices during routine wear. As a result, 
advancing technologies are exploring the potential for wireless, wearable 
photoplethysmography sensors to monitor physiological markers such as blood pressure 
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(Zhang et al., 2016) to replicate how heart rate is currently recorded via Fitbit. Other options 
are to follow the progression of microneedle patches placed directly on the skin (e.g. 
SugarBEAT, expected early 2018 and offers 24-hour wear per patch applied). Another factor 
that links with this notion is that interstitial glucose levels may not clearly show the 
physiological effect of movement behaviour when compared with traces captured using venous 
blood glucose samples. This is a challenge given the emphasis on using off-the-shelf 
technologies (i.e. continuous/flash glucose monitors, which monitor interstitial glucose levels) 
to try and demonstrate the effect that movement behaviours have on glucose during routine 
wear. Efforts are needed to increase the wear-ability of these physiological monitoring devices 
as well as fine-tune the signals to help reduce the medical stigma attached and improve their 
resonance in this space, respectively. 
Other key limitations to this thesis include the convenience sampling method for the brain 
activation pilot and the relatively small sample size for the intervention, albeit having a 
feasibility focus. In the brain activation pilot, convenience sampling resulted in participants 
being highly educated, reporting mostly as White British, generally physically active and 
normoglycemic. Ideally, we would have recruited people at greater risk of developing type 2 
diabetes (i.e. living with prediabetes) for the feasibility intervention. This would improve the 
generalisability of the study findings to the specific population of interest (Blair & Zinkhan, 
2016). 
5.3.2 Potential 
In addition to the potential already discussed, this thesis highlights the need for future research 
studies to utilise sophisticated, objective measurement and intervention tools. The next 
iteration of this work will need to wrestle with the timing, content and composition of the 
coupled feedback. Being able to provide temporally sensitive cues (e.g. nudge users after sitting 
for too long) via feedback would keep cognitive load low (Hargreaves et al., 2010) and help 
overcome the notion that individuals are often disassociated with the long-term implications of 
immediate decisions (Critchfield et al., 2001). Presenting coupled feedback may act as a potent 
nudge for individuals because they will see the acute physiological consequence of their 
movement behaviour. This thesis has shown that the devices in isolation show promise and are 
acceptable from a research study perspective. However, it is acknowledged that participants 
may feel obligated to comply with research study protocols (i.e. have greater wear adherence) 
whereas user interest in the ‘real world’ (i.e. opting or choosing to wear devices) will likely 
vary. To ensure long-term success, investigations into the ability of the technologies to be worn 
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continuously as a wearable lifestyle device and used as a tool to encourage self-management 
of health, need to be explored. Technologies monitoring both behaviour and physiological 
consequence of movement behaviours may, in turn, become more mainstream. As a result, 
their potential use is great and, with increased integration into pre-clinical programmes (e.g. 
the NDPP), these efforts may contribute to alleviating burden on the NHS. 
5.4. Future directions 
This section outlines several recommendations for future work informed by the limitations 
experienced and potentials noted in this thesis, as follows:  
• Strategies to sustain user interest in digital health technologies for chronic disease 
prevention. 
• Advocate and work with device manufacturers to integrate and harmonise behavioural 
feedback and the physiological consequence of behaviours into a single 
platform/module. 
• Identify the specific components of health messages and feedback provided by digital 
health technologies that are most effective for sustained behaviour change. 
• Elucidate the key ingredients in education sessions to increase physical activity. 
• Optimise stratification approaches to target those individuals in most need of 
interventions to prevent or delay the development of chronic diseases. 
• Examine the impact of providing individuals with coupled behavioural and 
physiological feedback through digital health technologies within existing large-scale 
interventions such as the NHS National Diabetes Prevention Programme. 
5.5. Overall conclusions 
Interventions to prevent type 2 diabetes are urgently needed. Despite the abundance of evidence 
supporting the health benefits of physical activity, population levels are still critically low. To 
date, interventions have focussed on lifestyle behaviours, such as increasing physical activity, 
but advancements in technology now allow individuals to see the physiological consequences 
of these behaviours; information that may yield sustained behaviour change. The present thesis 
highlighted the utility of examining brain activations in response to personalised physiological 
and behavioural feedback and observed that individuals at moderate-to-high risk of developing 
type 2 diabetes engaged highly with coupled feedback. This work supports future research 
providing objective feedback on movement behaviours and the physiological consequences of 
these behaviours in the context of chronic disease prevention.
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Appendix B 
Study One: Functional MRI Acquisition Overview. 
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Study Task design 
Magnet 
(T) 
TE (ms) TR (ms) 
Flip angle 
(degrees) 
Field of 
View 
(mm) 
Slice 
Thickness 
(mm) 
(Chua et al., 2009) Detail not provided 
Detail not 
provided 
Detail not 
provided 
Detail 
not 
provided 
Detail not 
provided 
Detail 
not 
provided 
Detail not 
provided 
(Chua et al., 2009) 
Mixed. 
Blocked: blocks 65 secs; fixation 20 secs. 
Event-related: trials 3.5 secs; fixation 4, 6 
or 8 secs (jittered). 
Total task 32 mins. 
3T GE Signa 
scanner 
30 2000 80 220 3.4 
(Chua et al., 2011) 
Blocked. 
Initial fixation 10 secs; blocks 24 secs (5 
trials); fixation 7 secs (4-10 secs). 
3T GE Signa 
Excite 2 
scanner 
30 
2000 
 
90 220 3 
(Cooper et al., 
2015) 
Blocked. 
Trials 17.7 secs (13.9-30 secs); rate ads 4 
secs; 
fixation ITI 4.1 secs (3.1-7.5 secs). 
3T GE Signa 
scanner 
30 2000 90 220 3 
(Dinh-Williams et 
al., 2014) 
Blocked. 
Aversive blocks and appetitive blocks; 
fixation 15 secs; trials 4 secs; blank 
screen ISI 0.5 to 1.5 secs. 
3T Siemens 
TRIO scanner 
 
30 3000 90 
Detail 
not 
provided 
3.5 
 vi 
 
(Dinh-Williams et 
al., 2014) 
Blocked. 
Blocks 25 secs (5 trials); trials 4 secs; 
blank screen ISI 1 second (0.5 to 1.5 
secs). 
3T Siemens 
TRIO scanner 
 
30 3000 90 
Detail 
not 
provided 
3.5 
(Do & Galvan, 
2015) 
Event-related. 
Trials 6 secs; button response 2 secs; 
ISI 10 secs (jittered). 
3T Siemens 
TRIO scanner 
 
30 2000 90 
Detail 
not 
provided 
4 
(Enax et al., 2015) 
Event-related. 
Trials 5 secs; fixation 4-6 secs; button 
response ITI 4-6 secs. 
Total task 30-40 mins. 
1.5T Siemens 
Avanto 
scanner 
 
45 2500 90 192 3 
(Falk et al., 2011) 
Blocked. 
14 ads 30 secs; 2 ads 15 secs; button 
response 4 secs; fixation; additional 
fixations every 4 blocks. 
3T Siemens 
Trio scanner 
 
30 2000 90 192 4 
(Falk et al., 2016) 
Trial 4 secs; response 3 secs; fixation ITI 
4.1 secs (3-7.5 secs) 
3T GE Signa 
scanner 
30 2000 90 220 3 
(Falk et al., 2015) 
Blocked. 
Blocks: initial suggestion (5 secs); 
reasons why/how (7 secs); brief reflection 
(6 secs); 
fixation 2.5 secs; 
3T GE Signa 
scanner 
 
30 2000 90 220 3 
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every 7th block contained a longer block 
(12 secs). 
(Gearhardt et al., 
2014) 
Blocked. 
‘Myth busters’ video; commercial breaks 
(10 trials) 2 mins 30 secs; commercials 
15 secs. 
Total task 34 mins 
3T Siemens 
Allegra 
scanner 
 
30 2000 80 
Detail 
not 
provided 
4 
(Jasinska et al., 
2012) 
Blocked. 
Blocks 24 secs (5 trials); fixation 7 secs 
(4-10 secs). 
3T GE Signa 
Excite 2 
scanner 
 
30 2000 90 220 3 
(Langleben et al., 
2009) 
Blocked. 
Fixation ISI 6 secs. 
Total task 10 mins 42 secs. 
3T Siemens 
Trio scanner 
30 3000 
Detail not 
provided 
220 3 
(Newman-Norlund 
et al., 2014) 
Blocked. 
Blocks 15 secs; 5 trials per block (2 
secs); Fixation 1 sec; Rest blocks 15 secs. 
Total task 41 mins 36 secs. 
3T Siemens 
Trio scanner 
 
30 1950 75 ? 3 
(Vollstadt-Klein et 
al., 2011) 
Blocked. 
1 block 33 secs (5 trials); trials 6.6 secs; 
button response 9.9 secs; fixation >3.3 
secs. 
Total task 15 mins. 
1.5T Siemens 
Magnetom 
Vision scanner 
 
60 0.6 90 220 4 
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Abbreviations: T, tesla; TE, echo time; TR, repetition time 
 
 
 
(Wang et al., 2013) 
Blocked. 
Initial fixation 16 secs; videos 30 secs; 
fixation ITI 16 secs. 
Total task 12 mins 36 secs. 
3T Siemens 
Tim Trio 
scanner 
 
30 2000 
Detail not 
provided 
220 3.4 
(Wang et al., 2015) 
Blocked. 
Trials 2 secs; blocks (6 trials); button 
response; fixation 10-13 secs. 
Total task 9.3 mins. 
3T Siemens 
Tim Trio 
scanner 
 
32 3000 
Detail not 
provided 
Detail 
not 
provided 
Detail not 
provided 
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Appendix C 
Study One: Functional MRI Acquisition Overview (continued)
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Author, year Template for normalisation Smoothing filter Analysis software 
(Chua, Polk et al., 2009) ? ? ? 
(Chua et al., 2009) MNI152 template 5 mm FWHM MCFLIRT program then SPM2 
(Chua et al., 2011) MNI152 template 5 mm FWHM MCFLIRT program then SPM2 
(Cooper et al., 2015) MNI template 8 mm FWHM SPM8 
(Dinh-Williams, Mendrek, 
Bourque et al., 2014) 
MNI standardised brain template 8 mm FWHM 
SPM5 
 
(Dinh-Williams, Mendrek, 
Dumais et al., 2014) 
standardised ICBM152 brain 
template 
8 mm FWHM 
SPM5 
 
(Do & Galvan, 2015) standard MNI space 5 mm FWHM FSL 
(Enax et al., 2015) MNI template 8 mm FWHM SPM8 
(E. B. Falk et al., 2011) MNI standard stereotactic space 8 mm FWHM FSL and SPM8 
(E. B. Falk et al., 2016) MNI template 8 mm FWHM SPM8 
(E. B. Falk et al., 2015) MNI template 8 mm FWHM AFNI and SPM8 
(Gearhardt et al., 2014) MNI T1 template brain ICBM152 6 mm FWHM SPM8 
(Jasinska et al., 2012) MNI 152 template 7 mm FWHM MCFLIRT then SPM 
 xi 
 
 
Abbreviations: AFNI, Analysis of Functional Neuroimages; EPI, echo planar imaging; FSL, FMRIB Software Library; FWHM, full width half 
maximum; ICBM, International Consortium for Brain Mapping; MNI, Montreal Neurological Institute; SPM, Statistical Parametric Mapping; 
T1, T1-weighted image
(Langleben et al., 2009) MNI T1 template 6 mm FWHM FEAT (FSL) 
(Newman-Norlund et al., 2014) DNP 8 mm FWHM SPM8 
(Vollstadt-Klein et al., 2011) MNI EPI template 12 mm FWHM SPM5 
(Wang et al., 2013) MNI T1 template 6 mm FWHM 
Expert Analysis Tool (FSL) and 
MCFLIRT 
(Wang et al., 2015) MNI T1 template 5 mm FWHM FEAT (FSL) 
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SIGNAL Protocol 
Whelan ME, Kingsnorth AP, Orme MW, Sherar LB, Esliger DE. Sensing interstitial glucose 
to nudge active lifestyles (SIGNAL): feasibility of combining novel self-monitoring 
technologies for persuasive behaviour change. BMJ Open. 2017;7:e018282. 
Original publication has been adapted to fit within this thesis. 
 
Introduction  
There is widespread concern regarding the increasing prevalence of chronic diseases such as 
type 2 diabetes (World Health Organization, 2014). Type 2 diabetes currently imposes an 
annual cost of £23.7bn through its associated complications (Hex et al., 2012); however, this 
cost is likely to rise as it is projected to directly impact 592 million individuals worldwide by 
2035 (Guariguata et al., 2014). Another imposing challenge is the proportion of the population 
living with undiagnosed diabetes (current prevalence estimated at 45.8%) (Beagley et al., 
2014); which is, in part, attributable to its asymptomatic state prior to the presentation of 
complications. Regardless of diagnosis status, preventing the development of type 2 diabetes 
is an international priority moving forward (Barry et al., 2017). Prediabetes, categorised as 
either impaired fasting glucose or impaired glucose tolerance represents abnormal glucose 
homeostasis and is placed between diabetes and normal regulation. Impaired fasting glucose 
has been defined as elevated fasting plasma glucose (100-126 mg/dl) whilst impaired glucose 
tolerance is characterised by an elevated two hour plasma glucose concentration (140-199 
mg/dl) following intake of a 75g glucose load (Genuth et al., 2003). One in seven adults have 
impaired glucose regulation (Diabetes UK, 2006) and, compared to individuals living with 
normal circulating glucose levels, pre-diabetics are five to ten times more likely to develop 
type 2 diabetes (Santaguida et al., 2005) with 5-10% of people becoming diabetic annually 
(Forouhi et al., 2007). Diabetes is projected to be one of ten leading causes of death worldwide 
(Tabák et al., 2012); thus, identification and prevention are crucial for early intervention. A 
lack of physical activity is considered one of the major risk factors for chronic disease and is 
comparable to the ill-effects of obesity (Olshansky et al., 2005) and smoking (National 
Research Council Committee on Population, 2011) individually. Given that physical inactivity, 
where insufficient levels of physical activity are achieved, is attributed to an estimated 7% of 
type 2 diabetes cases (Lee et al., 2012), it is an important modifiable lifestyle behaviour to 
target. With the prevalence of impaired fasting glucose doubling in individuals at 40-59 years 
and remaining consistent beyond 60 years (Cowie et al., 2009), targeting efforts toward specific 
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age cohorts is crucial. Individuals with abnormal glucose homeostasis are referred onto 
community-based lifestyle behaviour programmes such as The Healthier You: National 
Diabetes Prevention Programme (NDPP). Initiated in 2016, the programme aims to roll out 
nationally by 2020 as part of the NHS Five Year Forward plan (NHS England, 2016). The 
present study intends to implement a community screening approach, monitor participant 
retention and to investigate whether digital health technologies providing feedback about 
physical activity and glucose levels may play a role in the prevention pathway (which may be 
amenable to the NDPP framework). 
With increasing recognition toward the integration of technology into usual care pathways (i.e. 
emergence of NHS Digital), it is a crucial time to consider how technologies could contribute 
to the management of chronic diseases. Given recent consumer interest (Ferguson et al., 2015), 
wearable technologies allow people to self-monitor behaviour and health. Gardner and 
colleagues reviewed behavioural interventions and identified self-monitoring of behaviour as 
a particularly promising behaviour change technique (Gardner et al., 2016). Similarly, 
continuous glucose monitoring technology has shown promise for longer-term physiological 
outcomes (including glycated haemoglobin [HbA1c]) (Vigersky et al., 2012); supporting the 
suggestion that more frequent engagement leads to better health outcomes (Fonda et al., 2013). 
Self-monitoring of both behaviour and outcomes are listed within the taxonomy alongside 91 
other ingredients (including feedback and goal-setting) in behavioural interventions (Michie et 
al., 2013). As well as delivering key behaviour change techniques, digital health technologies 
also support Control Theory (Carver et al., 1982). More specifically, people are presented with 
information about a present state via feedback (e.g. 9,000 steps) and are often provided a set 
goal to achieve (i.e. 10,000 steps). Equipped with this information, people may make efforts to 
achieve the goal or desired outcome (i.e. ≥10,000 steps) because they have been informed how 
they are performing relative to it. The majority of research to date has focused on the 
deployment of technologies to self-monitor movement behaviours (e.g. Cadmus-Bertram et al., 
2015) or specific health markers (e.g. Polonsky & Fisher, 2013) in isolation. Although these 
approaches have shown to be beneficial to behaviour change in the short term, most user 
engagement is not sustained beyond six months (Ledger et al., 2014). Despite research 
conducted on short-term improvements, it is not yet clear whether results are sustained with 
prolonged use (Barwais et al., 2013; Tudor-Locke & Lutes, 2009). However, the rationale is 
that when provided with information about their current levels of activity, people may feel 
motivated to improve their behaviour.  
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With a view to sustaining the ‘honeymoon period’ of technology-bolstered behaviour change, 
a logical next step would be to deploy wearable technologies in combination. For example, 
studies investigating the acute effects of brief physical activity bouts or interruptions to 
prolonged sedentary behaviour on glucose levels in controlled settings have found reductions 
in postprandial glucose as a result of increased movement (e.g. DiPietro et al., 2013; Dunstan 
et al., 2012; Peddie et al., 2013; Reynolds et al., 2016). As a result, the present study proposes 
that delivering behavioural and physiological feedback in parallel may be more persuasive 
rather than feedback delivered in isolation. This approach may offer a platform for people to 
self-educate themselves about the relationship between movement and acute health status (i.e. 
walking after a meal leads to marked reductions in glucose levels); which may help sustain 
engagement with digital health technologies. With ongoing developments, technologies such 
as flash glucose monitoring offer a wealth of information to users without the need for invasive 
fingerprick samples; offering a useful tool for non-diabetic individuals (who are not 
accustomed to regular fingerprick blood samples) (Bailey et al., 2015). To date, an important 
limitation of the efforts to encourage people to be more physically active has been the 
assumption that we are willing to change our lifestyles today to reduce our risk of developing 
disease years or even decades later. Implementing specific behaviour change techniques such 
as self-monitoring, goal-setting and feedback (Michie et al., 2013), wearable devices could 
empower individuals to manage their health through a change in behaviour by recognising 
movement patterns and observing influences on health. Building on previous findings which 
observed greater levels of brain activation in response to personalised glucose related 
information (over behavioural information) (Whelan et al., 2017; Chapter Three), the present 
study aims to examine the role of providing novel digital health technologies presenting bio-
behavioural feedback in those living at moderate-to-high risk of type 2 diabetes. 
Aims and Objectives 
Primary aim 
The primary aim of this study is to investigate participant engagement using self-monitoring 
technologies for physical activity and glucose. 
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Secondary aims 
The secondary aims of this study are to explore (i) the feasibility of the intervention trial at 
baseline, 1, 2, 3, 4, 5, and 6 weeks; (ii) levels of physical activity and interstitial glucose levels 
at baseline, 1, 2, 3, 4, 5, and 6 weeks and (iii) levels of technology readiness, health literacy, 
health status and attitudes towards one’s own health at baseline and post self-monitoring. 
Methods 
Study setting 
Participants will be recruited from the community in Leicestershire, UK from May to August 
2017. All appointments (three or four in total, depending on group allocation) will take place 
at the National Centre for Sport and Exercise Medicine at Loughborough University, UK.  
Study design 
The feasibility study protocol has been prepared in accordance with the Standard Protocol 
Items: Recommendations for Interventional Trials (SPIRIT) (Chan et al., 2013) with reference 
to the Template for Intervention Description and Replication (TIDieR) (Hoffmann et al., 2014). 
The study will aim to recruit 45 individuals with 15 participants randomly allocated to each of 
the three groups. No specific sample size has been calculated due it’s the feasibility nature of 
the study, but results will inform the development of a full-scale intervention. 
Participant involvement in the Sensing Interstitial Glucose to Nudge Active Lifestyle study 
will last seven weeks. Following baseline (one week), participants will be randomised into one 
of three intervention groups. Participants will be notified of their group allocation at the second 
appointment before starting the intervention period (six weeks). Appointments will be arranged 
at the preceding appointment where possible. The study was registered on the International 
Standard Randomised Controlled Trial number (ISRCTN) Register (ISRCTN17545949) in 
May 2017. 
Randomisation 
Participants will be block randomised using a 1:1:1 study allocation ratio, coordinated by a 
remote internet-based service (http://www.sealedenvelope.com/). Randomisation will be done 
by a member of the research group, independent to the present study. Baseline measures will 
be conducted pre-randomisation. Participants will be notified of their group allocation at 
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appointment two. In the event of participants originating from the same household, identical 
group allocation will be employed to avoid any cross-contamination. 
Inclusion criteria 
Participants will be at least 40 years old, be at moderate-to-high risk of developing type 2 
diabetes (Gray et al., 2010) and use a compatible Android smartphone. 
Compatible smartphones at the time of the study will be defined as having the following 
characteristics: An Android operating system of 4.0 or higher, Near Field Communication 
(NFC), a screen resolution of 480x800 to 1080x1920 and a screen size of 8.9-14.5cm. 
Exceptions were the Samsung Galaxy 7, Samsung S8, Nexus 5X and Nexus 6P which cannot 
install the LibreLink application (app). 
Exclusion criteria 
Individuals with a clinical diagnosis of diabetes, a HbA1c of ≥6.5%, or have 
suspected/confirmed pregnancy will be excluded. Participants who are unable/unwilling to 
provide informed consent, cannot/unwilling to adhere to the study protocol or cannot read/write 
English will also be excluded. 
Recruitment 
Participants will be recruited at community sites through the distribution of posters and leaflets 
in community organisations and local businesses based in Leicestershire, UK. Individuals will 
also be recruited through existing participant databases. All individuals will be directed to 
complete a brief survey to determine level of risk for type 2 diabetes. The questions will be 
presented via an online survey platform (Qualtrics, Provo, UT) and will relate to sex, age, 
ethnic background, familial history of diabetes, waist circumference, body mass index and 
blood pressure. The validated survey has been used in studies applying risk score algorithms 
on primary care electronic data (Gray et al., 2012). Waist circumference will be replaced with 
clothing size and fit following guidance offered by Battram and colleagues (Battram et al., 
2011). Moderate-to-high risk individuals will be contacted by the research team to take part in 
the study. Participant information sheets will be provided. Ineligible individuals (i.e. low risk, 
increased risk or a moderate/high risk, but are not aged at least 40 years old nor use an Android 
smartphone) will be directed to Diabetes UK ‘Type 2 diabetes: What to do if you’re at risk’ 
information booklets. 
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Study procedure 
First appointment and baseline 
An outline of the study procedure is presented in the next Figure. Appointment one will involve 
informed consent, health measures (height, weight, percentage body fat, waist circumference, 
blood pressure, HbA1c, grip strength, quadriceps strength and aerobic fitness; full 
methodological details are provided in the measures section below) and a brief demographics 
questionnaire. Participants will complete a physical activity readiness questionnaire for 
screening purposes before completing the aerobic fitness assessment (Warburton et al., 2011). 
Participants will be fitted with a waist-worn accelerometer and a wrist-worn activity tracker. 
Additional details are presented in Appendix G. Neither device will provide feedback to the 
participant during the seven consecutive days of wear (Appendix H). Participants will be asked 
to install two mobile apps onto a personal Android smartphone to comply with the number of 
technologies deployed (further details provided in Appendix I). Both smartphone apps will sit 
idle on the smartphone for the duration of baseline. Participants will be asked to sync the 
activity tracker via the smartphone app; switching on Wi-Fi and Bluetooth simultaneously at 
least once every five days for ≥1 hour to ensure the sync occurs. 
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Figure. An outline of the study flow. G4GPA2 represents glucose feedback (4 weeks) followed 
by glucose and physical activity feedback (2 weeks); PA4GPA2 represents physical activity 
feedback (4 weeks) followed by glucose and physical activity feedback (2 weeks) and GPA6 
represents glucose and physical activity feedback (6 weeks). Abbreviations: G, glucose 
feedback; PA, physical activity feedback; GPA, glucose plus physical activity feedback. 
Second appointment and intervention 
One week later (following baseline), participants will attend appointment two where they will 
be informed of their group allocation. Participants will be asked to complete a brief 
questionnaire, to continue wearing the activity tracker during the intervention (settings may or 
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may not be adjusted) and to return the accelerometer. A glucose sensor will be deployed to 
each participant to measure glucose levels. An instruction manual will be provided according 
to the participants’ group allocations. Participants will be provided with additional supplies of 
glucose sensors to last for four (Groups 1 and 2) or six weeks (Group 3) of the intervention. 
Accounts for both the activity tracker and glucose sensor will be connected to Diasend 
(Diasend Inc., Chicago, IL). An overview of the three groups is provided below. 
Group 1 (glucose feedback then glucose plus physical activity feedback, G4GPA2) 
Glucose feedback will be presented to participants for four weeks via the LibreLink app 
(Abbott Diabetes Care Inc., Alameda, CA). Participants will install the LibreLink app (Abbott 
Diabetes Care Inc., Alameda, CA) onto a personal Android smartphone to interact with the 
Freestyle Libre via Near Field Communication for measurement of glucose. The glucose 
monitor has a lifespan that restricts wear to 14 consecutive days. The app will remind 
participants to scan every seven hours and to remove/replace after 14 days. The LibreLink app 
will continuously display the number of days left.  
Group 2 (physical activity feedback then glucose plus physical activity feedback, PA4GPA2) 
Physical activity feedback will be presented for four weeks via the Fitbit app. In contrast to 
G4GPA2, participants will not have the LibreLink app installed and so will not have access to 
glucose feedback. Participants will be informed that the glucose sensor is functional (recording 
data) and participants will be asked to remove and replace the expired sensor with another 
sensor after 14 days.  
Device unmasking for G4GPA2 and PA4GPA2 after four weeks 
At the end of the first four weeks of the intervention, participants in G4GPA2 and PA4GPA2 
will attend a brief appointment (up to one hour in duration). For Group 1, the researcher will 
adjust settings to reveal physical activity feedback via the Fitbit app and device. For PA4GPA2, 
the researcher will install the LibreLink app to reveal glucose feedback. All participants will 
be able to access glucose plus physical activity feedback for the remaining two weeks of the 
intervention. 
Group 3 (glucose plus physical activity feedback, GPA6) 
Participants in GPA6 will receive glucose plus physical activity feedback for the full six weeks 
via the two independent LibreLink and Fitbit apps. Participants will install the LibreLink 
mobile app onto a personal Android smartphone to interact with the Freestyle Libre to measure 
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glucose. The app will remind participants to scan every seven hours and to remove/replace the 
sensor after 14 days. 
Final appointment 
All participants (G4GPA2, PA4GPA2 and GPA6) will be asked to attend the final appointment 
at the end of the intervention where they will complete a questionnaire (identical to 
appointment 2, apart from the revised Diabetes Knowledge Test). All participants will also 
receive a personalised health report containing results from the health measures conducted at 
appointment one. 
Device masking 
All email accounts and password combinations will be manually generated and managed by 
the research team to prevent use of identifiable information. During baseline wear, the activity 
tracker will be physically masked using black tape applied to the screen; leaving only time and 
date viewable. Participants will be asked not to tamper with the screen; however, if they do 
manipulate the masking, it should be noticeable to the research team. Settings on the Fitbit app 
will also be adjusted to remove physical activity metrics from the device screen and 
notifications fully restricted on their phone and activity tracker (Appendix H). However, 
participants will not be locked out of the app due to the requirement to sync the device. Time 
spent on the Fitbit app will be inspected using Ethica Data (Kitchener, Ontario, Canada) to 
identify potential unauthorised use. The activity tracker will also be set to all day sync to 
minimise data loss with data automatically transferred (Wi-Fi and Bluetooth must both be 
simultaneously switched on). When required to prevent access to glucose feedback, 
participants will wear the glucose sensors for 14-day periods as normal but will not be asked 
to install the LibreLink app nor scan the sensor (i.e. no data will be collected). This will 
standardise wear across all three groups. 
Data management and storage procedures 
All data collected will be anonymised by assigning a participant ID. Accounts with the three 
apps (Fitbit, LibreLink and Ethica Health) will be setup using study-specific (‘dummy’) email 
addresses and passwords, accessible only to the research team, to minimise use of personalised 
information. All data will be stored securely on the Loughborough University server, as 
password protected, encrypted documents and original paperwork kept in locked storage. No 
directly personally identifiable information will be collected through these platforms. GPS 
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(global positioning system) will be collected via Ethica Data which could theoretically be 
‘reverse-engineered’ to re-identify individuals; however, all participants will be explicitly 
informed about all information monitored as part of the study. For individuals who do not wish 
to have their location services monitored, we will set up a ‘reduced access’ version of Ethica 
Data (app usage, screen state and survey responses only). 
Primary outcomes 
User engagement 
Time spent on the official free Fitbit and LibreLink apps will be quantified using Ethica Data 
as well as time-stamped data relating to when the smartphone screen was turned on and off. In 
combination, these two data sources will reveal the proportion of time that the devices’ apps 
were used in relation to total smartphone use. These data will be recorded at either a day level 
(e.g. aggregate time) or event level (e.g. record of each time an app was opened) depending on 
the Android smartphone model. How often and how much time spent on the two apps compared 
with other apps on participants’ smartphones will also be quantified. Number of times the 
activity tracker syncs (occurs when the app is opened, assumed to see feedback about physical 
activity) and scans of the glucose sensor (occurs when the participant scans and to see feedback 
about glucose levels) will also be recorded. Compulsory engagement will be participants 
having to sync the activity tracker at least once every five days and scan the glucose sensors at 
least once every seven hours. The number of syncs and scans recorded above compulsory 
engagement will reflect optional engagement. Identifying when and how often syncs and scans 
happen and how these patterns change over the course of the intervention (from week one to 
six) will indicate engagement with the technology. We will also identify if participants change 
the goal settings relating to steps, floors climbed and active minutes on the Fitbit app. These 
settings will be checked daily between the hours of 18:00-19:00 by the research team and 
changes will be flagged with details of the original and new setting logged. In addition, 
assessing whether participants responded to prompts offered by the activity tracker will also be 
conducted (i.e. did participants achieve 250 steps/hour? See Behaviour Change Techniques 
section for further detail). 
Remote monitoring of participant glucose and physical activity will be completed using 
Diasend (Diasend Inc., Chicago, IL) and Fitabase (Small Steps Labs LLC., San Diego, CA), 
respectively. Diasend will connect with the Freestyle Libre via the LibreLink app and data will 
be recorded and accessed through this software. Additional data sources to be monitored by 
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Ethica Data include battery status (i.e. smartphone plugged in? Charging?), Bluetooth and Wi-
Fi (turned on or off). Quantifying these data sources will provide valuable insight into 
participant behaviour (e.g. do participants only use Wi-Fi and Bluetooth for the purpose of our 
intervention? Are participants charging it more often in the intervention compared with 
baseline?). Ethica Data will also monitor location (GPS), motion (pedometer, accelerometer, 
gravity, gyroscope, linear acceleration, magnetic field, orientation) and survey responses. 
These digital streams will monitor smartphone usage and will provide detailed data on human 
behaviour during a free-living, naturalistic setting. In total, fourteen data sources will be 
monitored. In the event a participant raises concerns relating to the number and/or type of data 
sources being monitored, a restricted coverage option of only three data sources (app usage, 
screen state and survey responses) will be offered.  
Secondary Outcomes 
Feasibility 
The feasibility of deploying novel self-monitoring technologies in parallel was structured 
around the guidelines by Bowen and colleagues (Bowen et al., 2009; see Table). Practicality 
and acceptability will be the two components focused on in the present study. Practicality and 
acceptability each have several indicators that will be used to assess the feasibility of deploying 
self-monitoring technologies. 
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Table. An outline of the feasibility components 
Feasibility component Data source (indicator of feasibility) 
Practicality of 
technology/intervention 
• Fitabase (sync compliance, missing data and response to 
haptic prompt) 
• LibreLinkUp (scan compliance) 
• Diasend (missing data, identification of Freestyle Libre 
sensor-related issues) 
• Project records (identification of need to dispatch 
additional Freestyle Libre sensors, number of individuals 
screened, rate of eligibility, study uptake and retention) 
 
Acceptability of 
technology/intervention 
• Fitabase (Fitbit wear time) 
• Diasend (Freestyle Libre wear time, digital footprint of 
time taken to move onto the next Freestyle Libre sensor 
i.e. sensor delay) 
• Project records (changes to goal settings, manual 
withdrawals, appointment attendance, retention to 
follow-up) 
• Ethica Data (digital footprint of app usage, Bluetooth 
and Wi-Fi status, battery status, electronic withdrawal) 
aFull coverage: app usage, screen state, Bluetooth, Wi-Fi, GPS, pedometer, accelerometer, 
gravity, gyroscope, linear acceleration, magnetic field, orientation, battery and survey 
responses. bRestricted coverage: app usage, screen state and (exit) survey only. 
Withdrawal 
If a participant decides to withdraw from the study at any time prior to the final appointment, 
they will be able to leave the study via (i) the Ethica Health app on their personal smartphone 
(aligning with a dynamic consenting process [Teare et al., 2015]) or by (ii) contacting the 
research team via telephone or email. Participants that decide to withdraw via Ethica Health 
will be directed to complete a brief exit survey on the app. The research team will contact all 
participants for an optional exit interview (5-10 minutes) via telephone. This will be recorded 
using Tapeacall (http://www.tapeacall.com/) and will explore reasons for not completing the 
study. 
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Physical activity levels 
ActiGraph 
In an effort to determine the physical activity levels of the participants relative to general 
population, participants will be asked to wear an ActiGraph wGT3X-BT  accelerometer 
(ActiGraph, Pensacola, FL; see Figure) for seven days during waking hours and to remove for 
any water-based activities (e.g. showering and swimming). The waist-worn (i.e. over the right 
hip, mid-clavicular line) ActiGraph will quantify time spent sedentary, in light and moderate-
to-vigorous physical activity as well as daily step counts and will function as a data logger (i.e. 
no feedback). ActiGraph accelerometers have been validated (Melanson Jr & Freedson, 1995; 
Plasqui & Westerterp, 2007) and extensively deployed (Chaudhury & Esliger, 2008; 
Hagströmer, Oja, & Sjöström, 2007; Troiano et al., 2008) to measure physical activity under 
free-living conditions. Data from the ActiGraph will be collected at 100 Hz and integrated into 
60 second epochs using ActiLife (ActiGraph, Pensacola, FL) and processed using Kinesoft 
(Kinesoft, Loughborough, UK). Non-wear will be defined as 60 minutes of consecutive zeros 
(allowing for up to two minutes of interruptions) with a minimum wear of 10 hours used to 
define a valid day (Troiano et al., 2008). A minimum of 4 valid days will be used to define a 
valid file with sedentary time classified as <100 cpm, light activity as 100-2019 cpm and 
MVPA as ≥2020 cpm (Troiano et al., 2008).  
Figure. Images of the ActiGraph (left), Fitbit Charge 2 (middle) and Freestyle Libre (right) 
Fitbit 
The Fitbit Charge 2 (Fitbit Inc., San Francisco, CA) will be worn on the non-dominant wrist 
and, whilst being sweat, rain and splash proof, participants will be asked to remove the device 
for water-based activities. The Fitbit  records intensity (i.e. minutes spent lightly active, fairly 
active and very active) in addition to heart rate and step count (see Figure). Heart rate will be 
assessed using Fitbit’s proprietary PurePulse optical heart rate technology. To examine changes 
in physical activity over the study duration, participants will be requested to wear the device 
for the full seven weeks and data will be analysed in 60 second epochs following export from 
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Fitabase. Previous models of the Fitbit have been validated for step count (Lee et al., 2014). A 
waking protocol will be implemented with non-wear defined as a loss of a heart rate signal. 
Participants will be requested to sync the Fitbit at least once every five days (rather than the 
company recommendations of seven days) to minimise data loss. Syncs beyond seven days 
will result in day level data rather than minute level data. These syncs will either occur 
automatically (i.e. without the app open) or will be user-driven (i.e. with the app open) 
depending on how the all-day sync is set, and heart rate will be set to automatic (only record 
heart rate when device is worn). 
Glucose levels 
Freestyle Libre 
The minimally-invasive Freestyle Libre flash glucose monitor (Abbott Diabetes Care, 
Alameda, CA) will be covered with Tegaderm (3M Health Care, St. Paul, MN) to help maintain 
position and adhesion during the 14-day sensor lifespan. Three strips of Tegaderm will be 
provided to participants per sensor to allow for replacement when the Tegaderm becomes dirty. 
Participants will be asked to wear the device continuously without removal for water-based 
activities (see Figure). The Freestyle Libre demonstrates consistent accuracy throughout the 14 
days with a mean absolute relative difference of 11.4% compared with capillary blood glucose, 
a lag time of 4.5-4.8 minutes and is not impacted by physical characteristics including age, 
BMI and HbA1c ( Bailey et al., 2015). Participants will be requested to scan the glucose 
monitor at least once every seven to eight hours to minimise data loss. If participants experience 
skin irritation on the non-dominant arm in the region of app, participants will be advised to 
switch to their dominant arm. Interstitial glucose data will be downloaded in 15-minute epochs 
using Diasend, an online platform connected to the LibreLink app. Participant accounts will be 
linked to Diasend from the point of LibreLink app installation. The next Figure illustrates how 
the numerous components connect to achieve the primary and secondary aims. 
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Figure. A schematic of how the technologies and platforms connected together 
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Levels of technology readiness, health status and attitude 
All questionnaires will be completed electronically using an online platform for immediate data 
entry (http://www.onlinesurveys.ac.uk/; Bristol, UK). At appointment two, quality of life will 
be assessed via the 26 item EQ-5D-5L (Herdman et al., 2011), technology readiness via the 16 
item Technology Readiness Index (TRI 2.0) (Parasuraman & Colby, 2015), health literacy via 
the 8 item eHealth Literacy Scale (e-HEALs) (Norman et al., 2006), diabetes knowledge via 
the 20 item revised diabetes knowledge test (Collins et al., 2011) and general attitude toward 
developing diabetes via the 8 item general attitudes section of the Risk Perception Survey for 
Developing Diabetes (RPS-DD) (Walker et al., 2003). 
Other measures 
Participant Characteristics 
Self-reported age, sex, ethnic background, employment, household income, postcode (to 
provide an Index of Multiple Deprivation [IMD] score) and education will be recorded. 
Participants will be asked to provide these details at appointment 1. 
Health, physical functioning and fitness 
HbA1c will be assessed at the first appointment using an Afinion AS100 point-of-care system 
(Alere Inc., Waltham, MA). Results will be processed following collection and samples 
disposed of immediately. Participants receiving a result ≥6.5% will be ineligible, readings of 
6-6.4% classified as pre-diabetic (National Institute for Health and Clinical Excellence, 2012) 
and readings of <6% classified as euglycemic. A measure of height will be conducted using a 
Seca stadiometer (Seca, Hamburg, Germany) and weight and body fat percentage measured 
using Tanita scales (Tokyo, Japan). Participants will be asked to remove their shoes and socks 
prior to these measurements. Two measures of waist circumference will be taken at the 
midpoint between the lowest rib and top of the iliac crest; if the difference ≥1cm, the two 
measurements will be repeated (World Health Organization, 2011b). Three measures of resting 
blood pressure will be recorded using an Omron digital monitor (Omron Corporation, Kyoto, 
Japan) with the first measure taken after the participant has remained seated for ≥10 minutes. 
A rest period will be enforced between each of the three measurements. 
Grip strength will be assessed using a handheld Takei dynamometer (Takei Scientific 
Instruments, Tokyo, Japan) whilst standing with hands positioned down each side. Participants 
will be asked to completed three trials on each hand with brief pauses in between to minimise 
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muscle fatigue (Canadian Society for Exercise Physiology, 2004). Quadriceps strength will be 
assessed using the DAVID G200 knee extension machine (David Health Solutions Ltd., 
Helsinki, Finland). Aerobic fitness will be assessed using the modified Canadian Aerobic 
Fitness Test (mCAFT) (Canadian Society for Exercise Physiology, 2004). The mCAFT is a 
sub-maximal step-test protocol with participants instructed to complete ≥1 three-minute stages 
of stepping at a speed dictated by an audio track. Heart rate will be monitored throughout with 
the stepping stages continued until heart rate ≥85% of age-predicted maximal heart rate. 
Participants’ scores for aerobic fitness will be defined according to the following formula: 
10*[17.2 + (1.29 x oxygen cost at the final stage) - (0.09 x weight in kg) - (0.18 x age in years)] 
(Canadian Society for Exercise Physiology, 2004). 
Behaviour change techniques 
Prior to starting the intervention, the researcher will implement the default settings for levels 
of physical activity (BCT 1.1: Goal setting [behaviour]) (i.e. 10,000 steps and 10 floors 
climbed) and glucose (BCT 1.3: Goal setting [outcome]) (i.e. 4.0-5.9 mmol/L). Participants 
will be fully informed that they can freely change the goals set for physical activity as preferred 
(i.e. should the default value be too easy/difficult) via the Fitbit app. However, participants will 
be advised to not make any changes via the LibreLink app for the target glucose range. 
Attainment of a goal will be assessed as either complete or incomplete. Participants will be 
asked to sync the Fitbit (at least once every five days) and scan the Freestyle Libre (at least 
once every seven to eight hours) if they are in the respective group to receive feedback from 
these devices. This action has a dual purpose; to minimise data loss and to encourage continued 
engagement with the technologies. Participants will also receive haptic feedback (BCT 7.1: 
Prompts/cues; i.e. a gentle vibration) as a reminder to move by the Fitbit 10 minutes prior to 
the end of each hour (default 09:00-18:00) if 250 steps have not been taken. The reminder to 
move prompt aims to encourage interruptions in prolonged sedentary bouts as is recommended 
by the UK physical activity guidelines (UK Department of Health, 2011b). In relation to the 
other behaviour change techniques, participants will be able to monitor physical activity levels 
using the Fitbit Charge 2 (BCT: 2.3 Self-monitoring of behaviour) and glucose levels using the 
Freestyle Libre (BCT: 2.4: Self-monitoring of outcome(s) of behaviour) which is a minimally-
invasive device that presents feedback about glucose (BCT: Biofeedback).  
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Data analysis 
Analysis of primary outcomes 
Ethica Data is a fee-for-service platform that will be used to provide time-stamped data relating 
to app usage. This is an app installed on participants’ phones and sits idle during the study 
period. The number of scans and syncs will be unobtrusively assessed using the free 
LibreLinkUp app (Abbott Diabetes Care Inc., Alameda, CA) and Fitabase (Small Steps Labs 
LLC., San Diego, CA), respectively. Fitabase is a fee-for-service platform that permits access 
to download 60 sec epoch Fitbit data (i.e. levels of physical activity) and remote monitoring of 
Fitbit devices (e.g. battery level and time since last sync event) via Bluetooth and Wi-Fi. 
Identification of moments where participants have decided to change the goal settings will be 
completed by accessing the online Fitbit account. The researchers will remotely access 
participants’ accounts daily between 18:00-19:00 to note goal settings; recording the date and 
previous/current settings for all metrics (e.g. step count) to help identify any changes. 
Analysis of secondary outcomes 
To assess eligibility, uptake and retention, we will monitor how many individuals complete the 
screening survey, how many meet our inclusion criteria and of these how many decide to enrol. 
In addition, the screening survey will also identify recruitment sources. Identifying non-usage 
attrition and dropout attribution is crucial to assess the feasibility of an intervention as they are 
both important but distinct constructs (Alkhaldi et al., 2016). Non-usage attrition, where 
participants have disengaged from the intervention but have not dropped out, will be defined 
as participants who attend appointment two but do not sync the Fitbit or scan the Freestyle 
Libre. Dropout attrition will be defined as participants who explicitly withdraw from the study 
via Ethica Health or direct contact with the research team. The number of participants who 
enrol into the full coverage (all 14 data sources monitored) or restricted coverage (only three 
data sources monitored) for Ethica Data will also be recorded. Diasend is a fee-for-service 
platform that permits access to download 15-min epoch data from the Freestyle Libre and 
remote monitoring of multiple LibreLink accounts. Descriptive statistics of the sample will be 
conducted. In addition, two-way repeated measures ANCOVAs will be conducted to assess 
changes in engagement (dependent) according to group (independent) having adjusted for 
participant characteristics. Similarly, two-way repeated measures ANCOVAs will be 
conducted to assess changes in physical activity (dependent) according to group (independent) 
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having adjusted for Fitbit wear time. All data will be analysed using Statistical Package for 
Social Sciences (SPSS Inc. Chicago, IL). 
Dissemination 
The present study aims to consider whether these technologies may have potential use in 
existing pre-clinical care pathways; how engaging with self-monitoring technologies 
(providing glucose plus physical activity feedback in combination) may positively influence 
rates of uptake, adherence, retention and behaviour change. This line of research will inform 
the development a full-scale randomised-controlled trial. We will publicise study findings 
online, present them at international conferences relating to diabetes, physical activity and 
digital health and publish via peer-reviewed journals.
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Appendix G 
Study Three: An outline of device deployment decisions. 
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An outline of the data collection procedures for the three wearable technologies deployed. 
 ActiGraph (wGT3x-BT) Fitbit (Charge 2) Abbott (Freestyle Libre) 
Devices 24 devices used 45 devices used 
157 devices used 
0 handheld readers used 
Sample rate 100 Hz (.gt3x file format) 60 seconds 900 seconds 
Epoch 60 seconds 60 seconds 900 seconds 
Initialisation 
Deployed in delay mode on day 0. 
Commenced logging on day 1 at 
00:00:00; stop time applied 7 days after 
Commenced logging data at point of 
initialisation on day 0 
Commence logging data 1 hour after 
point of initialisation on day 8 (Groups 1 
and 3) or day 29 (Group 2) and after any 
additional sensor applicationapps 
Deployment 
Fitted by participant (on day 0) with 
guidance from researcher 
Fitted by participant (on day 0) with 
guidance from researcher 
Fitted on day 8 by participant (using step-
by-step instructions and guidance from 
research team) to inform subsequent self-
deployment of sensors 
Location Anterior hip, mid-line of the right thigh Non-dominant wrist 
Upper portion, non-dominant posterior 
brachium 
Wear duration 
Baseline: 7 days (10,080 epochs) 
Intervention: Not worn 
Baseline: 7 days (10,080 epochs) 
Intervention: 42 days (60,480 epochs) 
Baseline: Not worn 
Intervention: 42 days (60,480 epochs) 
Wear 
instructions 
Continual wear except for sleep and 
water-based activities 
Continual wear except for sleep and 
water-based activities 
Continual wear (24hr) with adhesive tape 
over sensor 
Charging Not required 
Requested to charge overnight every 
day 
Not required 
Non-wear 
≥60 min of consecutive zeros with 
allowance for 2 minutes of interruptions 
coded as non-wear. 
An absence of heart rate signal. 
Duration of sensor (up to 14 days) and 
classify missing data between sensors. 
Valid day 
criteria 
≥10 hours of valid waking wear time ≥10 hours of valid waking wear time ≥90% of data points per day 
Valid file 
Baseline: ≥4 valid days (baseline) 
Intervention: Not applicable 
Baseline: ≥4 valid days 
Intervention: ≥24 valid days 
Baseline: Not applicable 
Intervention: ≥4 days 
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Appendix H 
Study Three: Standard operating procedure for the Fitbit. 
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Masking the Fitbit Charge 2 
General 
Tape over the whole screen on the device itself but reveal 
date and time.  
Inform of syncing protocol (Bluetooth and Wi-Fi ON 
simultaneously for at least 30 minutes) 
Once completed the following process, check that the device 
is updated (i.e. only shows floors) 
 
 
Official Fitbit app 
 
Dashboard: 
On the dashboard, scroll down and press ‘Edit’. Now de-select all metrics by pressing the 
grey buttons so they become pink. Now press ‘Done’. 
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Account settings: 
• Adjust the settings from default to the following numbers: 
 
 
 
 
 
 
 
 
 
 
 
• Ensure that Quick View is turned OFF and All Day Sync is turned ON 
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• Ensure that notifications are switched OFF 
 
 
 
 
 
 
 
 
 
www.fitbit.com/login 
 
 
Settings 
 
Notifications: 
• Untick all boxes except ‘Low Battery’ under the Mobile column. 
• Scroll down, select ‘No emails’ and click ‘Save’ 
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Charge 2: Ensure the device settings are set to the following: 
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Ensure it is the non-dominant – Left or Right 
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Appendix I 
Sttudy Three: Additional information of the technologies used. 
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Bit.ly 
Interested individuals were directed to the SIGNAL Study website via 
http://www.bit.ly/signalstudy. Employing this website URL also allowed the research team to 
quantify the number ‘clicks’ or website visits that resulted. 
 
An illustration of the bit.ly metrics 
SIGNAL Study website 
The SIGNAL Study website was constructed to advertise the study and offer the chance for 
interested individuals to access information about the study (including the participant 
information sheet). It also clarified that the research was being conducted at Loughborough 
University and offered direct access to the survey (via ‘Click here to access the survey’). 
 
 
The SIGNAL Study website 
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Qualtrics survey 
Upon clicking the link to access the survey, individuals were directed to complete a few 
questions to determine eligibility to take part. The survey, produced and published within 
Qualtrics (Qualtrics, Provo, UT) contained questions relating to demographics, body 
compositions and family history; mirroring questions used within the Diabetes UK Risk 
Assessment tool. To note, the question requesting waist circumference was amended to instead 
ask individuals to confirm their trouser waist size and fit. In combination, responses were used 
to calculate an approximate waist circumference measure. Using Qualtrics permitted access to 
individuals’ survey responses to identify and contact potentially eligible individuals. There 
were two version of the survey: (1) ‘SIGNAL Study’ – identified high risk and (2) ‘SIGNAL 
Study – Copy’ – identified moderate-to-high risk. The first version was published live initially 
but after changing the inclusion criteria to include moderate-to-high risk, the second version 
was published live. 
 
The Qualtrics dashboard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
lii 
 
Participant smartphones 
Participants were asked to install the following official applications. 
The applications installed onto the smartphones 
          
Screenshots of the Fitbit application 
                    
       Screenshots of the LibreLink application 
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Fitabase 
Fitabase is a fee-for-service online platform that allows access to minute-level data recorded 
by the Fitbit. Ordinarily, if data were to be exported from Fitbit directly, data would be recorded 
at a day level and would require only one sync every thirty days. Fitabase collects minute-level 
data by communicating with the official Fitbit application. The Fitabase dashboard (accessible 
via the research team) allows the opportunity to remotely monitor multiple Fitbit devices at 
one time. Fitabase records time-stamped logs of all syncs and battery status using data from 
the Fitbit application; allowing the researcher to identify compliance to syncing and charging.  
 
The Fitabase dashboard 
 
The Fitabase dashboard demonstrating battery status 
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Ethica Data 
Ethica Data is a fee-for-service platform that records data directly from a participant’s 
smartphone. Of note, Ethica Data allows the research team to remotely monitor enrolment into 
the study and data provision and monitor rate and regularity of incoming data. In the study, we 
employed fourteen data sources. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The (i) restricted (n=3) and (ii) full (n=14 data sources) coverage options 
 
An overview of three participants’ status to monitor data capture 
 
 
(i) 
(ii) 
 
 
lv 
 
An overview of the data sources monitored 
Data Source Description 
Location sensors  
     GPS Measures the precise location of the device using GPS sources. 
     Wi-Fi Monitors Wi-Fi signals in the surrounding environment. 
Motion sensors  
     Accelerometer Measures the acceleration forced applied to a device (Including 
force applied from gravitational pull). 
     Magnetic field Measures the ambient geomagnetic field. 
     Gyroscope Measures a device’s rotation. 
     Linear acceleration Measures the acceleration forced applied to a device (Excluding 
force applied from gravitational pull). 
     Gravity Measures the force of gravity that is applied to a device. 
     Orientation Measures the orientation of a device. 
     Pedometer Count steps taken by the participant. 
Contact network sensors  
     Bluetooth Monitors Bluetooth signals in the surrounding environment. 
Digital footprint  
    Screen state+ Records the time that the screen turns on or off. 
    Application usage+ Records how often an application is used. 
Other  
     Survey responses+ Records user responses to survey questions. 
     Battery status Monitors the battery status of a device. 
+Data sources included within the Restricted coverage of Ethica Data 
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LibreLinkUp 
LibreLinkUp is a free smartphone application used as a software platform for the present study. 
Downloaded from the Google Play Store, LibreLinkUp collects time-stamped data reflecting 
each time a participant scans the Freestyle Libre sensor. This offers a real-time record for all 
participants and logs the data. Because the Freestyle Libre relies on users scanning at least once 
every eight hours to avoid data loss, determining whether participants have exceeded this can 
be identified using data collected from LibreLinkUp. This software also permits the research 
team to view multiple participants simultaneously by offering real-time data of participants 
scanning behaviour. In accessing this data, the research team are also able to monitor non-
usage attrition. A maximum of 20 individuals can be monitored at one time so multiple email 
accounts of LibreLinkUp were employed for the study. 
 
 
 
 
 
 
 
 
 
 
 
The LibreLinkUp application 
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Diasend Clinic 
Diasend offers two different methods of setting up an account. Firstly, participants will have a 
personal account with Diasend (accessed only by the research team). This account permits the 
connection of a Fitbit and Freestyle Libre to subsequently retrieve data. To allow the research 
team to access each participant’s data, these individual accounts are linked to a single Diasend 
Clinic account. Diasend Clinic is a fee-for-service platform that allows a researcher (normally 
a healthcare professional) to connect multiple individual accounts to retrieve data. The 
connection setup with the Freestyle Libre (via the LibreLink application) offers 15-minute 
epoch data over the study duration. This data will offer insight into wear time (transfer from 
one sensor to the next) and data loss (adherence to scanning). 
 
The Diasend Clinic dashboard 
